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 Technological advancements of particle therapy for high-precision cancer treatment 
require in situ and in vivo beam range and dose verifications to ensure safe and accurate targeted 
dose delivery while sparing healthy tissue and critical organs-at-risk. The use of prompt gamma 
(PG) rays, which are emitted as secondary by-products during beam irradiation, have been 
proposed as a promising means for in vivo Bragg peak (BP) tracking. Although significant 
research efforts have been made worldwide in the past two decades, the technological 
challenges for clinically applicable PG detection device development and associated system 
integration with the particle therapy treatment still remain to be tackled. 
The research effort of this thesis was targeted at those challenges in PG detection 
methodology and technology. This work thus spans three major aspects: (i) Systematic Geant4 
simulation studies of PG emission and detection characteristics from multi-dimensions of 
energy, space and time. This study aimed to determine optimal PG detection methodologies and 
technologies. (ii) Characterisation of commercially available advanced scintillation crystals to 
explore suitable high-performance detectors for energy- and time-resolved PG measurements 
toward a potential hybrid PG detection system. The measurements were performed at the 
Australian Nuclear Science and Technology Organisation (ANSTO). (iii) Performance 
evaluation of Monte Carlo simulation predictions of PG rays with a dedicated PG spectroscopy 
(PGS) prototype system at the Massachusetts General Hospital (MGH) (Boston, USA). 
The PG emission characteristics were investigated for the most commonly used particle 
therapy ions of proton, 12C and 4He ion beam irradiations of both homogeneous (water, PMMA, 
adipose tissue) and heterogeneous (DICOM-formulated head phantom) targets, while the 
detectable PG characteristics were investigated by virtue of an air-filled idealised detecting 
sphere encompassing the phantoms. Several important results were obtained: the PG signal is a 
reliable means for in vivo BP tracking in particle therapy, particularly the primary PG rays; 
quantitative data showed that the PG-BP correlation holds for heterogeneous targets as well as 
homogeneous ones; a movable detector coordinated with respect to the beam range could 
optimise the PG detection efficiency; and the time-of-flight (TOF) information was seen to 
correlate with the particle beam range, and so can be utilised not only for interference 
background rejection but also for beam range extraction. Hence, a hybrid PG detection system 
that utilises the energy, spatial as well as TOF information could offer superior in vivo range 
and dose monitoring. 
Abstract xvii 
 
The energy- and time-resolved spectroscopy capabilities of several scintillation 
detectors were characterised, and showed that LaBr3(Ce) offered superior time (34 ns rise time, 
790 ns decay time) and energy resolution (3.5% at 662 keV). Elpasolite crystals, such as CLYC 
and CLLBC, have not yet been studied for the purpose of particle range monitoring using PG 
rays, but have the added ability of gamma-neutron discrimination, and thus have the potential 
for hybrid PG systems. In this work, CLYC was seen to offer a good energy resolution of 3.4% 
at 662 keV. 
The performance comparison between Monte Carlo simuations and experimental data 
from the MGH PGS system was the first comprehensive evaluation study of both PG signal 
intensity and the interference background in a realistic clinical condition. Several important 
results were obtained: the Geant4 QGSP_BIC_HP physics list showed a suitable prediction of 
the overall proton-induced PG emission lines, yet it slightly overestimated the PG lines in the 
lower energy region (1-3.5 MeV) and underestimated the PG lines in the higher energy region 
(5-7 MeV), whereas QGSP_BIC_AllHP provides a better overall spectrum base shape, 
compared with the measured gamma spectrum; future PG simulations may benefit from taking 
into account potential neutron sources in close proximity to the measuring device, to more 
accurately predict the PG signal; and simulation results can greatly depend on the Geant4 
version utilised, so it is recommended to perform regression testing on some physical 
observables among different versions of Geant4, including the latest one. 
In conclusion, hybrid PG detection that utilises multi-features of PG rays in energy, 
space and time dimensions is highly recommended. High-throughput and highly efficient 
detector systems are needed for simultaneous energy- and time-resolved PG measurements. The 
current physics lists in the Geant4 simulation package need further improvement for its 
prediction accuracy of PG emissions and interference backgrounds. The studies in this thesis 
pave an effective pathway in the development of clinically applicable and reliable PG 
procedures and detectors, which can further improve cancer treatment precision and release the 
full clinical efficacy of particle therapy. 
 
 




I would like to express my gratitude to a number of people, many of whom are members of the 
University of Wollongong (UOW) Centre for Medical Radiation Physics (CMRP), and the 
Australian Nuclear Science and Technology Organisation (ANSTO) in Australia, as well as 
Massachusetts General Hospital (MGH) in Boston USA. 
I thank my supervisor Dist. Prof. Anatoly Rosenfeld (CMRP) for his constant support, 
contribution and dedication to the completion of this project. 
I thank my supervisor Dr. Dale Prokopovich (ANSTO, MedAustron since July 2020) for his 
assistance and contribution to this project. 
I thank Assoc. Prof. Susanna Guatelli (CMRP) for her support and contribution to this project. 
I thank Dr. Yujin Qi (CMRP) for his constant support, guidance and contribution to this project. 
I thank Dr. David Bolst (CMRP) for his constant help with Geant4 throughout this project. His 
assistance is much appreciated. I also thank Dr. Valentina Giacometti for her help with the 
Geant4 DICOM Head Phantom. 
I thank Dr. Thomas Bortfeld (MGH) and Dr. Joost Verburg (MGH) for accepting me to join the 
Prompt Gamma team at MGH and their contribution to this project. My sincere gratitude goes 
to Dr. Fernando Hueso-González for his constant support during my time at MGH and for his 
contribution to this project. 
This research has been conducted with the support of the Australian Government Research 
Training Program Scholarship. 
We would like to thank the University of Wollongong Information Management & Technology 
Services (IMTS) for computing time on the UOW High Performance Computing Cluster. 
We would like to thank Australia’s National Computing Infrastructure (NCI) for computing 
time on the Raijin and Gadi cluster. We would like to thank the National Computational Merit 
Allocation Scheme (NCMAS) 2020 grant scheme which provided computing resources used in 
the thesis project. 
My warmest gratitude and many thanks go to the people who have stood by my side through 
this time of hard work and dedication, my good friends and my loving family, without whom I 
would not have had the strength to carry on each day. Thank you.  
 19 
 
1   Introduction 
1.1 General Aspects of Particle Therapy 
 Particle therapy uses beams of charged particles, such as protons or the heavier helium 
and carbon ions, to deliver radiation dose to patients for the treatment of cancers. Robert R. 
Wilson first proposed the use of protons as a method of radiation therapy in 1946 [1]. The first 
patient treatment was performed in 1954 at Lawrence Berkeley Laboratory (LBL), Berkeley 
USA [2], and then heavier ions followed at the Bevalac facility at LBL in1975 [3]. Then in 1990, 
the first hospital-based proton therapy facility opened at the Loma Linda University Medical 
Center (LLUMC) in California [4]. Since then, research and developments have paved the way 
for improvements in radiation therapy dose delivery accuracy and techniques. Currently, there 
are 98 proton therapy facilities and 12 carbon ion facilities in clinical operation worldwide [5]. 
 The goal of radiation therapy is to deliver a highly localised and uniform dose to the 
target volume to kill cancer cells while sparing normal healthy tissue. Unlike conventional 
photon beams which have a high entrance dose as well as exit dose, beams of charged particles 
deposit most of the energy at the end-of-range with little entrance dose and lateral scattering, 
where the particles stop inside the patient at the distal edge of the target volume. The maximum 
energy deposition at the particle beam end-of-range is called the Bragg peak (BP), where a 
mono-energetic particle beam produces a Bragg curve with a single pristine BP. By summing 
several pristine BPs of varied energies, a so-called spread-out-Bragg-peak (SOBP) can be 
achieved, where the dose is uniform and maximum across the entire target volume. Hence, dose 
can be conformed closely to the target volume. Figure 1 shows the depth dose comparison of 
photon and proton (pristine BP and SOBP) beams. Particle therapy therefore has the potential 
for higher probability of local control and disease-free survival, and lower probability of normal 
tissue damage [6], reducing the risk of side effects and further complications. Additionally, the 
enhanced relative biological effectiveness (RBE) of heavy ions is beneficial for the treatment of 
radio-resistant or paediatric tumours [7]. However, the ability to fully exploit the advantages of 
particle therapy and to release its full clinical efficacy is still limited by various uncertainties in 
predicting and determining the beam range within the patient [8]. These uncertainties, which are 
discussed in the next section, affect the achievable treatment precision and lead to the 
employment of clinical safety margins [9]. Therefore, in vivo range verification and dose 
monitoring in real-time are desired so to ensure high quality particle therapy treatment, 
eventually limiting collateral effects to organs-at-risk (OAR) close to the treatment target. 
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Although much progress has been made, these methods are still unavailable in clinical routine 
and this project contributes to fill the knowledge gap, towards a clinical implementation of PG 
detection for particle therapy Quality Assurance (QA). 
 
Figure 1: Depth dose curves for photon and proton (pristine BP and SOBP) beams. From Ref. [10]. 
1.2 Requirements and Challenges of in vivo Range Verification and 
Dosimetry in Particle Therapy 
 In charged particle therapy, there exists an unavoidable technical issue, referred to as 
beam range uncertainty [8,9]. Due to the electromagnetic interaction characteristics between 
charged particles and human tissues, the beam range is very sensitive to the tissue composition 
and density, and further complicated by multiple Coulomb scattering (MCS) and nuclear 
reactions. The ion beam BP position and beam range can therefore be difficult to estimate and 
determine. 
The main causes of beam range uncertainty arise from both treatment planning and 
treatment delivery [11]. There exists some degree of errors in converting Hounsfield units (HUs) 
of CT images into particle stopping power maps, which can result in an uncertainty in 
predicting the beam range in tissues during the treatment planning [9]. To address this problem, 
proton CT (pCT) is a technique under development that directly measures relative proton 
stopping power with respect to water; uncertainties in proton therapy can be reduced, such that 
the uncertainty in converting x-ray CT HU to relative stopping power (RSP) and x-ray CT 
artifacts can be eliminated [12-15]. Additional uncertainties arise from patient position set-up 
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errors, intra-fractional organ motion and anatomical changes during the course of the treatment 
delivery. 
These uncertainties can largely affect the treatment accuracy and precision of charged 
particle therapy, and the delivered dose may be different to the prescribed dose distribution, 
which can result in under-dosing the targeted tumour volume or over-dosing the adjacent critical 
structures and healthy tissues. Therefore, conservative safety margins have been generally 
adopted in current clinical practices. For example, MGH employs a proton beam range margin 
of 3.5% plus an additional 1 mm, which result in about 8 mm of tissue added to the treated 
target volume [9]. Yet, with range verification techniques, the margins could be reduced. 
Worldwide research efforts have been made to develop clinically applicable detector systems 
and procedures for reducing range uncertainties and the safety margins over the past two 
decades. 
As the technology advances to intensity modulated pencil beam scanning (PBS) with 
sharpening beam spots to give the precision of a scalpel [16], the influence of these uncertainties 
become more significant, which deeply affect the accuracy of the delivered dose to the tumour 
target and limit the advantage of the PBS conformity. Significant challenges of clinical 
dosimetry for PBS charged particle therapy have been comprehensively discussed in a recent 
review paper, Giordanengo et al. (2017) [17]. In this context, the method of safety margin 
would inevitably lose its effectiveness. Spot-by-spot based beam range verification in situ and 
in vivo dosimetry for 3D treatment verification is required. The combination of prompt gamma 
(PG) ray measurements with 4D CT and motion monitoring has been proposed to control the 
range and dose distribution [18]. 
Moreover, other factors to consider in the clinical implementation of an in vivo 
dosimetry system include: the system itself should not physically interfere with the delivery of 
treatment; the monitoring process should not lengthen the time in which the patient is in the 
treatment room, considering the high throughput of patient treatments and operational costs; and 
the system should be able to handle the delivery characteristics of short irradiation times and 
high treatment beam intensities [19]. 
1.3 Overview of in vivo Range Verification and Dosimetry Methods 
Several approaches for in vivo range verification and dosimetry have been and are 
currently being developed for particle therapy QA. The method can be classified as direct, such 
that the beam range is obtained directly from dose or fluence measurements, or indirect, such 
that the beam range is determined from other signals. In vivo range verification methods, both 
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direct and indirect, have been reviewed in Knopf and Lomax (2013) [20]. Here, indirect 
methods will mainly be discussed as they are more relevant to this thesis. 
Indirect range verification methods use the by-products of secondary radiations that 
occur during irradiation and escape the patient, since the primary beam stops within the patient. 
Secondary radiation may include gamma rays, such as PG rays used in the PG imaging (PGI) 
method, or photons coming from positron-electron annihilation which are used in the positron 
emission tomography (PET) imaging method. Neutrons, along with photons, can also be used to 
identify a correlation between secondary radiation and dosimetric parameters [21], but the 
associated detection challenges are greater than those of photons. Other methods include 
magnetic resonance imaging (MRI), interaction vertex imaging (IVI), secondary electron 
bremsstrahlung (SEB), and ionoacoustic tomography. 
 Prompt gamma for beam range verification in particle therapy is becoming increasingly 
popular. While traversing tissue, the incident ions undergo nuclear reactions whereby the 
nucleus is excited to a higher energy state, and decays by emitting gamma rays. If the gamma 
ray is emitted promptly, i.e. within a few nanoseconds, it is referred to as a prompt gamma (PG). 
As the energy of the incident ion decreases in the medium, the total non-elastic nuclear 
interaction cross section increases up to a few millimetres before the BP. Then, the inelastic 
reaction cross section begins to drop, such that the incident kinetic energy falls below the 
Coulomb barrier threshold [22]. Hence, the position of production of PG rays is well-correlated 
with the beam range, but it is not exact, as the PG emission and dose deposition result from 
different physical processes. Thus, a consistent PG-dose distal fall-off difference is required for 
beam range verification [23]. Further details on the physics of PG emission via nuclear 
interactions are given in Section 2.1. Since PG rays are emitted within a few nanoseconds 
following the nuclear interaction generating an excited nucleus in the medium, they offer the 
ability to perform real-time monitoring of the dose delivery. This is a major advantage 
compared to PET, for example, which gives a delayed signal and also suffers biological 
washout effects. Figure 2 shows a time scale of PG emission compared to PET gamma emission. 
Furthermore, PG rays have a wide energy spectrum, up to around 15 MeV [24], which are 
unique and characteristic to the element since the excited nuclear states are quantised. The 
discrete spectral lines therefore contain valuable information of tissue composition and 
elemental concentration for spectral analysis [25]. Other advantages of utilising PG rays are the 
absence of washout effects, on-line treatment monitoring without additional dose, and high 
count rates [20,23,26-28]. However, the use of PG rays for beam range verification is still 
unavailable in clinical routine as challenges remain in detection methodology and technology 
(further discussed in the next section), yet significant efforts continue to be pursued and are 
discussed in the next chapter of this thesis. 









Figure 2: Schematic showing the time scale in emission of a PG ray and PET gamma rays. 
 
 Positron emission tomography (PET) uses coincident 511 keV gamma rays resulting 
from electron-positron annihilation. Inelastic interactions of protons with atomic nuclei can 
create positron-emitting isotopes (e.g. 11C, 13N and 15O [29]) via β+-decay. Positrons then 
annihilate with electrons of the target, resulting in the emission of two coincident annihilation 
photons of 511 keV, emitted in opposite directions [30]. For proton beams, β+-activation only 
results from induced target fragmentation, whereas for heavier ions the activation may arise 
from projectile as well as target fragmentation [31]. Hence the activation is dependent on the 
tissue composition, making the relationship between induced activity and dose distributions 
complicated, such that the same dose distribution delivered to different geometries/tissue 
composition results in different activity distributions [20,32]. Also, the PET signal is generated 
from various radionuclides of different half-lives, which translates to a change of the activity 
distribution with time, so PET imaging for range verification is sensitive to the time of data 
acquisition [31]. Similarly to PG emission, the threshold energies for β+ radioisotope production 
causes the activity distribution to fall before the incident particle dose distribution fall-off [29]. 
Hence, PET measurements must be compared with predicted activity distributions [31], such as 
from Monte Carlo calculations or a convolution of the dose distribution with a filter function 
[20,33]. PET imaging can be performed on-line (during irradiation) or off-line (a certain time 
after the treatment is completed) [29]. On-line allows shorter imaging times (however gaining 
sufficient statistics is important) and it minimises the effect of biological washout, patient 
repositioning errors and anatomical morphological changes since PET data are acquired with the 
patient at the treatment position, whereas off-line does not require capital investment for the 
installation of a scanner in the treatment room and has no impact on the patient treatment 
throughput [20,29,31]. 
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 Magnetic resonance imaging (MRI) reveals changes in the formation of human tissue 
caused by radiation. It involves imaging the nucleus of the hydrogen atom (i.e. the proton) 
which is abundant in the human body. The angular momentum of a positively charged proton 
produces a nuclear magnetic moment. In the absence of an external magnetic field, a collection 
of these moments (or spins) will have random orientations which results in zero net 
magnetisation, while in an external magnetic field each spin will align either parallel or anti-
parallel to the direction of the applied field. A radiofrequency (RF) coil is used for signal 
reception, to detect the rotating magnetisation, such that the changing magnetic flux through the 
coil induces voltage changes that are subsequently detected by a receiver [34]. For beam range 
verification, visual inspection of MRI images alone is not sufficient since the location of 
greatest signal intensity (SI) gradient does not exactly correspond to the greatest dose gradient, 
instead a relationship between dose and SI must be established. A dose-SI curve for fatty 
marrow conversion has been established for a data set of 10 spine patients, and used to estimate 
range errors in the lumbar spine distal dose fall-off region [35]. Similarly, a conversion has been 
established with a data set of 5 liver patients [36]. MRI scanners are widely available, the 
imaging offers superior soft tissue contrast and high spatial resolution, with no additional 
ionising radiation exposure. However, temporal evolution i.e. side-effects of irradiation (hours 
to days later) such as cellular depletion, haemorrhage etc, may interfere with the MRI signal as a 
result of fatty replacement. As well, a ground truth dose-SI relationship is essential. In summary, 
despite the advantages of MRI, the availability of such scanners, and previous studies showing 
promising outcomes, further work is necessary for the use of MRI for in vivo range verification 
[20]. 
Interaction vertex imaging (IVI) is based on the detection of secondary particles (such 
as protons that escape the patient) to reconstruct nuclear emission vertices. First proposed by 
Amaldi et al. (2010) [37], the technique has been studied in simulations [38-40] and 
experiments [39,41,42]. Popular for carbon ion therapy, IVI offers the ability for real-time 
monitoring since the secondary particles are emitted and detected promptly during irradiation. 
Yet, since the energy of incident carbon ions decreases significantly at the end-of-range, the 
corresponding secondary particles produced in this region will also be of low energy and so may 
not escape the patient for detection. Hence, IVI may not offer a method to directly measure the 
BP position, but using information from the distribution of reaction sites superficial to the BP 
can allow indirect localisation [40]. Two methods of IVI for real-time BP localisation have been 
described in an early study [38]: single-proton IVI (SP-IVI) where the vertex is reconstructed 
using the incident carbon ion trajectory that is determined by a beam hodoscope; and double-
proton IVI (DP-IVI) which detects coincidence between two protons emitted from the same 
vertex. This study found SP-IVI to be the more promising technique, with target thickness and 
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ion energy having a major influence on reconstructed vertex profiles. In a recent study [40], the 
group combined SP-IVI and DP-IVI, using a novel Triangulation IVI technique for reliable sub-
millimetre BP localisation, and developed a software filter used to classify secondary particles 
as appropriate candidates for reconstruction. The study also identified the relationship between 
the distal edge of the filtered vertex distribution and the BP position using a sigmoid fit of the 
entire distal edge, rather than using an inflection point as in previous studies [38,39,41]. With 
improved detector technologies, such as a larger area for reasonable statistics to produce useful 
images and accurate reference distributions for verification, IVI has the potential to be clinically 
implemented for carbon ion therapy range monitoring [40]. 
Secondary electron bremsstrahlung (SEB) involves the detection of bremsstrahlung 
along the beam path to monitor proton [43,44] and carbon ion [45,46] therapeutic beams. 
Bremsstrahlung radiation is produced through the acceleration or deceleration of a charged 
particle (such as the electron) passing through the electric field of a nucleus. An early 
experiment showed that the SEB process provides the dominant bremsstrahlung contribution 
[45], and in agreement with simulation results for the characteristic shape of the bremsstrahlung 
spectrum, the group demonstrated the feasibility of the method to estimate the ion beam range. 
Similar to PGI, a gamma camera is placed perpendicular to the ion path to acquire a distribution 
of the SEB production positions along the beam axis, with pinhole cameras [43,44,46] and slit 
collimators [43] being used in studies. Since SEB is emitted promptly, the method does not 
suffer from washout effects. As well, the sensitivity can be improved since the emission 
intensity is relatively large (compared to PG and PET gamma rays) and high-sensitivity imaging 
devices (collimators and detectors) can be easily fabricated for low-energy photons such as SEB 
[46]. Yet, the SEB method is limited by the background of PG rays, annihilation photons, 
scattered beam particles and secondary particles produced by the beam. The distribution of SEB 
from carbon beams extends beyond the BP position due to fragment components that penetrate 
beyond the BP and generate SEB, whereas this affect is not an issue for proton beams. Further 
work is being conducted for SEB therapeutic beam range estimation, where reducing the 
interference background and improving detection efficiency and sensitivity are required for 
clinical applicability [44,46]. 
Ionoacoustic tomography employs the thermoacoustic waves generated by the ions as 
they traverse tissue, whereby localised heating of the medium and a corresponding pressure 
pulse result from the ions’ energy deposition [47]. The ultrasonic pressure waves are detected 
by an ultrasound transducer, where the arrival time of the detected pulses relative to the beam 
pulse time is directly proportional to the distance from the BP to the detector. This provides the 
basis of the BP localisation within the patient [48]. The ionoacoustic signal depends on 
parameters such as the beam pulse width, energy, spot size, transducer position and sensitivity, 
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and measurement noise, where the signal amplitude corresponds to the dose deposition [47-49]. 
Multiple transducer detectors may be used to reconstruct a tomographic image of the dose 
distribution [49]. Ionoacoustic range monitoring has the potential to be simpler and more 
accurate for BP localisation than nuclear-based techniques [47] such as PG, PET and SEB. 
Studies indicate the possibility of BP localisation with about 1 mm accuracy [49] and the 
potential for sub-millimetre precision with new or next generation ion accelerators [47]. This 
method has the advantage of real-time feedback, the spatial resolution is relatively better and 
ultrasonic instrumentation is generally less expensive than nuclear-based methods [48]. 
However, in clinical conditions where the ion energies are high, challenges include an increased 
noise, lower signal amplitude (due to the greater spread in dose deposition), density differences 
in heterogeneous tissue, and generally higher signal attenuation [47,49]. Since this method relies 
on beam pulses, localising the SOBP can also be achieved by monitoring all pulses that make up 
the SOBP. Improved resolution, reduced noise and increasing the sensitivity of detection are 
necessary for the clinical application of ionoacoustic tomography for in vivo dosimetry in 
particle therapy [48,49]. 
On the other hand, direct methods of in vivo dosimetry utilise detectors positioned on or 
in the patient for dose or fluence measurements. Such detectors include diodes [50], metal oxide 
semiconductor field effect transistor (MOSFET) detectors [51,52], plastic scintillation detectors 
(PSDs) [53,54], thermo-luminescence dosimeters (TLDs) [55], among others. However, direct 
methods are invasive, such that detectors may need to be positioned on the patient skin surface 
or within body cavities. As well, dosimeters require calibration to obtain dose, they may suffer 
from an energy, angular, temperature or LET dependence, sensitivity changes with accumulated 
dose, and corrections [56]. These direct dose measurements are generally limited to specific 
locations and provide limited information of point doses only. Challenges are not only on the 
dosimetry itself, but also on the placement at suitable locations to extract meaningful 
information. Hence, indirect methods such as the PG method may be more favourable in 
specific cases, particularly because they eliminate the need for invasive procedures. 
The PG signal not only offers information on the BP position and range but also 
provides tissue composition and density information, which could offer a desirable means for in 
vivo dosimetry in particle therapy. That is, range verification is the determination of the BP 
position whereas dosimetry requires accurate tissue composition and density information to 
convert CT numbers into RSP. The PG signal can provide both information and thus lead to in 
vivo dosimetry. 
1   Introduction 27 
 
1.4 Challenges of in vivo Range Verification and Dosimetry Using 
Prompt Gamma 
This project was aimed at the characterisation and development of PG techniques for in 
vivo beam range verification during charged particle therapy treatment and further advancing 
toward in vivo delivered dose verification. The PG-based method has been considered as the 
most promising since it can provide in vivo, in situ and real-time range assessment during 
treatment delivery [57]. Using the PG method, information of range shifts or deviations of the 
range from the prescribed treatment plan can be obtained, and the delivered dose distribution in 
the patient could be reconstructed with Monte Carlo simulation calculations. Thus, the delivered 
dose distribution could be verified in vivo as well. 
Several major challenges are currently present in the development of clinically 
applicable and reliable devices and procedures regarding the PG method [19,57]. These include: 
(i) PG detection challenges: PG rays are generated from different nuclear reactions and have 
a broad and relatively high-energy range (between 2 and 15 MeV) [24], compared to PET, 
with strong interference background from neutrons and other stray radiations. PG 
detection systems must face a complex compromise or trade-off between the PG signal 
and the background. Innovative detection methods, by utilising either or complementary 
features of PG ray characteristics in spatial, energy and timing dimensions, are pursued to 
extract the PG signal from the background. Several types of detection methods and 
techniques, utilising either imaging or non-imaging capabilities, have been proposed and 
extensively explored worldwide over the past decade. Such detection methods and 
techniques are further discussed in the next chapter of this thesis. 
(ii) PG-based indirect in vivo dosimetry challenges: The correlation between PG emission 
and dose is complicated since the two result from different physical processes. Factors 
include the knowledge of tissue composition, attenuation of gamma rays within the target, 
the yield of PG rays emitted from various tissues and the intensity of the characteristic 
emission lines [58]. For accurate dose calculation, not only does the CT number to RSP 
conversion need to be accurate, but the detector energy resolution must also be superior to 
produce sufficient PG emission spectra. Studies on the correlation between PG 
measurements and relevant dosimetric parameters are still mostly lacking. 
(iii) Clinical environment and workflow constraints: These include the limitation of 
acceptable device size and weight incorporation into the treatment gantry. A compact and 
light weight PG system with low footprint set-up would be more favourable in clinical 
practice. 
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(iv) Beam delivery time structure and intensity constraints: In a PBS treatment, spatially-
resolved range verification requires spot-by-spot assessment. The macro time structure of 
the treatment beam imposes extreme load tolerance, electronic throughput capability and 
stability of the PG detection system against load leaps. The millisecond-level 
measurement time for individual beam spots may have statistical issues for both 
mechanical and electronic collimation based PGI systems to obtain adequate statistics for 
in vivo range verification. 
To overcome these challenges, the PG detectors play a crucial role. Hybrid PG 
detection methods with energy- and time-resolved detectors may be necessary to overcome the 
challenges of a broad- and high-energy PG distribution with dominating background 
interferences. High-resolution and high-performance novel detector systems with fast 
electronics for high-throughput processing are required. As reviewed in Pausch et al. (2020) 
[19], the key detector parameters required for a hybrid PG system have already been achieved 
[59-64], such as an energy resolution of 1.2-1.3% at 6.1 MeV, a time resolution (CRT) of 250 
ps at 4.5 MeV, 1 Mcps tolerable detector load, 500 kcps electronic throughput at tolerable 
detector load, 0.1% gain stability, and for detector/array sizes of 1 cm2 with 3-5 cm thickness 
for sufficient gamma ray absorption. However, achieving these requirements simultaneously for 
hybrid PG systems is the challenge. 
Furthermore, in vivo range verification and dose monitoring based on a PG method 
(developed methods and those under development are described in Chapter 2) would, in general, 
rely on comparing the reconstructed PG signal or dose in the patient with expected outcomes 
from theoretical calculations, to determine deviations from the prescribed treatment plan. Monte 
Carlo simulations, modelling particle transport and interactions in a medium, play a crucial role 
in obtaining such expected outcomes, calculating important physical quantities such as spatial 
distribution (1D, 2D, 3D), energy spectra or timing profiles [65]. Monte Carlo simulations are 
also important in PG system design and feasibility studies, supporting the development of a 
detector system for PG range monitoring in particle therapy. Yet, there are challenges with the 
Monte Carlo modelling that should be improved to advance the reliability and accuracy of the 
predictions for clinical implementation of PG rays for range/dose verification. Important aspects 
to consider include improving the accuracy of physics models in Monte Carlo simulations, 
increasing the speed of calculations, validation of the applied Monte Carlo codes, comparing 
measurements and expected results for heterogeneous targets, and analysing uncertainties 
(quantifying the influence of CT calibrations, etc) [65]. These will be discussed further in 
Section 2.4. 
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1.5 Research Scope and Motivation of this Thesis 
 Although significant research efforts have been made and prototype detection systems 
developed, PG range verification remains absent in clinical routine. Dose monitoring using PG 
rays requires further research efforts, particularly on the methodology and technology. The 
technique requires real-time BP tracking as well as on-line quantitative element analysis of 
tissue in the BP region. The latter can be achieved via PG spectral measurement and analysis, 
such that the obtained tissue composition information along with the CT numbers from the 
treatment planning system (TPS) may be used to accurately determine the tissue dose. This 
thesis therefore spans three major areas of work: 
(i) Geant4 Monte Carlo simulations investigating the emission and detection (for an ideal 
case) characteristics of PG rays from particle beam irradiations for potential hybrid 
systems. Hybrid PG detection systems, utilising multiple features of PG rays 
simultaneously, such as energy and TOF information, may significantly improve PG 
range monitoring and toward in vivo dosimetry. Recommendations on optimal PG 
detection methodologies and technologies resulted from this work. 
(ii) Exploring suitable detector technology for energy- and time-resolved PG measurements. 
The wide energy range of PG emissions and instantaneous count rates calls for high 
resolution, fast and efficient gamma ray detector technology. Thus, experimental studies 
were performed to investigate a suitable choice for fast PG measurements from a range 
of commercially available scintillation detectors. 
(iii) Studying the performance of simulations used for PG range verification and dose 
monitoring in a more realistic, clinical scenario. Clinical PG measurements have been 
compared to expected outcomes obtained from Monte Carlo simulations to quantify the 
accuracy of the results deriving from the in-silico calculations. This study is important 
because of the extensive use of Monte Carlo simulations to develop PG detection 
systems, and in practice, whereby the PG range/dose monitoring method may rely on 
comparing measured data with expected outcomes to determine deviations from the 
prescribed treatment plan. 
The novelty of this project is such that it combines several areas of research to improve 
the techniques (detection methodology and technology) and resources (simulation codes which 
play a major role in both research and clinical practice) of using PG rays for BP tracking and 
toward in vivo dosimetry in particle therapy. Furthermore, the characteristic properties of PG 
emission and detection have been investigated for proton and carbon ion beam irradiation, as 
well as helium ions for which the PG distributions have not yet been widely studied. The work 
of this thesis will aid in developing optimal strategies of PG detection for real-time dose 
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monitoring in particle therapy and support the implementation of clinically feasible PG systems 
for improving cancer treatment QA. 
The work involved in this project was conducted at three major sites: the Centre for 
Medical Radiation Physics (CMRP) at the University of Wollongong, Australia, the Australian 
Nuclear Science and Technology Organisation (ANSTO) in Lucas Heights, Australia, and the 
Massachusetts General Hospital (MGH) in Boston, USA. Geant4 simulations to characterise PG 
emission were performed at CMRP, thanks to the UOW IMTS High Performance Computing 
(HPC) Cluster and access to Australia’s National Computing Infrastructure (NCI) Raijin and 
Gadi. Detector characterisations to determine a suitable scintillation detector for fast and 
efficient PG ray measurements were performed at the Nuclear Stewardship facility at ANSTO. 
TOPAS modelling and clinical PG ray measurements were performed in the Radiation 
Oncology Research Department and Francis H. Burr Proton Therapy Center at MGH. 
 Since this project spans across three different areas of work, Chapters 3-5 of this thesis 
each present a research topic, while Chapter 2 presents a literature review of particle therapy 
and the role of PG rays for in vivo beam range verification and dosimetry. Chapter 3 contains 
the simulation work performed at the CMRP to characterise the emission and detection 
properties of PG rays. Chapter 4 presents the experimental measurements performed at ANSTO 
to characterise several scintillation detectors and determine a suitable choice for PG ray 
measurements. Chapter 5 shows simulation and experimental work performed at MGH in 
relation to the MGH PG detection system prototype. Finally, Chapter 6 presents a summary of 





2   Literature Review 
2.1 The Physics of Particle Therapy 
Charged particles, such as protons, alpha particles and heavier nuclei, undergo two 
fundamental interactions with the atoms of the tissue they traverse, electromagnetic and nuclear 
interactions. Electromagnetic interactions are Coulomb interactions with atomic electrons – 
which results in energy loss via ionisation of target atoms and determines the range of the 
particles – or with the atomic nucleus – which results in lateral scattering and determines the 
lateral beam spread. Nuclear interactions are particle-nucleus interactions that contribute 
significantly less to energy loss but results in the loss of beam fluence and the generation of 
various secondary particles such as protons, neutrons, gamma rays and light fragments [22]. 
Figure 3 shows illustrations of the particle interaction mechanisms. 
 
Figure 3: Illustration of particle interaction mechanisms: electromagnetic interactions (a) inelastic 
Coulomb interaction of the particle with atomic electrons (energy loss) and (b) elastic Coulomb scattering 
of the particle with atomic nucleus (lateral scattering/beam spread), and nuclear interactions (c) non-
elastic interaction of the particle with the atomic nucleus (loss of beam fluence and fragmentation). (p: 
proton, e: electron, n: neutron, γ: gamma ray). From Ref. [22]. 
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2.1.1 Electromagnetic Interactions 
 2.1.1.1 Energy Loss 
 For moderately relativistic charged particles (the general case in particle therapy) the 
predominant energy loss of the particles is via inelastic Coulomb interactions with atomic 
electrons i.e. ionisation and excitation of the atomic shell electrons. An electron ejected from the 
atom, called a delta (𝛿) ray, may have enough energy to cause ionisation itself along a separate 
track from the primary particle. The energy loss via Coulomb interactions with the atomic 
nucleus is minor [65]. 
The energy loss can be quantified by the stopping power 𝑆 (or LET, described later in 
Section 2.1.3) with units of energy/distance given by the differential energy loss for the particle 
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The stopping power describes the mean energy loss as it is defined for a beam, not an 
individual particle [22]. For a large energy range in terms of mean energy loss and shell 
















+ 𝑍 𝐿 (𝛽) + 𝑍 𝐿 (𝛽) + 𝐿 (𝛽)        (2) 
where 𝑒 is the electronic charge, 𝑁  is Avogadro’s number, 𝑚 is electron mass, 𝑍  is the charge 
number of the projectile, 𝛽 is the relative velocity of the projectile, 𝑍  is the atomic number of 
the material, 𝐴  is the molar mass of the material, 𝜌 is density of the material, and 𝐼 is the mean 
ionisation potential/excitation energy of the material. 𝛽 = 𝑣/𝑐, where 𝑣 is the velocity of the 
projectile and 𝑐 is the speed of light, and 𝛾 = (1 − 𝛽 ) / . 𝐶 is the shell correction term, 𝐿  is 
Barkas correction, 𝐿  is the Bloch term and 𝐿  is Mott and density corrections. Due to the 1/𝛽  
dependence, the energy loss increases as the particle energy decreases. The Bethe-Bloch 
formula is generally considered accurate at high energies, while other models are used to 
describe energy loss at lower particle energies such as the Lindhard theory [73] (where 𝛽 
becomes less than the orbital electron velocity) and the Anderson-Ziegler model [74] (where the 
Bethe-Bloch and Lindhard models can be joined by a polynomial). Detailed discussion of the 
Bethe-Bloch formula can be found elsewhere [7,69-72]. 
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As the particles continue to lose kinetic energy, they eventually come to a stop, and so 
the range is often referred to as the continuous-slowing-down-approximation (CSDA). The 
CSDA range as evaluated from the stopping power is: 
𝑅 = 𝑑𝑥 =
𝑑𝐸
𝑑𝐸/𝑑𝑥
                                                       (3) 
where 𝐸 is the initial energy and 𝐿 is the maximum range. The continuous ionisation energy 
losses of charged particles are normally modelled in Monte Carlo codes analytically (down to 
~2 MeV), based on a continuous-slow-down-approach that builds on the Bethe-Bloch equation, 
including relevant correction factors for 𝑍  [65]. Thus the range (like the stopping power) is 
essentially an average quantity defined for a beam, not for individual particles [22]. Figure 4 
shows the mass stopping power and corresponding range as a function of proton energy in water. 
The Bethe-Bloch formula shows that the energy loss is proportional to the inverse square of the 
particle velocity (1/𝑣  classically and 1/𝛽  relativistically) and the square of the ion charge, 
with no dependence on the projectile mass. Since the energy loss is predominantly due to 
Coulomb interactions between projectile and atomic electrons, the linear stopping power is also 
proportional to the material mass density (𝑁 𝜌𝑍 /𝐴 ) [22]. For the same energy per nucleon 
the proton range is about three times the range of 12C, while protons and 4He ions have the same 
range at the same velocity [69]. 
 
Figure 4: Plots showing the mass stopping power 𝑆 as a function of proton energy 𝐸 in liquid water, and 
the corresponding range 𝑅 calculated using the 𝑆 values with the CSDA. From Ref. [22]. 
 
The shape of the Bragg curve (position and height of the BP) is governed by several 
factors such as energy loss and stopping power, the removal of primary particles and the 
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emission of secondary particles from nuclear reactions, and the accumulation of lateral 
deflections from MCS (see Figure 5). As the particle velocity decreases with penetration depth, 
the interaction cross section increases and the energy loss increases, thereby causing the 
characteristic BP [22]. Additionally, as the particles slow down they get partly neutralised by 
the material through electron pickup, which reduces the particles’ effective charge (𝑍 )  or 
𝑍  (which must replace 𝑍  in equation 2) and therefore the Bragg curve exhibits the sharp fall-
off as the particles lose energy and stop [65,66]. The statistical fluctuation in energy loss of the 
particles cause the broadening in the BP, generally referred to as energy straggling or 
longitudinal straggling. The energy loss straggling is described by the asymmetric Vavilov 
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where 𝜎 = 4𝜋𝑍 𝑍 𝑒 𝑁∆𝑥(1 − /1 − 𝛽 ) . The energy loss variance 𝜎  can be used to 
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From this equation, the range straggling variance as a function of depth 𝑥  in the 






                                                            (6) 
where 𝑁 is the material electron density and 𝑧∗ is the effective charge of the projectile. 









                                                               (7) 
where 𝑓  is a slowly varying function that depends on the material [79]. Due to the 1/√𝑀 
dependence, the relative straggling is smaller for heavier ions than for protons e.g. a factor of 
3.5 for 12C ions [7,69]. 
Energy loss straggling varies with distance along the particle track; initially the 
distribution is narrow but becomes wider and more skewed with depth, and before the particle 
range the distribution narrows again due to the significant decrease in mean particle energy (see 
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Figure 5) [66]. Although the energy loss from MCS is negligible, it also contributes to lateral 








Figure 5: Left: Shape of a mono-energetic pristine BP (absorbed dose 𝐷 vs depth 𝑧) for an initial 154 
MeV broad proton beam. The protonic buildup region (buildup of secondary protons) is mainly attributed 
to proton-induced non-elastic nuclear interactions. The sub-peak region is where the stopping power’s 
dependence on the inverse-square of the proton velocity is most significant, nuclear reactions cause 
removal of protons and liberation of secondary particles, and accumulation of lateral deflections (very 
small fields) from MCS. (𝑧BP, 𝑧d80, 𝑧d20: depth of maximum dose at the BP, distal-80% and distal-20% 
depths, respectively. 𝑙 80-80, 𝑙 d80-20: 80%-to-80% pristine peak width, distance between distal-80% and 
distal-20% depths, respectively). From Ref. [22]. Right: Energy E distributions of an initially mono-
energetic beam of charged particles along penetration depth X. From Ref. [66]. 
 
 2.1.1.2 Lateral Beam Spread 
The beam spread is predominantly caused by elastic Coulomb interactions with atomic 
nuclei, but secondary particles produced by nuclear fragmentation reactions also contribute to 
the spread. Single scattering gives a small deviation angle on average, while plural scattering 
refers to a greater number of Coulomb scattering events but less than a few tens of interactions 
which occurs in thin targets [69]. In thicker targets, MCS dominates the lateral scattering and 
hence the beam spread. A theoretical calculation of the scattering angle was performed by 
Molière (1948) [80], and other more practical derivations have been performed [81-84]. For 
small angles, the angular spread can be approximated by a Gaussian distribution with a standard 













                                  (8) 
where 𝑑 is the thickness and 𝐿  is the radiation length of the absorber material. This equation 
shows that the angular spread increases for thicker targets and materials of higher atomic 
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number. The scattering for a particular particle decreases at higher energy due to the 1/𝛽𝑝𝑐 
term [69]. For particles with the same range, the heavier ions undergo smaller scattering e.g. the 
angular spread for 12C ions is three times less than that for protons for a 15.6 cm range in water 
(150 MeV protons and 285 MeV/u 12C ions) [7]. 
 The angular beam spread in practice arises mainly from two sources: scattering caused 
by materials in front of the patient, and scattering within the patient. At low energies, the former 
represents the dominant contribution due to the distance (0.5-1.0 m) the beam travels before 
entering the patient, while the latter is the dominant contribution at higher energies due to the 
larger penetration depths [7]. Although MCS in the scattering foils in the treatment head allows 
the beam to spread laterally to useful dimensions in proton therapy, MCS in the treatment head 
and patient blurs lateral penumbral sharpness. These factors, as well as implanted metal objects 
such as fiducial markers, need to be considered in clinical practice regarding the effects of MCS 
[22]. 
2.1.2 Nuclear Interactions 
Charged particles may interact elastically or non-elastically with the atomic nucleus. In 
elastic collisions, the kinetic energy is conserved and the nucleus remains intact; they are due to 
strong rather than electromagnetic interactions, and although do not occur frequently they still 
cause broadening of the beam. On the other hand, in non-elastic collisions the total kinetic 
energy is not conserved, whereby the nucleus is transformed and secondary particles may be 
knocked out by the projectile [22,65]. As discussed in Section 1.3, it is these secondary particles 
that may be used for beam range verification/dosimetry in particle therapy treatment delivery. 
To enter the nucleus, particles need to have sufficient energy to overcome the Coulomb 
barrier of the nucleus, which depends on its atomic number. The Coulomb barrier can be 
described by 𝐵 = 𝑍𝑧𝑒 /𝑅, where 𝑍 and 𝑧 are the atomic numbers of the projectile and target, 𝑒 
is the electric charge, and 𝑅  is the distance (cm) at which the Coulomb repulsion can be 
overcome [85]. In the atomic nuclei of biologically relevant elements, such as oxygen and 
carbon, the total inelastic cross section for proton-induced nuclear reactions has a threshold of 
the order of 8 MeV [22]. 
Gamma rays emitted via de-excitation of the nucleus have energies that are essentially 
equal to the difference in energy between the initial and final nuclear states. PG emission 
usually occurs without beta decay, depending on the reaction channel, but if so then the gamma 
rays will appear with a half-life characteristic of the parent beta decay but with energy reflecting 
the energy level structure of the daughter nucleus [66]. Prominant PG ray emissions include: 
2.23 and 2.74 MeV (single escape peaks), 5.11 MeV (double escape peak), and 5.62 and 6.13 
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MeV (single escape peaks) from 16O; 4.19 MeV (double escape peak), and 4.70 and 5.21 MeV 
(single escape peaks) from 15O; and 3.42 MeV (double escape peak), and 3.93 and 4.44 MeV 
(single escape peaks) from 12C [86]. 
The spatial distribution of the absorbed dose is therefore altered by the presence of 
nuclear interactions, since some of the kinetic energy that would be deposited as local ionisation 
and excitation is instead carried away by neutrons and gamma rays [86]. The correlation 
between incident particle dose deposition and PG ray emission is therefore not one-to-one, since 
(at typical particle therapy energies) charged particles deposit dose primarly by imparting 
energy to atomic electrons through electromagnetic interactions whereas PG rays (and positron 
emitter production in the PET method) arise from nuclear reactions. 
Nuclear interactions cause a significant loss of beam fluence and a build-up of lower-Z 
fragments. This becomes more pronounced with increasing penetration depth, for which the 
exponentially diminishing flux of primary particles causes the peak-to-entrance dose ratio to 
gradually decrease [7]. Nuclear fragmentation is an important aspect in particle therapy, 
particularly heavy ion therapy. In a typical carbon therapy treatment, only 50% of the primary 
ions reach the BP while the remaining undergo fragmentation [69]. The fragments contribute to 
the broadening of the BP due to straggling, and move (typically forward directed) with 
approximately the same velocity as the incident particles, which generally have longer ranges 
and thus cause the dose tail beyond the BP (also more pronounced at larger depths) [7]. Figure 6 
shows an example of the depth dose profiles of primary 330 MeV/u 12C ions and the associated 
secondary fragments (left), and build-up curves of secondary fragments produced by 400 
MeV/u 12C ions (right), in water. In practice, where opposite beams are used, the dose tail is 
within the high dose region in the patient, but in single beam angles projectile fragmentation 
becomes non-negligible to the normal tissue dose. This is a concern for normal tissue effects in 
heavy ion therapy, whereas in proton therapy the concern is target fragmentation [69]. 
In most Monte Carlo codes, the probability of the incident particles not having 
undergone a nuclear interaction after travelling a distance 𝑥, or in other words the number of 
particles remaining at depth 𝑥  (which depends on the inelastic nuclear cross section), in a 






                                                            (9) 
where 𝑁(0) is the number of incident particles, 𝑁(𝑥) is the number of incident particles after a 
distance 𝑥, and the mean free path or interaction length is given by 𝜆 = 𝐴 /𝑁 𝜎𝜌, where 𝜎 is 
the total cross section [65]. 
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Figure 6: Left: Depth dose profiles of primary 330 MeV/u 12C ions and the associated secondary/tertiary 
fragments in water. Right: Build-up curves of secondary fragments produced by 400 MeV/u 12C ions in 
water. From Ref. [87]. 
 
The modelling of nuclear reaction processes involving protons and heavier ions are 
slightly different; Figure 7 illustrates the reaction process of protons and that of heavier ions 
with target nuclei. Proton-nucleus interactions initiate a series of nucleon-nucleus collisions 
which leads to the emission of secondary particles and to equilibration of the remnant nucleus. 
This process can be described in three stages: intra-nuclear cascade (INC), pre-equilibrium and 
de-excitation. The (generalised) INC describes the incident particle interacting with quasi-free 
nucleons in the target nucleus through a series of two-body interactions. In pre-equilibrium, the 
energy of the particles has reached a lower limit (few tens of MeV) but the nucleus is not yet in 
thermal equilibrium. Finally, de-excitation depends on the mass of the target nucleus and the 
remaining energy, for which the remaining energy can be dissipated via nuclear evaporation, 
fission, Fermi-breakup or gamma emission [65]. 
For heavier ions, nucleus-nucleus interactions are variants of the abrasion-ablation 
model [88]. During abrasion, the projectile and target nuclei overlap and an excited quasi-
projectile (with most of the initial velocity) and a quasi-target fragment (at rest) are formed, as 
well as several excited light fragments. During ablation, the projectile, target and fragments that 
remain de-excite by evaporating light nuclei or fragments. Here, both projectile and target 
nuclei can fragment, in comparison to protons where only the target nuclei can fragment [65]. 
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Figure 7: Top: Illustration showing a nucleon-nucleus reaction for protons, whereby a neutron is created 
and a gamma emitted from the residual target nucleus. Bottom: Illustration showing a nucleus-nucleus 
reaction for heavy ions, whereby light fragments are created and gamma rays can be emitted from both 
residual projectile and target nuclei. From Ref. [65]. 
 
2.1.3 Comparison of Different Ion Species 
Aside from protons and carbon ions which are used clinically in particle therapy today, 
other ions are gaining interest such as helium, lithium, oxygen and neon [89-93]. In this thesis, 
proton, helium and carbon ions are studied, so the discussion in this section will focus on these 
three particle species. The main differences between protons and heavier ions, such as helium 
and carbon, are that heavier ions exhibit reduced multiple scattering inside the patient, result in 
a dose tail beyond the BP due to secondary fragments that are produced from nuclear reactions 
along the beam path, and have an increased LET, RBE and OER [7,94]. The RBE for heavier 
ions is low in the plateau region and increases to a significant enhancement in the BP. The 
average RBE for protons is around 1.1 [95], while for carbon ions the RBE distribution in the 
target volume varies between 2 and 5 [96,97] and for helium ions between around 1.2 and 2.9 
[98,99]. The RBE is largely a reflection of LET, which is related to DNA damage; the greater 
the RBE the higher the LET, and in turn, more cellular damage that is less likely to repair, in 
addition to improved effectiveness in killing hypoxic cells that are normally radioresistant 
[89,100]. Hence, this is related to the OER which, as stated in Tommasino et al. (2015) [89], is 
“defined as the ratio of doses under hypoxia to normoxic conditions needed to obtain the same 
biological effect”. Lighter ions, such as protons and helium, produce high LET at the distal edge 
of the BP only, whereas carbon ions produce high LET in the entire BP resulting in high LET to 
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healthy tissue proximal to the BP [89]. Furthermore, the projectile particles caused by nuclear 
fragmentation reactions have the same velocity as the primary particles but with reduced mass 
and charge. This results in a complex radiation field which contribute a low LET dose to the 
tumour, and since low LET particles travel further in tissue they may also contribute to a dose to 
normal tissue beyond the BP [7,100]. Due to the 𝑍  dependence of LET, fewer carbon ions are 
necessary to deposit the same amount of physical dose as protons. Considering the higher RBE 
in the SOBP region, typically 102 times more protons than carbon ions are required to irradiate a 
given tumour volume at the same therapeutic dose [57]. 
Studies have explored and compared the physical and biological properties of various 
ions [101-105]. It has been found that the charge collection efficiency for heavier ions is lower 
due to less lateral and longitudinal straggling and superior ionisation density. The beam width of 
secondary particles was found to be larger for helium ions than for carbon ions, which 
corresponds to the lighter fragments originating from the fragmentation of helium ions and since 
fragments from heavier ions are more forward directed [104]. Yet, the lateral straggling of 
helium ions due to MCS was shown to be about half that of protons [106]. From depth and 
lateral dose distributions, the SOBP characteristics for the different ions seem to be consistent. 
Helium ions offer a lower fragmentation tail and an advantageous entrance dose compared to 
heavier ions, with similar lateral and distal fall-off properties [104]. A recent study [91] 
presented a simulation model for therapeutic 4He beams, experimentally validated by means of 
physical and biological dosimetries, and showed that detailed treatment planning studies with 
such beams is possible. Yet heavier ions remain of clinical interest for certain types of tumours, 
such as hypoxic tumours, due to the difference in achievable LET [104]. 
As with dosimetric comparisons between the ion species, the secondary radiation field 
also differs, and hence in the PG emission. Due to the greater number of fragmentations, heavier 
ions produce more PG rays than protons per projectile. The PG yields for carbon ions are higher 
than those for protons, generally by a factor of 5-6 [57]. The secondary particles are also a 
source of PG ray production, both in the build-up region and beyond the BP, justifying the need 
for discrimination techniques (e.g. TOF) for carbon ions. The PG fall-off is therefore more well-
defined for protons compared to carbon ions, with less background. Hence, it is unlikely that 
millimetric precision can be achieved for on-line carbon ion verification with the gamma 
cameras currently under development; efficiencies of the order of 10-2 would be required [57]. 
The prompt photons produced by various ions in a PMMA target were recently studied [94], 
where measurements confirmed that 4He beams of therapeutic energy produce non-negligible 
prompt photon yields, with resolutions below 2-3 mm obtained in different scenarios, 
supporting the feasibility of 4He and 12C beams for PG range verification techniques. 
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Unlike protons and carbon ions, clinical data available to support simulations for helium 
ions is limited. Although experimental studies have been performed [91,94,106-108], further 
measurements of dose profiles and fragmentation cross sections would help to benchmark and 
improve the beam models adopted in Monte Carlo codes. Further experimental efforts would 
also be beneficial to implement helium (and other) ions in treatment planning software, such as 
obtaining RBE data over a wide range of energies and cell lines. This would be important in the 
future, where radiation-quality optimised treatments based on particle species selection may be 
personalised to the patient and the specific disease [89]. 
2.2 Gamma Ray Detection and Measurement 
2.2.1 General Properties of Radiation Detectors 
This section presents general properties of radiation detectors that are relevant to 
Chapter 4 of this thesis, where the study on the characterisation of scintillation detectors for 
potential hybrid PG detection systems for fast and efficiency beam range monitoring is given. 
 2.2.1.1 Energy Resolution and Detection Efficiency 
The energy resolution of a detector describes its ability to resolve fine detail in the 





                                                                   (10) 
where 𝐹𝑊𝐻𝑀 is the full-width-at-half-maximum of the detector response function (peak in the 
differential pulse height spectrum) and 𝐻  is the centroid of that peak. 𝑅  is therefore a 
dimensionless fraction that is commonly expressed as a percentage; the smaller this value, the 
better the energy resolution of a detector. That is, the peak width reflects the amount of 
fluctuations recorded from pulse to pulse regardless that each event deposited the same energy 
in the detector. Semiconductor detectors used for alpha spectroscopy can have an energy 
resolution <1%, while scintillation detectors used for gamma ray spectroscopy range from 3% 
to 10% [66]. 
The detection efficiency describes the ability of a detector to record events considering 
the number of radiation quanta (particles or photons) incident on the detector. The detection 
efficiency is divided into two classes: absolute and intrinsic. Absolute detection efficiency is 
dependent on both the detector itself and geometric properties, such as distance from the 
radiation source to the detector, and is defined as: 
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𝜀 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑢𝑙𝑠𝑒𝑠 𝑟𝑒𝑐𝑜𝑟𝑑𝑒𝑑
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑎𝑑𝑖𝑎𝑡𝑖𝑜𝑛 𝑞𝑢𝑎𝑛𝑡𝑎 𝑒𝑚𝑖𝑡𝑡𝑒𝑑 𝑏𝑦 𝑠𝑜𝑢𝑟𝑐𝑒
                         (11) 
Intrinsic detection efficiency mostly depends on the detector material, radiation energy, and the 
detector thickness in the direction of radiation incidence, and is defined as: 
𝜀 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑢𝑙𝑠𝑒𝑠 𝑟𝑒𝑐𝑜𝑟𝑑𝑒𝑑
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑎𝑑𝑖𝑎𝑡𝑖𝑜𝑛 𝑞𝑢𝑎𝑛𝑡𝑎 𝑖𝑛𝑐𝑖𝑑𝑒𝑛𝑡 𝑜𝑛 𝑑𝑒𝑡𝑒𝑐𝑡𝑜𝑟
                       (12) 
For isotropic sources, the absolute and intrinsic efficiencies are related by 𝜀 = 𝜀 ∙
(4𝜋/Ω), where Ω is the solid angle of the detector subtended from the source position [66]. 
Further discussion on detection efficiency will be discussed in Chapter 4. 
 2.2.1.2 Dead Time 
The term dead time (or resolving time) refers to the minimum time separation between 
two events such that they can be recorded as two individual pulses. The time limitation may 
arise from the detector processes or associated electronics. For example, for scintillation 
detectors, the dead time is the combination of three time intervals: time taken to produce the 
scintillation (i.e. the decay time of the scintillator), time taken for electron multiplication in the 
photocathode (order of 20-40 ns), and time taken to amplify and record the signal. The resulting 
dead time of a scintillatior is of the order to 1-5 μs, in comparison to gas-filled detectors which 
is much larger, in the order of tens to hundreds of microseconds [109]. 
2.2.2 Conventional Gamma Detector Technology 
Here, the focus is on scintillation detectors, outlining the physics of their operation and 
performance in terms of timing, since they are investigated as potential PG measurement 
devices in Chapter 4 of this thesis. Associated photo-detectors for scintillation light readout are 
also discussed, specifically photomultiplier tubes (PMTs) and silicon photomultipliers (SiPMs). 
An overview of pulse processing, shaping and timing is also given, which are also relevant for 
the study presented in Chapter 4. 
 2.2.2.1 Scintillation Detectors 
Scintillation detectors are used for a wide range of applications, for the detection and 
spectroscopy of ionising radiation. The choice of scintillation material is subject to the specific 
application, such that there is a compromise between the properties of the particular scintillator. 
Ideally, a scintillator should be of high efficiency, the light yield should be proportional to the 
deposited energy over a wide range, the decay time of induced luminescence should be short to 
generate fast signal pulses, the index of refraction should be near that of glass (~1.5) to allow 
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efficient coupling to a PMT (discussed further in the next section) or other light sensor, among 
other factors [66]. 
Scintillation in inorganic materials depends on the energy states which are governed by 
the crystal lattice of the material. With energy absorption, electrons can rise from the valence 
band (where electrons are essentially bound at lattice sites) to the conduction band (where 
electrons move freely through the crystal) leaving a hole in the valence band (electron-hole pair), 
and when the electron returns to the valence band the de-excitation results in the emission of a 
visible photon. To increase the probability of visible photon emission, small amounts of 
impurities (activators) are added to the scintillator which creates energy states within the 
forbidden band (between the lower and upper bands where electrons cannot exist in pure 
crystals). The energy structure of the de-excitation sites (luminescence centres or recombination 
centres) in the crystal lattice governs the emission spectrum of the scintillator [66,109]. 
From the creation of electron-hole pairs, the positive hole quickly drifts to an activator 
site and ionises it while the electron moves freely through the crystal until it encounters such an 
ionised activator. The electron can arrive at the activator site and create its own set of excited 
energy states. If transition to the ground state is possible in an excited configuration activator 
site, the de-excitation will occur rapidly and with high chance of a photon emission. Such 
excited states commonly have lifetimes of the order of 30-500 ns [66]. The decay time of the 
excited states therefore determines the emitted scintillation light timing characteristics. A 
possible scenario that can occur is electron capture at the activator site, termed quenching, 
whereby no photon is produced. Moreover, electron-hole pairs can alternatively move together 
in a loose configuration referred to as an exciton. They move freely through the crystal until 
they reach an activator atom site, where excited activator configurations can again be formed 
and scintillation light produced from the de-excitation to the ground state [66,109]. 
For the detection of photons, scintillators have superior timing resolution and good 
energy resolution, whereas for charged particles, they have good timing resolution but 
semiconductor detectors have better energy resolution. Gas-filled detectors have very low 
efficiency of gamma rays and x-rays compared with scintillation detectors, since the incident 
radiation travels through the low-density gas with few interactions. Also, for scintillators, alpha- 
and beta-gamma radiation measurement (simultaneous and separate) can be achieved by pulse 
analysis, the size and weight can be much lower, the temperature range is not limited by 
condensation, they do not require gas supply or gas refilling, and the uniformity of the response 
across the sensitive area is comparable to gas-filled counters. Scintillators are an excellent 
choice for particular applications with the advantage of excellent efficiency, high precision, high 
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counting rates achievable, relatively simple experimental set-up and accurate energy/intensity 
measurement i.e. spectroscopy (particularly for gamma rays) [110,111]. 
 2.2.2.2 Photo-detectors for Scintillation Light Readout 
 A PMT is an instrument that converts the weak light output of a scintillator into a 
usable electrical signal. The main components of a PMT include: a photocathode, focusing 
electrodes, dynodes and anode. These components are enclosed within a vacuum tube in order 
for low-energy electrons to be accelerated efficiently by internal electric fields, such that the 
photocathode is at negative potential and the anode at positive potential. Figure 8 shows the 
elements and basic principles of a PMT. The photocathode is a photosensitive layer that 
converts the incident scintillation light to a few hundred low-energy electrons (photoelectrons). 
Dynodes are electrodes that re-emit electrons once energy is deposited in its surface by incident 
electrons. Amplification results in 107-1010 electrons from a typical scintillation pulse and are 
then sufficient to serve as the electrical signal for the original scintillation event; this charge is 
collected at the photosensitive anode for the output signal. PMTs generally perform 
amplification linearly, such that the output pulse at the anode remains proportional to the 
number of initial photoelectrons across a wide range of amplitudes [30,66,109]. 
 
Figure 8: The components and basic principles of a PMT. From Ref. [30]. 
 
A SiPM is a semiconductor device that consists of an array of small avalanche 
photodiode (APD) cells (tens of microns) produced using complementary metal-oxide 
semiconductor (CMOS) processes on a silicon chip and operated in Geiger mode. Avalanche 
photodiodes feature an internal gain through which high electric fields increase the number of 
collected charge carriers. Geiger mode refers to the principle that charges produced in the initial 
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interaction are multiplied without limit, but quenching by an active or passive external circuit 
ceases the self-sustaining avalanche. The avalanche photodiode cells are so small that the 
probability for a scintillation photon to hit a cell during a scintillation pulse is low. The number 
of cells producing an avalanche is thus proportional to the number of incident scintillation 
photons. When operated in Geiger mode, the output of each cell are close in amplitude, and 
adding these in parallel generates an analogue pulse where the amplitude is proportional to the 
number of photons detected [66]. 
 The time characteristics of a PMT is determined solely by the electron trajectories, since 
the time for electron emission in the photocathode and dynodes is very short (0.1 ns or less). 
The average time taken for an electron burst to occur at the anode from the corresponding 
photon arrival at the photocathode is termed the electron transit time; ranging from 20-80 ns for 
various designs of PMTs [66]. However, in most timing applications the transit time is not of 
great importance since it generally introduces only a fixed delay in the derived signal. The time 
width of the pulse of electrons arriving at the anode is more important. This transit time spread 
is primarily due to the distance between the photocathode and first dynode; photocathodes are 
therefore usually curved to minimise the affect across its diameter. The variation in emitted 
photoelectron velocities is another source of spread in the transit time, but can be minimised by 
employing a large voltage difference between the photocathode and first dynode. Operating the 
PMT at maximum voltage permissible is generally done for superior timing performance, as a 
high inter-dynode voltage can also decrease the effect of time spread in the electron multiplier 
region. However, improving the time response of the PMT can be a compromise to the 
photoelectron collection efficiency and therefore the electron gain; the time resolution is 
basically inversely proportional to the square root of the number of photoelectrons per pulse 
[66,112,113]. 
Photodiodes (or SiPMs) are also effective devices for coincidence and other timing 
applications, such that the time response is comparable to that of PMTs since the distances in 
which the charges move are relatively small. The rise time of SiPMs is determined by the 
avalanche formation rise time and the variation in the transit times of signals arriving from 
different points on the sensor’s active area; careful design of the tracking to minimise the transit 
time spread can improve the rise time. On the other hand, the decay time of a pulse (or recovery 
time of the sensor) is determined by the microcell (operating unit of a single photon avalanche 
diode and quench resistor) recharge time constant, given by 𝜏 = 𝐶 (𝑅 + 𝑅 ∙ 𝑁), where 𝐶  
is the microcell effective capacitance, 𝑅  is the microcell quench resistor, 𝑅  is any resistance in 
series with the sensor, and 𝑁 is the total number of microcells in the sensor. Although the 
microcell can respond during the recovery time, the gain will be reduced proportional to the 
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reduced overvoltage. The percentage of sensor surface area that is sensitive to light is termed the 
fill factor. For a lower fill factor (smaller microcells) the recovery times are shorter and the 
dynamic range is larger, but compromises to a lower photon detection efficiency and gain, and 
results in lower capacitances [114]. For single-celled avalanche photodiode SiPMs, timing 
resolutions on the order of tens of picoseconds are achievable, while for array cells are on the 
order of hundreds of picoseconds [66]. 
Advances in semiconductor photodiodes have led to them potentially replacing PMTs 
for particular applications. Photodiodes generally offer higher quantum efficiency and so 
potentially superior energy resolution, lower power consumption, compact size, improved 
ruggedness and insusceptibility to magnetic fields. However, SiPMs have a nonlinear response 
to intense light pulses such that the probability of hitting a cell is no longer low, but a correction 
based on an initial calibration can restore linearity. Thermal noise and dark noise are additional 
challenges, as is the dependence of SiPM gain, noise and photon detection efficiency on 
temperature and voltage [66]. 
 2.2.2.3 Pulse Processing, Shaping and Timing 
The output signal from a PMT or SiPM becomes the input to the pulse processing 
system, where the series of current pulses occur randomly and typically vary in amplitude and 
duration. The system output is generally a count rate (rate of pulses that meet specific criteria) 
or an energy spectrum (pulse energy depositions in the detector). The main components of a 
typical pulse processing chain include: a preamplifier, shaping amplifier, discriminator or 
trigger, and counter or multichannel analyser (MCA). The preamplifier integrates the current 
pulse to generate a voltage step that is proportional to the corresponding charge in the detector. 
The shaping amplifier then converts this signal into a suitable form, where the output voltage 
pulse height is proportional to the deposited charge. The output should return to baseline as 
quickly as possible to prevent pulses from overlapping, or pulse pile-up, which in turn distorts 
the measurement. High- and low-frequency noise filtering is also performed by the shaping 
amplifier to improve the signal-to-noise ratio. The shaping amplifier is therefore characterised 
by a shaping time constant that relates to its output pulse duration; a short shaping time 
minimises pulse pile-up but is a trade-off to greater noise. Shaped pulses then go through a 
selection process; an integral discriminator selects all pulses with height above a particular 
threshold, whereas a differential discriminator (or single channel analyser) selects those with 
height between upper and lower thresholds. The output result is an accumulation of the selected 
events over a certain period of time, which can be presented with a counter or MCA. A counter 
simply counts the number of selected events over the certain time period, whereas an MCA 
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measures and assigns the pulse height of selected events to a particular range or channel to 
produce a pulse height spectrum [66,109]. 
 Signal pulses can either be linear, whereby the pulse amplitude and at times the shape 
holds information, or logic, whereby the pulse only carries information through its presence or 
particular arrival time. A linear tail pulse has its leading edge time determined by the detector 
charge collection time, while its decay (return to zero) is determined by the time constant of the 
collection circuit; the latter must be larger than the former to ensure complete charge collection. 
The rise time of the leading edge of linear tail pulses is an important property in particular 
applications, which is commonly defined as the time interval between 10% and 90% of the 
pulse’s final amplitude. On the other hand, the decay time is commonly used to refer to the time 
interval between 90% and 10% along the pulse tail. With regards to scintillators, the decay time 
characterises the prompt scintillation yield from a material [66,113]. 
Since the amplitude of pulses correlates to the charge 𝑄 deposited in the detector, pulse 
pile-up can be a major issue. Shaping the pulses in such a way that significantly reduces the 
pulse tail, but maintaining the proportionality of its amplitude to 𝑄, is an ideal solution. Shaping 
may be in the form of a CR (capacitor-resistor) differentiator/high-pass filter, RC (resistor-
capacitor) integrator/low-pass filter, CR-RC shaping, Gaussian shaping, active filter shaping, 
triangular or trapezoidal shaping. Shaped linear pulses commonly have a time width of several 
microseconds only, compared to 50 or 100 μs decay times of tail pulses [66]. Pulses can pile-up 
on the tails of preceding pulses which have not completely decayed to zero, such that a 
superposition of pulses arises, or there may be an undershoot of the preceding pulse, either of 
which result in the amplitude no longer being an adequate measure of 𝑄; referred to as tail pile-
up. The use of pole-zero cancellation or active baseline restoration techniques can solve these 
issues [66]. Another form of pulse pile-up is where two pulses occur so close in time that they 
are treated as one pulse; referred to as peak pile-up. This has a major effect on the amplitude of 
the recorded pulse, for which the combined pulse will have amplitude equal to the sum of the 
two individual pulses. Commercial linear amplifiers are generally capable of discarding pulses 
that are expected to be affected by pile-up. Pulse shape discrimination can also be employed, 
since piled-up pulses have a different shape to those not affected by pile-up. Digital pulse 
processing is a technique which allows rejection of pile-up as well as the possibility to recover 
information lost by pile-up [66]. 
As with pulse height measurement, obtaining timing information is another common 
goal in many applications, the accuracy of which depends on the properties of the detector being 
employed as well as the type of electronics used for signal processing. The characteristics of 
timing heavily depend on the dynamic range (amplitude) of the signal pulses; better timing 
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performance is achieved for systems that have signal pulses confined to a narrow range of 
amplitudes [66]. Time pick-off units, or triggers, are essential in timing measurements; they are 
devices that generate a logic pulse whose leading edge signifies the time at which an input linear 
pulse occurs. Sources of uncertainty may be due to time jitter, when the input pulse amplitude is 
constant (e.g. electronic noise, statistical fluctuations), or amplitude walk, when the input pulse 
amplitude varies. Leading edge triggering is the easiest, most direct and common method, 
whereby the pulse is triggered when it crosses a fixed discrimination level. Setting the 
discrimination level very low minimises the effects of amplitude walk, but setting the level in a 
steep slope region on the pulse leading edge minimises time jitter; optimal time resolution is 
achieved for levels set at around 10-20% of the average pulse amplitude [66]. Figure 9 shows 
time jitter and amplitude walk in the leading edge triggering method. 
 
 
Figure 9: Top: Time jitter in leading edge triggering resulting from random noise. Signal pulses with the 
same amplitude and shape, but with random noise, are enclosed in an envelope. Bottom: Amplitude walk 
in leading edge triggering. Two pulses that have the same time of occurrence and shape, but different 
amplitude, cross the trigger level at different times. From Ref. [66]. 
 
2.2.3 Challenges of Detector Technology for Prompt Gamma Measurement 
As mentioned in the previous chapter, PG emissions from charged particle therapy 
present complicated spectral distributions of high-energy, broad range of discrete energy lines 
with strong interference background from neutrons and other stray radiation induced continua. 
These impose significant challenges on detector technology for PG measurements. Hybrid PG 
detection methods are desired to combine the spectral and temporal information of PG rays. 
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This requires advanced detector technology with high stopping power, high energy and timing 
resolutions for both energy- and time-resolved spectral measurements. 
Another challenge is on the detector system load capability for high instantaneous count 
rates (~107 events per second) from pencil beam spot scanning. This requires fast detector 
response with ultra-fast electronics and data acquisition systems, as well as innovative data 
processing techniques such as pile-up rejection, scatter rejection, spectral line extraction, etc.  
A recent breakthrough of clinical prototype for proton range verification has been 
demonstrated from the Massachusetts General Hospital (MGH) group [59]. This prototype 
utilised a high-performance detector array based on LaBr3(Ce) for energy- and time-resolved 
spectral measurements of PG rays. The gamma ray backgrounds from neutron-induced and 
proton-induced continua can be well resolved and rejected. Then, the discrete PG lines can be 
well resolved and obtained in both energy and time dimensions. 
2.2.4 Overview of Advanced Detectors for Prompt Gamma Detection 
To overcome the challenges stated in the previous section, advanced detectors based on 
fast, dense and high light yield scintillators are desirable to provide high-throughput 
measurements with high energy and timing resolutions. For a typical PBS treatment, estimating 
108 incident protons per second at a beam current of 2 nA, PG timing detection systems should 
have a time resolution equal or better than ~200 ps FWHM (i.e. not exceed the minimum bunch 
spread of 200 ps FWHM at 230 MeV), energy resolution <5% FWHM at 662 keV (to support 
sharp energy cuts and clearly identify PG emission lines), detector and data acquisition counting 
rates >106 counts per second to achieve statistics of 104 for the PG rays of interest (to determine 
range variations of 5 mm with >80% probability) [60]. 
Cerium-activated lanthanide halide and cerium bromide scintillators have very 
promising properties to meet the requirements for PG detection. Energy resolutions of <3% at 
662 keV and timing properties down to 100 ps can be achieved with LaBr3(Ce) detectors in 
optimal conditions, with crystal size being one variable studied and various PMTs [115-119]. 
CeBr3 has very short rise (<1 ns) and decay (17-24 ns) times, good energy resolution <4% at 
662 keV, excellent time resolution of 120-150 ps FWHM for 60Co energies, high count rates and 
reasonable photo-absorption probability [60,120-122] (see Table 1). CeBr3 was also found to 
have an energy resolution of 2.2% at the higher PG energy of 4.4 MeV, with a time resolution 
of 190 ps FWHM [123]. However, CeBr3 is limited by its characteristic scintillation self-
absorption and re-emission processes which cause a lower light yield compared to LaBr3(Ce). 
Yet due to the reduced intrinsic activity of CeBr3, its detection sensitivity is, on average, around 
5 times greater than that of LaBr3(Ce) [124]. 
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Other scintillators are also commercially available, such as SrI2(Eu), GYGAG(Ce), 
CLYC, CLLB, CLLC and CLLBC. A study characterising SrI2(Eu), CeBr3 and GYGAG(Ce) 
found energy resolutions at 662 keV of 4.0% for SrI2(Eu), 4.4% for CeBr3 and 5.2% for 
GYGAG(Ce) [125] (see Table 1). The study showed SrI2(Eu) having an excellent energy 
resolution but a very long decay time, whereas CeBr3 had the fastest response with a good 
energy resolution, and GYGAG(Ce) had high efficiency with good energy resolution and the 
possibility to be produced in all shapes/dimensions. 
The elpasolite crystal family, including CLYC (Cs2LiYCl6(Ce)), CLLC 
(Cs2LiLaCl6(Ce)), CLLB (Cs2LiLaBr6(Ce)), CLYB (Cs2LiYBr6(Ce)) and CLLBC (Cs2LiLaBr6-
xClx(Ce)), are very promising scintillation detectors for identifying and discriminating gamma 
and neutron radiations. They have been widely studied by several groups [126-131]. CLYC has 
an energy resolution better than NaI(Tl) but worse than LaBr3(Ce), yet features at least 100 
times less internal radiation than LaBr3(Ce). CLYC also has very high efficiency in identifying 
thermal neutrons, particularly if enriched with 6Li as it uses the reaction 6Li + n = 3H + α which 
has a cross section of 940 barns for thermal neutrons [132]. The pulse shape produced by 
gamma rays is characterised by a quicker rise and decay time compared to the neutron pulse, 
while also containing the core-to-valence luminescence (CVL) component of the scintillation 
light which is not present in the pulse produced by thermal neutrons. Pulse shape discrimination 
techniques can therefore be used to distinguish gamma rays and neutrons. In a recent study, two 
CLYC scintillators were characterised, one enriched at 95% of 6Li and another at 99% of 7Li 
[125]. Energy resolutions at 662 keV were found to be 4.8% for the crystal enriched with 6Li 
and 4.5% for that with 7Li. The decay time for the fast component of the gamma ray signal for 
CLYC was found to be 72 ns, while for CLLBC was 89 ns and CLYB was 53 ns [127]. The 
gamma-neutron discrimination can be utilised for further improvement of PG measurements; 
such study has not yet been reported and is worth for further exploration. 
And so, the requirements for a good PG range monitoring system can be achieved with 
available detector systems, but achieving the requirements simultaneously for potential hybrid 
systems is a challenge. Table 1 presents a summary of scintillation detector performance 
achieved in various studies. 
When choosing a scintillator for a particular detection system, the applicability should 
be explicitly verified and optimal conditions can be achieved depending on the crystal volume, 
doping percentage, the PMT used and associated electronics [124,132,133]. A technique known 
as co-doping has the potential to increase the scintillation crystal proportionality and detector 
mechanical properties, whereby the reliability and energy resolution of the detector are 
significantly improved. The non-linearity between low-energy electrons and scintillator photons 
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is predominantly induced by non-radiative electron recombination, which is related to hole 
mobility in inorganic crystals. Better linearity is achieved with larger hole mobility, and 
therefore better energy resolution. Inserting a secondary dopant, such as Sr++ in LaBr3(Ce) or 
Ca++ in CeBr3 can improve detector performance, for example, achieving an energy resolution 
of 2% for LaBr3(Ce) and 3% for CeBr3, at 661 keV [133]. Commercial PMTs are generally 
matched for a particular scintillator size and coupling mechanism/material. To reach superior 
time resolutions, PMTs should be specifically designed and trigger set-ups improved, such that 
the time resolution has a dependence on the scintillation decay time and the number of 
photoelectrons [123]. Operating the PMT at higher bias voltage and optimising the constant 
fraction discriminator (CFD) settings (external delay and walk adjustment) with respect to the 
timing resolution have also been explored for improving timing properties [122]. 
Table 1: Summary of energy resolutions and timing properties of several scintillators published in the 
literature, with reference given. 
Scintillation 
detector 
Energy resolution at 
662 keV (%) 
Rise time (ns) Decay time (ns) 
Timing resolution 
FWHM (ps) 











LaCl3(Ce) 3.2 [135] 
3.5 [117] 
3.8 [136] 















189 (at 4.4 MeV) [123] 
SrI2(Eu) 3.0 [137] 
3.3 [123] 
4.0 [125] 
 1200 [137] 
~7000 [125] 
824 (at 4.4 MeV) [123] 
NaI(Tl) 6.1 [117] 
9.0 [123] 
 ~210 [116] 856 (at 4.4 MeV) [123] 
CLYC 4.8 (95% 6Li) [125] 
4.5 (99% 7Li) [125] 
5 [129] 65 [129] 
72 [127] 
 
CLLBC 4.1 [138]  ~55 [138] 
89 [127] 
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2.3 Current Research Status of Prompt Gamma for in vivo Beam 
Range Verification and Dosimetry 
The use of PG rays for monitoring the beam range in particle therapy was first proposed 
by Stichelbaut and Jongen in 2003 [139], and a proof of principle was performed by Min et al. 
(2006) [27] with a collimated detector for proton beam irradiation of a water phantom. The 
close correlation between the PG emission and the BP position was reported within 1-2 mm 
accuracy. Since then, many authors have reiterated the feasibility of utilising PG emission for 
range verification, with simulations and experimental work being performed to understand PG 
emission during particle beam irradiations and its use for monitoring the BP during treatment, as 
well as to optimise PG detection methodology and overcome the challenges of PG detection 
technology. 
The viability of employing PG rays for in vivo BP tracking for mono-energetic particle 
beams of therapeutic energies has been demonstrated [26,91,140-142], particularly for proton 
beams with heavier ions, such as helium and carbon, becoming of greater interest. The notion 
has also been demonstrated for passively scattered SOBP fields. The good correlation between 
the production position and intensity of PG rays with the dose delivered has been shown in 
homogeneous and heterogeneous media. However, as the PG production fall-off position does 
not exactly equal the dose profile fall-off, since they result from different physical mechanisms, 
a consistent PG-BP fall-off difference may be a key factor to enable direct correlation of the 
distributions [23,140]. 
The characteristics of PG emission during particle irradiations have been studied for a 
range of target compositions. The gamma energy spectrum has been shown to be characteristic 
to the elemental composition of the irradiated material, with emission lines from specific 
nuclear de-excitations determined: 16O, single escape peaks 6.13 and 5.62 MeV, double escape 
peak 5.11 MeV, and single escape peaks 2.74 and 2.23 MeV; 15O, single escape peaks 5.21 and 
4.70 MeV, and double escape peak 4.19 MeV; and 12C, single escape peaks 4.44 and 3.93 MeV, 
and double escape peak 3.42 MeV [26]. The PG emission line of 6.13 MeV was found to be 
directly proportional to the oxygen concentration in a volume of irradiated tissues, whereas the 
4.44 MeV PG peak is dependent on both carbon and oxygen concentration [26]. The relative 
intensity of gamma emission peaks was found to be a function of both the elemental 
concentration and the physical density of the tissue [143]. Due to the characteristic spectra of 
PG rays, which depends on the medium composition, the PG signal can potentially be used to 
determine the elemental composition of the irradiated tissue [26,28,140]. A greater yield of low-
energy gamma rays are produced during irradiation, though it is the higher energy gamma rays 
that have been found to better discriminate the distal dose fall-off, since these high-energy 
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gamma rays experience less scattering when traversing and leaving the target and so their 
production has improved localisation with respect to the dose fall-off [27,141]. 
The capability of verifying the beam range in vivo using PG rays depends greatly on the 
design optimisation of not only intrinsically efficient detectors, but also detector position 
relative to the target to maximise detection efficiency. The angular dependence of PG detection 
has therefore also been investigated [144]. It was found that regardless of proton beam energy, 
the total PG and 16O gamma detection rates were higher at locations proximal to the proton 
treatment nozzle, with no significant dependence on the azimuthal angular rotation of the 
detector around the beam axis. Another study found that for a narrow angular collimation 
window, the PG profile displays a steep fall-off that is well-correlated with the BP, whereas a 
wider window allows for gamma spatial profiles to be detected while still exhibiting a good fall-
off correlation with the BP position [145]. 
The interference background induced by neutrons presents one main challenge for 
accurate BP tracking using PG detection, particularly for heavier ions, such as carbon, due to 
nuclear fragmentation reactions. Exploiting the timing properties of PG rays has been shown to 
be a promising method for overcoming this challenge. A TOF technique to reject the neutron 
background of PGI by means of a shifting 1 ns TOF acceptance window, which accounts for 
proton propagation through the patient, has been studied [145] (see Figure 10). The Monte 
Carlo codes predicted than at a proton energy of 200 MeV, more than 99.6% of neutrons are 
rejected between initial entrance and the proton range. Testa et al. (2010) [142] implemented 
this TOF technique experimentally for 95 and 305 MeV/u 12C beams irradiating PMMA and 
water phantoms. A clear correlation was obtained between the carbon ion range and the PG 
profile. The study demonstrated that a collimated set-up can be used to detect single photons by 
means of TOF measurements at therapeutic ion energies. As well, the detected photon count 
rates provide sufficient statistics to allow real-time control of the longitudinal BP position under 
clinical conditions [142]. The TOF technique, which differentiates the PG signal from the 
interference background, does not only improve the PG signal-to-noise ratio, but could also 
















Figure 10: Yield of PG rays (blue and red) and neutrons (black) registered in the detector, and depth dose 
profile for a mono-energetic 100 MeV proton pencil beam, as a function of the longitudinal distance 𝑧 in 
a PMMA phantom (purple), without (left) and with (right) a 1 ns shifting TOF acceptance window. PG 
profiles are shown for a narrow angular collimation window ∆θ2 (red) and a wide window ∆θ1 (blue). 
Simulated data with Geant4 is presented as (1) and MCNPX as (2). Bin width along 𝑧 is 1 mm. Depth 
dose was calculated with Geant4 and is given in arbitrary units (a.u.). From Ref. [145]. 
 
The behaviour of PG rays during proton beam irradiation is quite well-understood. 
Several studies for carbon ions have been performed mainly with TOF techniques [146-148]. 
However, further research is still required to fully understand the use of PG rays for in vivo 
range and dose verification, mainly for other heavy ions which are becoming of greater interest. 
Recent dosimetry characteristics studies of helium ions have shown their potential to offer a 
more conformal treatment in clinical applications, which would result in increased tumour 
control [89,91,104], but the PG emission characteristics from helium ion irradiation have not yet 
been widely studied [94]. This knowledge is also required for the development of clinically 
suitable and reliable PG detection systems. For accurate and efficient range/dose verification 
using PG emission, the detection system is required to measure the high-energy PG rays and 
determine with millimetre precision their production position, in addition to excellent timing 
resolution (particularly if the temporal characteristics of PG rays are to be employed also). 
Detector designs and developments have advanced through the years, but the challenges 
of PG detection technology are still present, which inhibit this technique from becoming a 
clinically wide-spread application for particle therapy QA. Several avenues of employing PG 
rays for range verification have been explored, including imaging and non-imaging modalities. 
Techniques to overcome some of the PG detection challenges have also been studied, with a 
particular interest in utilising the timing properties of PG rays for discriminating the PG signal 
from the interference background induced by neutrons, as well as for BP tracking itself. 
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2.3.1 Prompt Gamma Imaging (PGI) 
Various imaging detector designs have been explored for locating the position of PG 
origination, including passive (mechanical) collimation systems [27,149-152] such as slit 
cameras placed perpendicular to the beam direction which offer a 1D projection of the ion track, 
and active (electronic) collimation systems [153-156] which rely on Compton kinematics to 
trace the gamma source and offer 2D or 3D images. 
2.3.1.1 Passive Collimation Imaging System 
In the proof of principle study, Min et al. (2006) [27] constructed a multi-layered 
collimator system to measure PG rays while moderating and capturing fast neutrons, and 
preventing interference gamma rays from reaching the scintillation detector. The correlation 
between the PG production distribution and the BP was found to be within 1-2 mm difference in 
position at 100 MeV proton beam energy. 
In another study, a pinhole camera was designed to image PG rays while shielding 
neutrons and stray gamma rays, with the aperture shape and position selected in order to view 
the endpoint of the proton range [149]. A 0.2 mm shift in the peak of the total gamma 
distribution was observed for an energy variation of 1 MeV. This study showed that pinhole 
cameras may be a simple and viable tool for dose deposition verification in a patient, when the 
therapeutic beam range is less than a few centimetres. 
Slit cameras have also been developed and tested for real-time beam range monitoring 
[150] (see Figure 11). The 1D projection of the beam path shows the gamma profile sharply 
decrease at the BP, such that gamma rays predominantly produced by primary protons along the 
beam path are emitted isotropically and not heavily influenced by scattering before exiting the 
target, and so the fluence of these gamma rays indicate the beam range. Gamma rays between 4 
and 5 MeV were found to offer the most useful information for identifying the beam range. The 
prototype slit camera with knife-edge aperture using the HiCam system in Ref. [150] achieved a 
1-2 mm standard deviation on estimating the beam range. A recent Geant4 study by Kim et al. 
(2019) [157] for a multi-slit PG camera showed that merging the PG distributions of several 
individual spots improved the statistical precision of the measurement. Beam range verification 
accuracy within ~1.4 mm error was achieved, demonstrating the viability of the technique to 
improve PG statistics. Knife-edge shaped slits provide a larger field-of-view than parallel-edge 
slits, and a higher photon collection efficiency can be obtained compared with a pinhole camera. 
A knife-edge slit in combination with a position-sensitive gamma camera placed perpendicular 
to the beam direction has been studied [151], and results showed that under common therapy 
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conditions for proton spot scanning, sufficient data may be collected during one spot-step (~10 







Figure 11: Left: Concept of the PGI method with a slit camera, whereby the slit collimation gives a 1D 
projection of PG emissions along the beam path on a scintillation detector. From Ref. [158]. Right: 
Simulated incident 160 MeV protons (blue) and secondary photons (green) which are emitted and reach 
the detector after passing through the collimator. From Ref. [150]. 
 
Recently, Richter et al. (2016) [152] performed clinical proton therapy measurements 
with a prototype knife-edge shaped slit camera developed by IBA. The prototype consisted of 
an array of 40 individual scintillation detectors arranged in two rows and optimised for 
detecting gamma rays of 3-6 MeV. The PG depth distribution was measured during passive 
scattered proton therapy (PSPT) treatment of a head and neck tumour for seven consecutive 
fractions. Inter-fractional global range variations in the range of ±2 mm were obtained for all 
evaluated fractions. Xie et al. (2017) [159] also employed a knife-edge slit camera, performing 
clinical range verification for a brain cancer patient where the measured profiles of individual 
pencil beam spots were compared to predicted profiles from the treatment plan. With a spot 
aggregation kernel of 7 mm sigma, 52 spots could be retrieved with accuracy better than 1 mm. 
The group demonstrated the feasibility of PGI for in vivo proton beam range verification in 
actively delivered PBS on spot-by-spot tracking. However, the count statistics is still one of the 
main issues in such systems to achieve higher statistical precision. Petzoldt et al. (2018) [160] 
derived a geometrical correction model for a knife-edge slit camera from Monte Carlo 
simulations in water. The correction considered four parameters: the beam range, the distance 
between collimator and beam axis, the distance between camera and collimator, and the offset in 
the beam direction between the BP position and the camera field-of-view centre. The geometric 
correction was shown to improve the agreement between simulated and measured PG profiles 
which improved range retrieval and the accuracy for absolute range verification. 
Mechanically collimated PG cameras may be a more straightforward approach, and the 
slit width can be adjusted to optimise system efficiency and resolution, but the neutron 
2   Literature Review 57 
 
background and stray gamma rays have presented a challenge in early configurations, requiring 
thick layers of collimation. Electronically collimated systems, on the other hand, measure the 
position and energy of scattered photons and electrons to reconstruct the location and direction 
of incident gamma rays by means of Compton kinematics. 
2.3.1.2 Active Collimation Imaging System 
Compton cameras use multi-stage detectors in which the energy deposited and position 
of each gamma ray interaction is measured while scattering in the various stages of the camera, 
and the gamma ray is traced back to its position of origin. That is, from the interaction positions 
and deposited energies the direction of the incident gamma can be restricted to a cone with 
Compton kinematics. The vertex of the gamma origin is then obtained via the superposition of 
the multiple cones. Compton cameras offer an increased efficiency of potentially up to two 
orders of magnitude compared to collimated gamma cameras, since performance-limiting 
absorbing collimators are replaced by an electronically operating collimator [153-156]. Double-
scattering Compton cameras enable direct analytical reconstruction and offer an improved 
spatial resolution [154]. Richard et al. (2011) [154] performed a Monte Carlo simulation study 
on design guidelines for a double-scattering Compton camera for PGI during ion beam therapy. 
In order to maximise the camera efficiency and minimise the spatial resolution, the source-to-
camera distance should be considerably small, the detectors should be relatively thick, and the 
area of the second scatter detector should be larger than the first with the absorber detector 
larger than the second scatter detector. Recently, Draeger et al. (2019) [161] demonstrated the 
feasibility of a single Compton camera prototype to perform 3D PGI for proton range 
verification; detecting beam range shifts as small as 2 mm for a 2 Gy spot. A three-stage 
Compton camera has also been studied in terms of design specifications and to determine its 
feasibility to measure and image PG rays emitted during proton beam irradiation [155] (see 
Figure 12). Geant4 was used to model three high-purity germanium detector stages arranged in 
parallel-plane geometry, with an isotropic gamma source (0-15 MeV) used to determine the 
lateral width and thickness of the detector stages that yielded the optimal detection efficiency, 
and then a proton beam (50-250 MeV) irradiating a tissue phantom used to determine the 
overall efficiency of the camera. Overall efficiencies varied from ~10-6 to 10-3 PG rays detected 
per incident proton, and the suitability of a three-stage Compton camera for PGI during proton 
therapy was demonstrated. In order to minimise the radiation damage resulting from neutrons, 
as well as the cost, and the need for cryogenic coolants in the case of high-purity germanium, 
room-temperature alternatives such as cadmium zinc telluride (CZT) and cerium bromide 
(CeBr3) would be more suitable. CZT is a semiconductor detector which offers good energy 
resolution for high-energy gamma rays, yet it lacks in sensitivity for high-energy gamma and is 
poor for timing measurements. Alternatively, CeBr3 is a scintillator which offers good energy 
2   Literature Review 58 
 
resolution, excellent sensitivity and timing for high-energy gamma measurements. The 
feasibility and effectiveness of using the stochastic origin ensemble (SOE) algorithm for 
reconstructing proton pencil beam images from a three-stage Compton camera and for 
modelling the distal fall-off of secondary gamma emission has also been demonstrated [24]. 
Yao et al. (2019) [162] proposed modifications of origin ensembles with resolution recovery 
(OE-RR) algorithm based on Markov chains [163] to accelerate the algorithm and improve 
image quality. The modifications were in calculating the acceptance probability to implement 
ensemble transitions, using random sampling method in sequence to obtain the initial event 
density distribution in the volume of interest based on corrected values, and a correction for the 
finite energy resolution. The results demonstrated good resolution recovery and accurate 
estimation of the PG emission peak and distal fall-off with significantly faster reconstruction. 
 
Figure 12: Concept of a three-stage Compton camera (two scatter detectors and one absorber detector). 
The gamma rays with energies (E0, E1, E2) scatter in the detectors (D1, D2, D3) with Compton scatter 
angles (θ 1, θ 2). The projected cone (into the target/patient) is used to reconstruct the images. The 
interaction position and energy deposition in each detector is shown. From Ref. [155]. 
 
An alternative method, such as the electron tracking Compton camera (ETCC) has been 
developed for reconstructing 3D tracks of scattered electrons in the Compton process for sub-
MeV and MeV gamma rays [164]. The direction of the incident gamma ray is determined for 
each individual photon by measuring the direction and energy of the recoil gamma ray as well 
as the scattered electron. Background rejection is realised with Compton kinematics of a 
residual measured angle between the recoil electron and scattered gamma ray. The ETCC 
comprises of a gaseous time projection chamber (TPC) for 3D tracking of the electrons, and 
pixel scintillator arrays (PSAs) for detecting recoil gamma rays. Tests have been performed with 
140 MeV proton beam irradiation of a water target [165]. The TPC (10 × 10 × 15 cm3) was 
filled with Argon and C2H6 (9:1) at 1 atm pressure, based on micro pixel chamber (μ-PIC). The 
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PSAs were GSO(Ce) (6 × 6 × 26 mm3) coupled to a multi-anode PMT (H8500). The overall 
efficiency of the system was determined to be ~3×10-6. 2D PG images showed correlation to the 
BP position, but further study and improvements are required. 
Gamma electron vertex imaging (GEVI) was explored in a simulation study by Kim et 
al. (2012) [166]. The technique relies on the conversion of high-energy gamma rays, by 
Compton scattering, to electrons which are subsequently traced by hodoscopes to determine the 
location of the gamma source of vertices of the nuclear interactions. A prototype system was 
developed for proton beam range measurements [167]. It comprised a beryllium (Be) plate, two 
double-sided silicon strip detectors (DSSDs), a plastic scintillation detector, as well as dedicated 
signal processing and DAQ systems. The 1.08 mm thick Be plate (electron converter) was 
chosen to ensure a high probability of Compton scattering and limit MCS on the converted 
electrons. The DSSDs were used to determine the trajectories of the converted electrons, each 
with an active area of 50 × 50 mm2 and 16 strips on each side, with thickness of 150 and 300 
μm for the first and second layer, respectively. The plastic scintillator (100 × 100 × 20 mm3) 
measured the energy of the converted electrons. Triple coincidence logic and multiple energy 
windows were used to select only PG events. The detectors of the GEVI prototype were 
evaluated for electronic noise, energy and timing resolution, with the imaging capability tested 
with a 90Sr beta source, a 60Co gamma source, and a 45 MeV proton beam incident on a PMMA 
phantom. The study showed promising results for imaging PG vertices from proton irradiation. 
More recently, Kim et al. (2018) [168] performed experimental measurements of GEVI for 
proton therapy and determined a beam range verification accuracy within 2.7 mm. Although the 
group demonstrated the feasibility of GEVI for real-time beam range monitoring, further work 
for practical clinical applications are necessary, such as experiments for various number of 
protons, phantom materials, and beam incidence position and size. Though, the technique is 
promising since GEVI requires no mechanical collimation, provides higher imaging sensitivity 
than other PGI systems, and offers the potential to obtain images of almost no noise, i.e. using 
triple-coincidence logic and triple energy windows, only trajectories of the electrons produced 
from the PG rays can be selected, thereby effectively excluding proton and neutron signals from 
the detection system [168]. 
In conclusion, extensive work has been carried out in the area of PGI for BP tracking 
during particle therapy treatment delivery. However, the count statistics remains a major issue 
in PGI systems to achieve higher statistical precision of in vivo beam range verification. The slit 
cameras only offer 1D range information in the longitudinal beam direction, lacking information 
in the lateral spread. Compton cameras may offer 2D or 3D imaging but such systems suffer 
from challenges in detectors and image reconstruction to achieve clinically acceptable images 
[169]. Other monitoring techniques using PG rays are also being explored, which take 
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advantage of specific characteristics of PG emission. For example, novel techniques exploiting 
the temporal properties of PG rays have the potential to offer a simpler means of beam range 
verification, and eliminate the need for expensive, bulky equipment in the clinic. The following 
non-imaging approaches for in vivo beam range verification have an advantage of low footprint 
detector set-up in clinical practice. 
2.3.2 Prompt Gamma Spectroscopy (PGS) 
 This method of beam range verification directly relates measurements of discrete PG 
lines to nuclear reaction cross sections. Verburg et al. (2014) [170] studied this concept with the 
aim to develop a method entirely based on quantitative physics models and is robust in the 
presence of tissue with an unknown elemental composition. Differential cross sections were 
measured for 15 PG lines from proton-nuclear interactions with 12C and 16O at proton energies 
up to 150 MeV. Fitting measured cross sections with detector models, an optimisation method 
was developed to simultaneously determine the proton range and the composition of the 
irradiated tissue. A small-scale prototype detector was also used to test experimentally this 
method with various phantoms. Cerium-doped lanthanum (III) bromide (LaBr3(Ce)) crystal was 
used as the primary detector, read out by PMTs, with a tungsten collimator (127 mm thickness, 
9.5 mm slit opening). The prototype achieved statistical precision of ~1 mm standard deviation 
for absolute range verification and 0.4 mm for relative verification, based on 5 pencil beams 
delivering 5 × 108 protons. However, improving the detection efficiency by an order of 
magnitude was anticipated to be feasible for a full-scale system and can achieve the clinically 
required dose for millimetre accuracy [170]. More recently, preliminary experimental 
measurements of the full-scale prototype were published in Hueso-González et al. (2018) [59]. 
The energy- and time-resolved spectral measurements of PG rays were employed with slit 
collimation and integrated with a Monte Carlo simulation-based treatment planning system. In 
realistic clinical conditions, the clinical prototype can verify the absolute range of the proton 
pencil beams with high spatial precision (1.1 mm). In this approach, the temporal information of 
PG rays was used to reject the background gamma rays from proton-induced and neutron-
induced continua, but the temporal information could further be employed with hybrid PG 
detection systems for extracting beam range information. 
2.3.3 Prompt Gamma Timing (PGT) 
PGT is a novel method of range assessment proposed by Golnik et al. (2014) [171], 
which is based on an elementary physical effect whereby ions traversing tissue have a time 
interval of transit from entering the patient to stopping in the target volume. It has been 
determined that protons with a 5-20 cm range have a 1-2 ns transit time. Since the transit time 
increases with the particle range, there are measureable effects in the PGT spectra that can be 
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used for beam range tracking. The PGT spectrum was defined in this study as the transit time of 
the ion through the material as well as the flight time of the PG ray to the detector. In this study, 
kinematical relations were used to describe the relationship between PG emission and resultant 
time profiles. The technique was explored for homogeneous and inhomogeneous targets. Proton 
irradiation experimental measurements were also performed to verify the concept, at the AGOR 
cyclotron KVI-CART University of Groningen. The proton beam energy was fixed at 150 MeV 
for all the experiments, with various PMMA and graphite targets irradiated, and PGT spectra 
measured with a GAGG(Ce) scintillator coupled to a Photonis PMT. Model calculations 
precisely reproduced the experimental results. The analysis was focused to an energy window 
ROI set to 4.3-4.5 MeV. The proton transit time was shown to directly correlate to, and be 
measurable, with statistical moments such as the mean μ and standard deviation σ of the PGT 
spectra, and hence also correlate to the proton range (see Figure 13). A change in the target 
position corresponded to a change in the PGT spectrum mean. Increasing the thickness of 
protons traversing the target from 5 to 15 cm led to a broadening in the PGT spectra, which was 
also observed when increasing the beam energy from 50 to 230 MeV corresponding to a change 
in the range from 2 to 17 cm. Range variations of 2 mm were expected to be clearly detectable 
with this monitoring approach [171]. More recently, Werner et al. (2017) [172] demonstrated 
the feasibility of the PGT method to enable range verification with 2-3 mm accuracy in clinical 
conditions. Six PG detection units were employed, each consisting of a 2” × 1” diameter or 2” 
× 2” diameter CeBr3 scintillation detectors, with no collimation hardware; the use of multiple 
detectors improves the measured statistics. The main limiting factors of this method were 
identified as the long-term phase shifts and strongly damped phase oscillations between the RF 
and proton bunches after changing the beam energy between PBS layers. Yet, introducing a 
bunch phase monitor may improve the accuracy of the method. Further work by the group is 
being conducted to construct a ‘PGT snout’ that integrates up to 8 CeBr3/U100 detection units 
in the beam delivery system of the proton therapy facility [172]. Unlike PET and other 
collimated PGI systems, PGT is based on straightforward measurements with an uncollimated 
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Figure 13: Range-dependent mean 𝜇γ (left) and standard deviation 𝜎γ (right) values of modelled PGT 
spectra. Proton energies are in the range of 50 to 230 MeV, corresponding to proton ranges of 2 to 27 cm 
in a PMMA target. The assumed system time resolution is 450 ps. From Ref. [171]. 
 
2.3.4 Prompt Gamma Peak Integration (PGPI) 
PGPI is a technique that has also been introduced as a simple and cost-effective means 
of detecting deviations from the prescribed treatment during particle therapy, using the integrals 
of uncollimated PG timing distributions. As with the PGT method, the correlation of the mean 
value and width of TOF distributions with the energy and range of incident particles is utilised. 
However, this PGPI technique uses, in addition, the integral to verify the beam range and 
energy deposited, thus approaching in vivo dosimetry. Krimmer et al. (2017) [173] performed 
measurements with 65 MeV protons, where the proton range inside a homogeneous PMMA 
target was varied using a modulator wheel. Scintillation detectors LaBr3(Ce) (25.4 × 25.4 × 
72.2 mm3) and BaF2 (hexagonal shaped, with an edge length of 50 mm and length of 140 mm) 
were positioned at 90o or 45o, with respect to the beamline, to reduce background events (since 
neutrons are predominantly forward emitted). PG rays registered with the LaBr3(Ce) scintillator 
were read out via a dedicated DAQ card. The high frequency signal of the accelerator served as 
time reference for determining the TOF. The measured variation of the PG TOF peak integrals 
as a function of the modulator position was found to be consistent with simulations. With 108 
incident protons and detectors covering a solid angle of 25 msr (corresponding to a diameter of 
3-4 inch at a distance of 50 cm from the beam axis), deviations of a few per cent in the PG count 
rate can be detected. For the configuration in the study, this change in count rate corresponded 
to a 3 mm change in the proton range in a PMMA target. A displacement of the target toward or 
away from the detector alters the PG count rate due to the difference in the absorption, whose 
effect is of the same order of magnitude as a possible deviation to be detected. Moreover, 
simulations showed that the signals from multiple detectors may be combined as ratios to obtain 
information about the target placement or as (geometric) mean which is independent on the 
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actual target position. This technique may be a simple monitoring device used independently 
from other monitoring devices of the beamline [173]. 
Each approach developed to utilise PG rays for beam range monitoring for particle 
therapy treatment delivery has its own advantages and limitations. The techniques however 
exploit one specific feature of the PG rays (such as spatial in PGI, energy in PGS and time in 
PGT), where complementary features are used for event filtering (such as using timing 
information in PGI and PGS for reducing background interference caused by neutrons) rather 
than extracting range information [19]. Hybrid detection methods may instead be essential in 
overcoming the challenges of a broad- and high-energy PG ray distribution, significant 
interference background, high instantaneous count rates, and compatibility constraints with 
patient irradiation. This therefore calls for systematic studies of PG ray emission and detection 
characteristics in multi-dimensions of space, energy and time. 
2.4 The Role of Monte Carlo Simulations in in vivo Dosimetry Using 
Prompt Gamma 
Monte Carlo simulations play a crucial role in in vivo range and dosimetry verifications 
with PG rays because such verifications are based on comparisons between measured data and 
predicated ones. The role of simulations and PG has been reviewed by Krimmer et al. (2018) 
[57] and that of Monte Carlo simulations in the context of range uncertainties discussed by 
Paganetti (2012) [9]. In this section, some of these aspects are mentioned but focus is placed 
upon the topics of relevance to this thesis. 
Simulation tools are not only employed for the research of PG rays as reviewed in the 
previous section, they are also used clinically as a means of comparing the obtained 
measurements with expected outcomes. The predicted results are obtained from simulations that 
are based on specific DICOM data (patient planning CT volume and treatment plan) and beam 
models (radiation quality). Thus, it is important that the physics models and data in the 
simulation are accurate and reliable, since the production of PG rays depends on the particle 
energy and target nucleus [57]. 
The predicted outcomes may be obtained via Monte Carlo or analytical methods. Using 
Monte Carlo to simulate PG emissions for treatment plans can be very time consuming [174-
176]. Ways to improve efficiency include, for example, a GPU-oriented implementation of the 
Monte Carlo engine, such as goCMC which can accurately calculate dose within a few tens of 
seconds (without electron and neutron transport) and CUDA gPMC which can improve the 
efficiency by three orders of magnitude [177,178]. Approximate methods, such as condensed 
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history transport and basic Variance Reduction Techniques (VRT), can also improve efficiency, 
which are already implemented in most Monte Carlo packages [179]. Analytical models using 
ray-tracing is more efficient, whereby PG emission profiles are generally precomputed with 
Monte Carlo simulations (e.g. PENELOPE [180]) and scored in tables while getting proton 
differential cross section data from ICRU report No. 63 [181] [57]. 
In the work of this thesis, the Monte Carlo simulation tools Geant4 (GEometry ANd 
Tracking) [182,183] and TOPAS (TOol for PArticle Simulation) [184] were employed to 
investigate PG rays for range verification and toward in vivo dosimetry in particle therapy. 
Geant4 is a Monte Carlo code written in C++ and uses the Object-Oriented Technology for 
simulating the passage of particles through matter [185]. It is used from High Energy Physics to 
medical physics, nuclear and accelerator physics, as well as space science. Geant4 provides a 
complete set of tools for radiation physics related problems, including extensive physics 
capability coupled with powerful geometry functionality. It also has other components, such as 
tracking, detector response modelling, visualisation, event biasing techniques, analysis, etc 
[186]. TOPAS is dedicated to proton therapy simulations. It wraps and extends the Geant4 
simulation toolkit with a unique parameter control system that allows the user to assemble and 
control a rich library of simulations objects, such as geometry components, particle sources, 
scorers, etc, with no need to write C++ code. However, simulation objects in C++ code may still 
be implemented in TOPAS via an extension mechanism. The full flexibility of Geant4 can be 
exploited while user-written objects benefit from underlying functionality of TOPAS base 
classes and the parameter system [187]. 
Geant4 has been extremely popular for the development and clinical implementation of 
particle therapy techniques. Validation studies of the Geant4 models for protons [174,188-193], 
carbon ions [174,194-199] and helium ions [200] have been performed. TOPAS has also been 
used in several studies, particularly for proton therapy applications [201-204]. A validation of 
TOPAS was performed for proton therapy treatments with passive scattering at MGH based on 
routinely performed QA measurements [205], and the feasibility and accuracy of TOPAS for 
carbon ion therapy has been investigated [206]. 
In terms of calculating the stopping power and particle range in Monte Carlo, the main 
uncertainties are from the material density and the ionisation energy 𝐼  in water. As mentioned 
in Section 1.2, stopping powers obtained from CT scans have uncertainties, such as calibration 
of the CT scanner and conversion from HU. Stopping power models in Monte Carlo are 
typically benchmarked with standard QA in-house dosimetry measurements performed with 
ionisation chambers, calorimeters, and Faraday cups. The validation of these models at 
therapeutic energies is important [65]. In terms of the PG emission and yield, uncertainties in 
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modelling nuclear interactions are mainly from cross sections, where total cross sections and 
double differential (energy and angle) cross sections are most relevant. Uncertainties also arise 
when tissue composition is inferred from CT scans. Dosimetry can assist in the validation of 
nuclear models, which can be done in-house with Faraday cup measurements, but it is often 
impossible to perform direct experimental validation [57,65]. 
Several studies have evaluated nuclear models for secondary particle production and 
depth-dose profiles, and quantitatively characterised PG emission yields with Monte Carlo 
codes [174,207-212]. Differences of the PG emission between Monte Carlo codes and existing 
evaluated data exist depending on the target and gamma line under consideration. Le Foulher et 
al. (2010) [207] compared simulation with experiments and found that simulations overestimate 
PG detection yields by a factor of 12. Verburg et al. (2012) [143] simulated proton-induced 
nuclear reactions using Geant4 and MCNP6 with TALYS and EMPIRE, and optimised input 
parameters and model selection. The results were compared to evaluated ENDF/B-VII cross 
sections, where model estimates of the total gamma production near the end-of-range differed 
by a factor of about 2. Recent efforts to assess and improve the accuracy of PG productions in 
Geant4 physics for particle therapy have been reported. Dedes et al. (2014) [208] found 
improvements of the Geant4 hadronic models when decreasing the width of the Gaussian wave 
function in the QMD model. Jeyasugiththan et al. (2015) [209] found that the precompound 
model with modified initial exciton state of 2 produced more accurate discrete gamma lines in 
comparing with available gamma production cross section data. Vanstelle et al. (2017) [212] 
found INCL++ to more accurately reproduce PG emission compared to BIC and QMD, in 
comparing with experimental data. Further work is required for the improvement of hadronic 
models and differential cross sections as well as PG yield measurements from particles at 
clinical energy range [22]. Although experiments have been performed for protons [170,211,213] 
and carbon ions [94,148,214] to evaluate PG emission yields, more precise nuclear physics 
models and accurate data for predicting the PG distribution are necessary in clinical routine [57]. 
2.5 Further Research Required in the Prompt Gamma Method 
 After years of research, the first clinical application of PGI-based range verification was 
performed with the knife-edge slit camera design by Richter et al. (2016) [152], with successful 
measurements of PG profiles during proton therapy, obtaining inter-fractional global range 
variations in the range of ±2 mm for all evaluated fractions. With the same camera design, Xie 
et al. (2017) [159] also performed clinical measurements and obtained range shift precision 
better than 2 mm. However, despite the developments for using PG rays to promote in vivo 
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particle beam range verification and beam dose delivery in real-time, the technology remains 
clinically unavailable. 
Dedicated detector systems are required to overcome the challenges of the broad PG 
energy spectrum, large background, high instantaneous count rates, and compatibility 
constraints with patient irradiation [24,28,140]. Hybrid detector systems, which utilise more 
than one feature of PG rays for extracting range information or dosimetry have potential, but a 
system that meets the requirements of such PG measurement require further research efforts; 
excellent energy and time resolution, high-throughput spectroscopy, and comprehensive data 
analysis and reconstruction [19]. As well, although studies have shown a good correlation 
between the PG production position and dose delivered, there is no exact one-to-one 
relationship representing this correlation since they result from different physical processes. 
Hence, numerous factors influence the accuracy of beam range and dose verification using PG 
rays, including also changes in the primary particle energy and phantom properties [215]. A 
recent study from Krimmer et al. (2017) [173] showed that the count variations of the PG TOF 
peak integral have a strong correlation with the beam range deviation. Further investigation into 
the effect of heterogeneous targets, beam type and energy, as well as the necessary technology 
for fast timing detection, may lead to a simple cost-effective technique for particle range 
verification during particle therapy treatment. Furthermore, the challenges of Monte Carlo codes 
should also be addressed to improve the accuracy and efficiency of the codes for use with the 
PG method. 
Our project aims to further develop the understanding of PG ray characteristics with 
determining optimal methodologies for PG detection, detector technology requirements and 






3   Characterisation of Prompt Gamma Rays for 
Beam Range Verification 
 
 The detection of PG rays is challenging due to the broad and relatively high-energy 
range (compared to PET) with strong interference background from neutrons and other stray 
radiations. Innovative detection methods, by utilising either or complementary features of PG 
ray characteristics, are pursued to extract the PG signal from the background; this can therefore 
lead to hybrid PG detection systems. Hence, the Monte Carlo simulation Toolkit Geant4 
[182,183] was adopted in this study for the characterisation of PG rays in terms of energy, space 
and time to determine optimal detection methodologies and technologies for particle beam range 
monitoring. Initially, a homogeneous spherical-shaped water phantom was used to characterise 
the emission and detection with an ideal detecting sphere surface encompassing the phantom. In 
this study, three different ion species were investigated: proton, helium (4He) and carbon (12C). 
Each particle beam was simulated at four different energies to also observe the influence of 
varying beam range on PG emission and detection profiles for range monitoring purposes. To 
study the PG characteristics from various target materials and the effect of phantom geometry, 
homogeneous cylindrical-shaped water, polymethyl methacrylate (PMMA) and adipose tissue 
phantoms were also irradiated with the same three ion species. To then investigate the PG 
characteristics from heterogeneous phantoms, a realistic head phantom, the Computerized 
Imaging Reference Systems (CIRS) paediatric head phantom, Giacometti et al. (2017) [216], 
was modelled in the Geant4 simulation as treatment target and irradiated with 100 MeV protons. 
The model was also adapted such that the head phantom was made water-based, with only the 
air-pockets remaining. This allows direct comparison between a water-based and realistic head 
phantom, to investigate the effect of modelling a realistic target treatment, with different tissues, 
on the proton beam range as well as the characteristic properties of PG rays. 
Part of the work in this chapter has been published in Characterization of prompt 
gamma ray emission for in vivo range verification in particle therapy: A simulation study, 
Physica Medica, 62, 2019 (Ref. [217]). Certain figures have been reproduced from the 
publication. 
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3.1 Monte Carlo Geant4 Simulation Set-up 
3.1.1 Homogeneous Spherical and Cylindrical Phantoms 
Geant4 (version 10.02.p02) was used to investigate the characteristic emission of PG 
rays from particle beam irradiations of a homogeneous spherical-shaped water phantom (density 
of 1 g/cm3). The simulation set-up is shown in Figure 14. Mono-energetic pencil beams of 
proton, 4He and 12C ions were studied, irradiating the phantoms with the beam axis crossing the 
centre of the phantom. The primary particles originate at the phantom surface, such that they do 
not interact with air before reaching the target; the beam is therefore not degraded before 
irradiating the phantom. The phantom size was chosen as 40 cm diameter to represent the size 
of a human abdomen, and for simplicity, a spherical shape was initially used. Depth dose curves 
were obtained by calculating the energy deposited in the phantom along the direction of 
incidence of the beam (z-axis). The bin size of the depth dose profile was 1 mm. At the position 
of the BP the energy deposited along the x-axis was also calculated, for a longitudinal width of 
10 mm. Proton and 4He beams of 62, 150, 200 and 250 MeV/u, and 12C beams of 120, 285, 385 
and 490 MeV/u were simulated. These energies correspond to ranges (80% distal dose fall-off) 
of approximately 30, 160, 260 and 380 mm in water, as determined from the simulation results 
of this thesis. These values are consistent with NIST [218] for proton/helium ions and SRIM 
[219] for carbon ions taking into consideration that they calculate the ranges with the CSDA and 
projected range algorithm (PRAL), respectively. These energies were chosen since they are 
typical of therapy treatment for the respective particle types with the exception of the energies 
250 MeV/u of 4He and 490 MeV/u of 12C, which were also included for comparison. 
To study the characteristic PG emission from different material compositions and the 
PG detection from phantom geometric effects, the study was repeated for cylindrical-shaped 
water, PMMA and adipose tissue materials of 40 cm diameter and 40 cm height. Adopting the 
same set-up, the cylindrical phantoms replace the spherical phantoms in Figure 14. The cylinder 
phantom materials were based on the Geant4 NIST materials database [220]: water (H2O, 
density of 1.0 g/cm3), plexiglass (C5H8O2, density of 1.19 g/cm
3) (also referred to as PMMA) 
and adipose tissue (ICRP) (primarily H (11.4%), C (59.8%) and O (27.8%) with 0.7% N, 
density of 0.95 g/cm3). The particle beam energies for each phantom were: 
Water – proton 61, 149, 197, 248 MeV, 4He 60, 148, 196, 247 MeV/u, 12C 112, 282, 
380, 486 MeV/u; 
PMMA – proton 66, 163, 216, 272 MeV, 4He 65, 162, 215, 271 MeV/u, 12C 122, 309, 
418, 536 MeV/u; and 
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Tissue – proton 60, 147, 195, 245 MeV, 4He 59, 146, 194, 244 MeV/u, 12C 109, 280, 
379, 484 MeV/u. 
These energies correspond to ranges of approximately 30, 160, 260 and 380 mm, such 
that the deviation between the respective beam range in the phantoms were within 3 mm. 
In all cases, the number of incident particles was 108 for protons, 107 for 4He ions and 
106 for 12C ions to obtain a statistical uncertainty of 5% in the yield of PG rays. The statistical 
uncertainty was calculated with 1/√𝑁, where 𝑁 is the number of counts. The uncertainties are 
purely statistical; those that affect physics concepts are not taken into account here. 
Characterising the photon and neutron radiation fields escaping the phantom provides 
beneficial information which assists in choosing potential PG detectors. To score the photons 
and neutrons that are emitted from the phantom, an air-filled idealised detecting sphere surface 
(referred to as detection sphere) encompassing the phantom was used, with a diameter of 100 
cm. When the photon/neutron traverses the surface of the sphere, they are counted. 
A fixed point-of-reference, corresponding to the centre of the Geant4 simulation 
coordinate system (see Figure 14), was chosen at the surface of the phantom for simplicity. An 
alternative option would have been to select the BP position as point-of-reference, however, this 
position varies within the phantom depending on the particle beam energy, therefore it was not 
identified as a suitable reference point for all the simulation set-ups considered; the chosen 
point-of-reference is similar to the clinical practice of having a fixed point-of-reference on the 
patient surface. 
The angular emission characteristics of PG rays was studied in terms of the polar angle 
θ between the incident beam direction and the line connecting the point-of-reference to the point 
𝑃 traversed by the photon on the detection sphere (see Figure 14). φ is the azimuthal angle 
between the x-axis and the line connecting the point-of-reference to the point 𝑃 traversed by the 
photon on the detection sphere. The angular emission study allows identifying eventual 
preferential PG emission directions, which would allow identifying preferential locations of the 
PG detector/s to maximise the detected PG yield and minimise the neutron yield. 
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Figure 14: Left: Geometrical simulation set-up of the spherical water phantom in an air-filled detection 
sphere. Right: The angle θ  is formed from the longitudinal beam direction (z-axis) with the line 
connecting the centre of the coordinate system and the point 𝑃. 𝑃 is the PG detection position on the 
detection sphere traversed by the photons, and φ is the azimuthal angle. For the case of the cylindrical 
phantom, it replaces the spherical phantom in the simulation set-up, with the main axis along the direction 
of the incident beam. 
 
A modularised Geant4 Physics List was used which included both electromagnetic 
(G4EmStandardPhysics_option3) and hadronic physics processes (QGSP_BIC_HP). The 
G4RadioactiveDecayPhysics and G4HadronElasticPhysicsHP modules were active. The 
QGSP_BIC_HP was chosen as it was found adequate for proton and carbon therapy studies in 
Ref. [190,199,221]. Total cross sections are described by the Glauber-Gribov theory [222] and 
the final state of inelastic scattering is generated by the Binary Cascade model [223]. The High 
Precision (HP) Neutron Data Libraries [224] were used to more accurately model the neutron 
interactions from thermal energies up to 20 MeV. 
The simulation output consisted of the yield of photons and neutrons generated within 
the phantom, and those that reach the detection spherical surface. The yield was normalised to 
the number of incident particles on the phantom. The PG emission time was calculated as the 
time interval between the origin of the primary particle in the simulation (particle incident on 
the surface of the phantom) and the time of origin of the PG ray in the phantom. The PG 
detection time, defined as TOF, was calculated as the time interval between the origin of the 
primary particle in the simulation and the time when the PG ray reaches the detection sphere. 
The gamma TOF distribution mean and integral were retrieved from the simulation. 
The primary PG rays are referred to those produced from the primary particle 
interactions, and the secondary PG rays are referred to those produced from the interactions of 
the secondary radiation field. The primary and secondary PG rays were differentiated to more 
closely study their correlation to the particle beam range. 
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In the post-simulation data analysis, several parameters of PG emission and detection 
were investigated: 𝑅, the particle beam range defined as the position of 80% BP distal fall-off 
along the beam path in the phantom; 𝑅 , the PG range defined as the position of 80% PG 
emission yield fall-off in the phantom; ∆fall-off, the difference 𝑅 − 𝑅  used to quantify the 
longitudinal correlation between the PG emission fall-off and the beam range; ∆FWHM, the 
difference between the lateral PG emission distribution FWHM and lateral dose distribution 
FWHM for a 10 mm longitudinal thickness at the BP position; 𝑇 , the 80% fall-off of the PG 
emission time distribution; and 𝑇 , the time difference between 80% rise and fall-off of the 
TOF spectra peak. 
The energy spectrum of all photons generated in the water phantom, via any physical 
interaction process, allowed the observation of the prominent PG emission lines and the 
selection of two energy regions of interest: an energy threshold of ≥1 MeV, which eliminates 
the low-energy background photon counts [225] (e.g. positron annihilation photons at 0.511 
MeV), and a 3.0-7.0 MeV energy window, which includes the prominent PG emission lines and 
has been employed in previous studies [176,226]. The energy threshold and window were used 
to analyse the PG emission yield, the spatial correlation between PG rays and the BP position, 
and the temporal and detection properties. In addition, in Section 3.4, when calculating the PG 
emission yield to deposited energy ratio for the different ion species, the energy deposited and 
scored at the BP maximum was taken. 
3.1.2 Realistic DICOM-formulated Head Phantom 
The high resolution voxelised head phantom utilised in this work was created from the 
CT scan of the ATOM® Model 715 HN, CIRS Inc., Norfolk, VA, paediatric head phantom. In 
this study, Geant4 (version 10.04.p02) was used to simulate a mono-energetic 100 MeV proton 
beam irradiating the realistic head phantom. At this energy, the proton CSDA range is 7.7 cm in 
water and 8.1 cm in adipose tissue (ICRP) according to NIST [218]. The proton beam energy 
was chosen so that the position of the BP corresponds to the centre of the phantom. The beam 
had a radius of 2.5 mm and a sigma_r (traverse standard deviation of beam position profile) of 
11 mm. The protons are incident on the left-side of the head phantom, with an air gap between 
the initialisation of the beam to the phantom surface of approximately 30 cm, which is a 
common distance in particle therapy. Figure 15 shows an image of the realistic head phantom as 
implemented in the Geant4 simulation. 109 incident protons were simulated to obtain a 
statistical uncertainty of 3% in the yield of PG rays. Depth dose curves were obtained by 
calculating the energy deposited in the phantom along the direction of incidence of the beam (x-
axis). The bin size of the depth dose profile was 1 mm. This study also included the idealised 
detecting spherical surface as used in the previous section; in this case the centre of the 
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detection sphere corresponds to the centre of the phantom. This was done so to have the centre 
of the detection sphere and phantom correspond also to the position of the BP; as mentioned, the 
proton beam energy of 100 MeV was chosen to have the beam range at the centre of the 
phantom. The Geant4 physics, scoring/simulation output, and post-simulation data analysis are 
as described in the previous section. Additionally, the realistic heterogeneous head phantom as 
readily available in Geant4 was modified to obtain a water-based head phantom. That is, air 
pockets in the phantom remained unmodified while all other voxels were changed to water 
(density of 1 g/cm3) such that only two materials, air and water, made up the head phantom. 
 
Figure 15: Geant4 visualisation of a slice of the realistic head phantom, as implemented in the Geant4 
extended example DICOM [216]. The proton beam is not to scale. 
3.2 Energy Spectra of Prompt Gamma Emission 
In this section, the results for the PG emission spectra of proton, 4He and 12C ions 
irradiating water, PMMA and adipose tissue phantoms are presented. PG rays have a broad 
energy spectrum with strong interference background from secondary neutrons and stray 
gamma rays, which makes their detection a challenge. And so, an optimal energy threshold or 
window to be applied potentially in practice for improving the PG signal-to-noise ratio was 
investigated. Additionally, the PG spectrum is characteristic to the elemental composition of the 
target material, and so this aspect was also investigated for both homogeneous and 
heterogeneous (a realistic paediatric head) phantoms. 
3.2.1 Homogeneous Phantoms 
In this study, the energy spectra of photons generated within the spherical water 
phantom was first examined. Figure 16 shows the spectra resulting from any physical 
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interaction (including gamma photons induced by neutrons) for the three beam particle types. A 
consistent shape over a wide energy range is seen in the spectra for each particle type, with 
several characteristic emission lines produced by inelastic particle-nuclei interactions with 
major constituent elements of the phantom material. 
Positron annihilation from the decay of 15O and 11C nuclei, among other isotopes, 
contributes to the 0.511 MeV peak. Secondary thermal neutron capture by hydrogen nuclei 
results in the 2.22 MeV peak. A 2.31 MeV peak arises from 14N* by proton and alpha spallation 
reactions with 16O [227], which may be difficult for a detector to resolve from the 2.22 MeV 
emission line. The prominent PG emission lines are observed with energy 4.44, 5.21 and 6.13 
MeV, which are the most proposed for beam range verification. The 4.44 MeV PG emission 
line originates from the de-excitation of 12C* nuclei, derived from nuclear interactions of 
particles with oxygen nuclei. The 5.21 and 6.13 MeV PG emission lines arise from 15O* and 
16O* de-excitations, respectively. The distinctive 6.92 and 7.12 MeV lines are higher nuclear 
level emissions from 16O*. The intensity of 4.44, 5.21 and 6.13 MeV lines are comparable to the 
2.31 MeV line, but the 2.31 MeV line could be challenging to detect since it could be merged 
with the neutron capture line and detection will depend on the energy resolution of the detector. 
The 0.718 MeV PG line can also potentially be used for beam range verification but it may too 
be challenging to resolve in some detectors, such as LYSO detectors where detector intrinsic 
radioactivity may interfere with the PG signal. 
The energy spectra of gamma ray emission within PMMA and adipose tissue phantoms 
also show a spectrum characteristic to the elemental composition of the materials. Figure 17 
shows the spectra from homogeneous cylindrical water, PMMA and tissue phantoms for the 
three beam particle species with a range of ~16 cm in the materials. A higher concentration of 
carbon or oxygen in the target material is representative in the corresponding gamma emission 
spectra. The gamma energy spectra from PMMA and tissue show a larger intensity of the 4.44 
MeV line due to the higher concentration of carbon in the materials. On the other hand, the 
water phantom gives a larger intensity peak at the 5.21 and 6.13 MeV lines due to its larger 
concentration of oxygen when compared to the other materials under study. In addition, two 
peaks are seen to arise in the spectra from PMMA and tissue targets, at 3.21 and 4.94 MeV, 
from 12C and 13C respectively, which are not present in the spectra obtained with the water 
phantom. The characteristic gamma emission spectra, which are dependent on the elemental 
composition of the irradiated target can thus be exploited for identifying the target material, as 
studied in Ref. [26,28,140]. 
 
 























Figure 16: Energy spectra of photons generated in the homogeneous spherical water phantom deriving 
from pencil beams of protons, 4He and 12C ions. The emission lines are characteristic to the major 
constituent elements of the phantom material. The distinctive PG emission lines of energy 4.44, 5.21 and 
6.13 MeV result from 12C, 15O and 16O nuclear de-excitations, respectively. 
 
 























Figure 17: Energy spectra of photons generated in the homogeneous cylindrical water, PMMA and 
adipose tissue phantoms deriving from pencil beams of protons, 4He and 12C ions with a range of ~16 cm 
in the materials. The emission lines are characteristic to the major constituent elements of the phantom 
material. The distinctive PG emission lines of energy 4.44, 5.21 and 6.13 MeV result from 12C, 15O and 
16O nuclear de-excitations, respectively. 
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3.2.2 Realistic Head Phantom 
Figure 18 shows the energy spectra of photons originating within the water-based and 
realistic heterogeneous head phantoms, which show PG emission peaks characteristic to the 
elemental compositions of the phantom. The 2.31 MeV peak from 14N is clearly evident in the 
spectra arising primarily from the air pockets in the phantom: the material of air in the model 
comprises 70% nitrogen. However, as mentioned in the previous section, this peak may be 
difficult for a detector to resolve from the 2.22 MeV peak. The prominent PG emission lines of 
4.44, 5.21 and 6.13 MeV from 12C, 15O and 16O nuclei, respectively, remain dominant in the 
spectrum. In the water-based head phantom the intensity of emission peaks from oxygen (e.g. 
5.21 and 6.13 MeV) appear larger, while in the realistic phantom those from carbon (e.g. 3.21 
and 4.44 MeV) are larger, as expected, since for example materials such as adipose tissue 








Figure 18: Energy spectra of photons generated in the water-based and realistic head phantoms irradiated 
with a 100 MeV proton beam. The emission lines are characteristic to the major constituent elements of 
the phantom material. The distinctive PG emission lines of energy 4.44, 5.21 and 6.13 MeV result from 
12C, 15O and 16O nuclear de-excitations, respectively. 
 
The relative intensity of emission lines for the prominent PG energies 4.44, 5.21 and 
6.13 MeV from 12C, 15O and 16O, respectively, show a dependency on the material composition 
of the target. In water, the 6.13 MeV emission line from 16O is largest, followed by the 4.44 and 
5.21 MeV lines. In PMMA and adipose tissue, as with the realistic head phantom, the 4.44 MeV 
emission line is seen to increase, due to the greater concentration of carbon in the materials. In 
considering evaluated nuclear cross section libraries ENDF/B-VIII.0 [228] and TENDL-2017 
[229], for which the IAEA website [230] was referred to, the simulation is seen to reproduce 
these prominent PG emission lines relatively reasonably. For example, cross section data from 
ENDF/B-VIII.0 show for 16O(p,)16O a maximum of ~0.40 barns at an incident proton energy 
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of ~10 MeV, while for 12C(p,)12C a maximum of ~0.25 barns at ~8 MeV, and for 16O(p,)15O a 
maximum of ~0.1 barns at ~30 MeV. However, for incident helium ions cross section data from 
TENDL-2017 suggest that the emission yield for 12C(4He,)12C reactions is greater than 
16O(4He,)16O, followed by 16O(4He,)15O, with a maximum cross section of ~0.3 barns for 
12C(4He,)12C and ~0.14 barns for 16O(4He,)16O for an incident ion energy of ~35 MeV, and a 
maximum cross section of ~0.1 barns for 16O(4He,)15O at ~40 MeV. The simulated gamma 
energy spectra from PMMA and tissue phantoms seem to agree with the cross section data 
available in the literature [230], although the greater concentration of carbon in the materials is 
also an influencing factor. Yet in the water phantom the 4.44 MeV emission line from 4He 
irradiation appears to be underestimated. 
3.3 Spatial Correlation between Prompt Gamma Emission and Particle 
Beam Range 
In this section, the results of the PG emission spatial correlation with the particle beam 
range are presented. The spatial correlation between PG production and dose deposition is not 
one-to-one, since the two result from different physical processes. Here, the correlation was 
studied quantitatively in homogeneous and heterogeneous phantoms to observe the correlation 
resulting in the different types of targets. PG rays were also differentiated into primary and 
secondary to more closely study their respective correlation to the beam range. 
3.3.1 Homogeneous Phantoms 
Figure 19 shows the longitudinal and lateral distribution of gamma rays with an applied 
1 MeV threshold originating in the phantom. The Bragg curve (depicted for a range of ~16 cm) 
is plotted with the total, primary and secondary gamma ray longitudinal emission distribution to 
show their correlation with the dose deposition. The primary PG profile is seen to exhibit the 
closest correlating relationship to the beam range regarding the sharpness and fall-off in the BP 
region, which can offer reliable BP monitoring in particle therapy. The secondary PG profile, 
which is more dominant in the heaver ions compared to protons, shows a broader distribution 
with a long tail beyond the BP downstream, which could cause significant interference for BP 
monitoring. A discontinuity can be seen in the PG emission of 4He and 12C beams, which may 
be due to the transition to the precompound model at low energy nuclear reactions. The 
transition between high- and low-energy nuclear reaction models occurs at around 140 mm for 
4He and at around 160 mm for 12C. The lateral profiles of PG emissions are consistent with the 
lateral dose spreads; the PG emissions are broader with increasing beam energy, and the carbon 
ion beam shows narrower lateral spread than the proton beam, as expected. 















Figure 19: Left: Longitudinal yield distribution of total, primary and secondary gamma rays ≥1 MeV 
originating in the water phantom for protons (150 MeV), 4He (150 MeV/u) and 12C (285 MeV/u) ions. 
The percent depth dose is normalised to the dose maximum at the Bragg peak. Right: Lateral yield 
distribution of total gamma rays ≥1 MeV for a longitudinal width of 10 mm at the BP positions for each 
of the beam energies. 
 
Table 2 presents data for the particle beam range and corresponding PG range for the 
applied energy threshold and window, for each incident particle type and energy studied. The 
quantified longitudinal difference, ∆fall-off, shows that the PG rays within 3.0-7.0 MeV offer 
better correlation to the particle range, particularly in the case of incident protons. For a ~16 cm 
beam range, the ∆fall-off values are (-5.1 ± 0.5) mm, (+0.2 ± 0.5) mm and (+0.3 ± 0.5) mm, 
for proton, 4He and 12C ions, respectively. Negative ∆fall-off values indicate that the PG range is 
upstream of the particle range, while positive values indicate downstream of the particle range. 
It was found that the selected energy window offers a lower gamma statistical yield (see Table 
5), whereas the energy threshold which still incorporates the prominent PG rays while 
eliminating low-energy background counts offers the benefit of a higher yield with good 
particle-PG range correlation, i.e. ∆fall-off values of within ~1.2 mm for 4He and 12C ions. 
Helium and carbon ions are seen to offer an improved accuracy (∆fall-off) in estimating the 
3   Characterisation of Prompt Gamma Rays for Beam Range Verification 79 
 
beam range compared to protons. The quantified lateral difference, ∆FWHM, shows millimetre 
conformity of the PG production with the dose deposition laterally. 
Table 2: Particle beam range and corresponding PG range for the applied energy threshold and window 
studied, for each particle beam type and energy. The ∆fall-off and ∆FWHM, defined in Section 3.1.1, are 

























































































































































































































* Negative values indicate that the PG range is upstream of the particle range, while positive values 
indicate downstream of the particle range. 
Table 3 presents the data for the particle beam range and corresponding PG range for 
each incident particle type with a range of ~16 cm in water, PMMA and adipose tissue. The 
quantified longitudinal difference, ∆ fall-off, is found to not vary largely between the three 
homogeneous phantoms, i.e. within ~1.4 mm for protons and within only ~0.3 mm for 4He/12C 
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ions. Rather, a more considerable difference is observed between the ion species, with ∆fall-off 
values of around 5-6 mm for protons and around 0-1 mm for 4He/12C ions. This suggests that for 
the case of homogeneous targets, regardless of composition, there is a somewhat consistent PG-
BP fall-off correlation for a particular beam type. 
Table 3: Particle beam range and corresponding PG range in water, PMMA and adipose tissue for the 
applied energy threshold and window studied, for each particle beam type with ~16 cm range. The ∆fall-






























































































* Negative values indicate that the PG range is upstream of the particle range, while positive values 
indicate downstream of the particle range. 
3.3.2 Realistic Head Phantom 
The longitudinal emission distribution of gamma rays within the head phantoms rises 
and falls in relation to the beam entering the various materials of the phantom, such that the 
emission is sensitive to the elemental composition and the medium density. In higher density 
materials (e.g. bone) the gamma emission increases and in lower density materials (e.g. air) the 
gamma emission decreases. The published work, Zarifi et al. (2017) [231] (see Appendix 1), 
shows effects of target inhomogeneity, whereby the PG emission from a proton beam irradiating 
a multi-layered phantom was investigated. 
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Figure 20 shows the longitudinal distribution of total, primary and secondary gamma 
rays with a threshold of 1 MeV originating in the water-based and realistic head phantoms. The 
Bragg curve is also plotted to show the correlation of the gamma emission with the dose 
deposition. A (3.6 ± 0.7) mm shift in the proton beam range is seen between the water-based 
and realistic head phantoms, whereby the PG emission closely correlates to this shift. That is, 
for both phantoms the PG-BP fall-off difference remains at around 2-3 mm (see Table 4). This 
suggests that the PG emission fall-off closely correlates to the BP fall-off for heterogeneous 














Figure 20: Longitudinal yield distribution of total, primary and secondary gamma rays ≥ 1 MeV 
originating in the water-based and realistic head phantom for 100 MeV protons. The percent depth dose is 
normalised to the dose maximum at the Bragg peak. A (3.6 ± 0.7) mm shift in the proton beam range is 
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Table 4: Particle beam range and corresponding PG range in the water-based and realistic head phantom 
for the applied energy threshold and window studied, for a proton beam of 100 MeV. The ∆fall-off, 





















* Negative values indicate that the PG range is upstream of the particle range. 
It is therefore seen from these results that the primary PG emissions from the beam’s 
nuclear interactions offer the closest correlation to the deposited dose with sharp fall-off in the 
region of the BP, which is most suitable for BP monitoring in particle therapy. The PG-BP 
correlations are better for the heavier ions (millimetre accuracy) than for proton beams (within 
~7 mm). In studying the quantified longitudinal difference between three different 
homogeneous target materials, a larger difference is observed between the ion species rather 
than the ∆fall-off values for a particular material. This suggests that for homogeneous targets the 
PG emission fall-off consistently correlates to the BP fall-off for a particular beam type. The PG 
emission fall-off was also seen to closely correlate (within ~3 mm) to the BP fall-off for 
heterogeneous targets (water-based and realistic head phantoms) as well as the homogeneous 
ones. In the lateral spread, the PG emission and dose deposition were also observed to be 
correlated with millimetre accuracy. These properties indicate that the PG signal is a reliable 
means for in vivo beam range verification and dose monitoring in particle therapy. However, the 
primary and secondary PG rays are not quite differentiable in experimental measurements, such 
that the measurable PG signal is largely masked by the concurrent emission of secondary PG 
rays which arise from the nuclear reactions of secondary particles/fragments created along the 
primary ion path. This becomes a greater challenge for heavy ions whereby the secondary PG 
emissions (broad distribution and tail beyond the BP region) are more prominent. 
3.4 Prompt Gamma Emission and Detectable Yield 
In this section, the results on the emission yield of PG rays orginiating within the 
phantom and the detectable yield of those reaching the idealised detection sphere are presented. 
The possible available statistics, which may be one challenge for range verification in particle 
therapy due to the specific beam delivery structure and intensity constraints, were investigated. 
The PG emission yield and corresponding dose deposition was also investigated to determine a 
possible correlation which may be valuable to in vivo dosimetry. 
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3.4.1 Homogeneous Phantoms 
Table 5 presents the yield values of gamma photons originating in the spherical water 
phantom and those reaching the detection sphere, and with applied energy threshold/window, 
normalised to the number of incident particles on the phantom. For each beam type, the PG 
emission yield increases with particle depth, as expected. The 12C beam produces the highest 
yield of gamma emission, with a relatively larger yield of low-energy photon counts. For 
example, comparing the beam types with the same range of ~16 cm, the total gamma yield per 
incident particle is 0.87 for 150 MeV protons, 2.60 for 150 MeV/u 4He ions and 17.35 for 285 
MeV/u 12C ions, while the yield for PG rays within 3.0-7.0 MeV is 0.07, 0.22 and 0.62, 
respectively. This gives a ratio of total gamma to PG of 12.4, 11.8 and 28.0 for proton, 4He and 
12C, respectively. In other words, for 150 MeV protons the energy deposited at the BP 
maximum is ~3 MeV/ion, with a PG yield of ~7×10-4 /ion, which corresponds to ~2×10-4 PG 
rays emitted per MeV deposited energy at the BP. For 150 MeV/u 4He ions the energy deposited 
at the BP maximum is ~13 MeV/ion, with a PG yield of ~1×10-3 /ion, and ~8×10-5 PG/MeV at 
the BP. For 285 MeV/u 12C ions the energy deposited at the BP maximum is ~69 MeV/ion, with 
a PG yield of ~4×10-3 /ion, and ~6×10-5 PG/MeV at the BP. 
The detectable yield is less than the emission yield as expected, since the gamma rays 
interact within the water phantom and can eventually be absorbed. The detectable PG yield 
within 3.0-7.0 MeV on the detection sphere is found to be around 65%. The results again show 
that the 12C beam produces a larger yield of detectable PG rays per incident ion compared to the 
proton and 4He beams. The PG yield within 3.0-7.0 MeV per incident particle for the beams 
with ~16 cm range is 0.05 for protons (150 MeV), 0.14 for 4He (150 MeV/u) ions and 0.40 for 
12C (285 MeV/u) ions. 
Table 6 presents the yield values of gamma photons originating in the cylindrical water, 
PMMA and adipose tissue phantoms and those reaching the detection sphere, normalised to the 
number of incident particles on the phantom, for a beam range of ~16 cm. For each particle type, 
the gamma yield is greatest in the PMMA target and least in the tissue target. For example, for 
water, PMMA and tissue phantoms the total gamma yield per incident particle is 0.90, 0.92 and 
0.74, respectively for protons, 2.70, 2.87 and 2.27, respectively for 4He ions, and 17.73, 17.94 
and 14.39, respectively for 12C ions. In other words, for protons in water, ~1×10-4 PG rays 
within 3.0-7.0 MeV are emitted per MeV deposited at the BP maximum, i.e. ~3 MeV/ion with 
PG yield of ~3×10-4 /ion. Table 7 presents this quantitiative data for each particle type and 
target material. The detectable PG yield within 3.0-7.0 MeV on the detection sphere is found to 
be around 60% for a beam range of ~16 cm within the cylindrical phantoms. 
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Table 5: Yield of gamma photons originating within the spherical water phantom and those reaching the 
detection sphere once emitted from the phantom. The simulation statistical uncertainty is within 5%. 
Particle 
type 




       Gamma yield per incident particle 
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Table 6: Yield values of gamma photons originating within the cylindrical water, PMMA and adipose 
tissue phantoms for the beam energy corresponding to a range of ~16 cm, and the gamma yield reaching 






       Gamma yield per incident particle 
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Table 7: Yield values of PG rays within 3.0-7.0 MeV emitted per MeV deposited at the BP maximum 
within the cylindrical water, PMMA and adipose tissue phantoms for the beam energy corresponding to a 
range of ~16 cm. The simulation statistical uncertainty is within 1%. 






































3.4.2 Realistic Head Phantom 
Table 8 presents the yield values of gamma photons originating in the head phantoms 
and those reaching the detection sphere, normalised to the number of incident particles on the 
phantom. The gamma emission yields are found to be considerably different for the two targets; 
a factor of around 2-3 higher for the realistic head phantom than the water-based head phantom. 
The realistic to water-based head phantom ratio of total, ≥1 MeV and 3.0-7.0 MeV gamma 
yield is 2.2, 3.3 and 2.5, respectively. This is a result of the higher density materials within the 
realistic head phantom, in particular the bone structures. In other words, for 100 MeV protons in 
the water-based head phantom the energy deposited at the BP maximum is ~4.1 MeV/ion, with 
a PG yield within 3.0-7.0 MeV of ~6×10-4 /ion, which corresponds to ~1×10-4 PG rays emitted 
per MeV deposited energy at the BP. In the realistic head phantom the energy deposited at the 
BP maximum is ~4.3 MeV/ion, with a PG yield of ~5×10-4 /ion, and ~5×10-5 PG/MeV at the 
BP. In terms of dose at the BP position (1 mm thickness), ~6×105 PG rays emitted in the water-
based head phantom and ~5×105 PG rays emitted in the realistic head phantom correspond to 
approximately 0.02 Gy and 0.03 Gy delivered, respectively. 
The detectable PG yield within 3.0-7.0 MeV on the detection sphere is found to be 50% 
for the water-based head phantom and 80% for the realistic head phantom. Again, the higher 
yield of PG rays for the realistic head phantom compared to the water-based phantom may be 
due to factors such as elemental composition and material density. A higher concentration of 
elements such as carbon and oxygen increase the PG emission intensity at, for example, 4.44 
and 6.13 MeV, respectively. At higher density media (compared to water), the PG production 
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yield also increases, and in lower density media, the gamma ray attenuation is less, resulting in 
an increased detectable yield. 
Table 8: Yield values of gamma photons originating within the water-based and realistic head phantoms 
for 100 MeV proton beams, as well as the gamma yield reaching the detection sphere once emitted from 
the phantom. The simulation statistical uncertainty is within 3%. 
Head phantom Gamma energy selection (MeV) 
       Gamma yield per incident particle 
In phantom  Detection sphere 



















An important concept in particle therapy is whether there are enough PG statistics for 
spot tracking in PBS. Considering a typical PBS proton beam with a rate of 108 protons per 
second and a spot duration of about 20 ms, each spot will have 2×106 incident protons. Taking 
the case of the realistic head phantom and if the simulated beam incidence is considered as a 
single spot, for 2×106 incident protons at 100 MeV, the total detectable PG yield at energy ≥1 
MeV on the idealised detecting sphere would be ~1.6×105 with a production yield of ~2.0×105 
within the phantom. Considering a 5 ×  5 cm2 detector size on the simulated sphere, the 
detectable PG counts are ~3×102, yielding a statistical error of about 6%. This implies that spot-
by-spot monitoring using PG rays for this particular beam energy/geometry/detector size is a 
challenge in terms of obtaining sufficient statistics for clinical practice. However, improving the 
statistics can be achieved by accumulating data from several beam spots when they correspond 
to the same expected range, but this is at the expense of spatial resolution [57]. 
3.5 Angular Distribution for Detectable Prompt Gamma Rays 
In this section, the results on the angular distribution of PG rays reaching the idealised 
detection sphere are presented. This would allow identifying eventual preferential PG emission 
propagation, and in turn, identifying preferential positions for the PG detector/s to maximise the 
detected PG yield and minimise the neutron yield. Moreover, two different shaped phantoms, 
spherical and cylindrical, were studied to investigate the phantom geometric effects on PG 
detection. 
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3.5.1 Homogeneous Phantoms 
Figure 21 shows the angular distributions of total gamma rays reaching the idealised 
detection sphere once emitted from the spherical water phantom, normalised per incident ion per 
steradian, for each beam ion species and energy studied. At the low energies of 62 MeV/u 
(proton and 4He beams) and 120 MeV/u (12C beam), the detectable gamma rays are slightly 
preferred backward in θ = 100-180o (angle θ is defined in Section 3.1.1, see Figure 14). Yet at 
higher beam energies the detectable gamma rays become more forward in θ = 20-40o. Hence, 
with increasing depth of the BP position, the favourable PG detection is likely to be increasingly 
forward, and such forwardness appears to increase for the heavier ion species. The published 
work, Zarifi et al. (2017) [231] (see Appendix 1), shows further analysis from proton beam 














Figure 21: Angular distribution of total gamma rays reaching the idealised detecting sphere once emitted 
from the spherical water phantom normalised per incident ion per steradian for the lower two beam 
energies (left) and the higher two beam energies (right) for protons, 4He and 12C ions. 
 
Figure 22 shows the angular distributions of total gamma rays reaching the idealised 
detection sphere once emitted from cylindrical phantoms for each beam ion species and the 
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lowest/highest energy, normalised per incident ion per steradian. At the lowest energy (a beam 
range of ~3 cm) the detectable gamma rays from the different phantom materials are slightly 
preferred in θ = 100-180o, whereas at the highest beam energy (a beam range of ~38 cm) the 
detectable gamma rays become more forward in θ  = 20-40o. Hence, the angular detection 
distribution properties for the cylindrical phantoms (see Figure 22) are similar to those for the 
spherical phantoms (see Figure 21), such that with increasing depth of the BP position within 
the phantom the favourable PG detection is likely to be increasingly forward. However, the 
geometric effects of the phantom on the angular distribution are evident on the idealised 
detection sphere. The noticeable troughs in the plots are indicative of the greater path length the 
gamma rays travel within the phantom, and hence increased probability of 














Figure 22: Angular distribution of total gamma rays reaching the idealised detecting sphere once emitted 
from the cylindrical water, PMMA and adipose tissue phantoms normalised per incident ion per steradian 
for the lowest beam energy (beam range of ~3 cm) (left) and the highest beam energies (beam range of 
~38 cm) (right) for protons, 4He and 12C ions. 
 
3   Characterisation of Prompt Gamma Rays for Beam Range Verification 90 
 
By using an idealised detecting sphere, the angular distribution of detectable PG rays 
was investigated as a global context, for each particle type and energy under study. The 
observed non-isotropic longitudinal distribution of the detectable gamma rays is likely due to 
the kinematics of the nuclear reactions. The default cascade model of Geant4 physics was 
employed in this simulation study, which does not take into account angular momentum 
coupling of the gamma quanta emitted in a cascade. Understanding the influence of activating 
angular momentum coupling on the angular distribution requires further study. 
Attenuation/absorption of gamma rays within the phantom was considered, and so the geometric 
effect (e.g. phantom shape and size) also play a role in the angular variances seen on the 
idealised detecting sphere. In replacing the sphere phantom with a cylinder phantom, it was seen 
(Figures 21 and 22) that the shape of the phantom does have a considerable effect on the angular 
distribution due to attenuation/absorption. Additionally, since the target is not in the centre of 
the detection sphere, this introduces a dependency from the origin of the PG rays with 1/𝑟 . 
These factors may explain why the results of angular distribution in this study, which show a 
non-isotropic trend, are different to the experimental data in Ref. [94], for which no angular 
dependence was observed in the prompt photon yield at 90o and 60o measured with a LYSO 
detector (for deposited energy >2 MeV). Therefore, further investigation is necessary for the 
factors influencing the angular distribution of the detectable PG rays. 
3.6 Temporal Properties of Prompt Gamma Emission and Detection: 
Relationship with Particle Beam Range 
In this section, results on the timing properties of PG rays emitted within the phantom 
and those reaching the idealised detection sphere are presented. The relationship between the 
emission time and TOF distributions with the particle beam range were investigated, which may 
provide valuable information for in vivo range and dose monitoring using the temporal feature 
of PG rays, such as in the PGT [171] and PGPI [173] methods. 
3.6.1 Homogeneous Phantoms 
Figure 23 shows the emission time distribution of total gamma rays and those ≥1 MeV 
for each particle type and energy. The emission time profiles vary with particle energy, as 
expected, since the beam range/transit time also increases and so gamma rays are produced at 
greater depths in the phantom and hence at later time. The profiles with the applied threshold 
show a clear fall-off which is correlated to the dose profile fall-off. The PG emission time 𝑇  
for gamma rays ≥1 MeV is (2.5 ± 0.1) ns, (2.7 ± 0.1) ns and (1.9 ± 0.1) ns for protons, 4He 
and 12C ions with a range of ~38 cm. The gamma ray emission time from carbon ions is seen to 
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be quicker than that of proton and helium ions; possibly due to the carbon ions moving at 
greater speed as they traverse the phantom. Similar time emission properties are seen for 














Figure 23: Emission time distribution of total gamma rays (left) and gamma rays ≥1 MeV (right) 
























Figure 24: Emission time distribution of total gamma rays (left) and gamma rays ≥1 MeV (right) 


























Figure 25: Emission time distribution of total gamma rays (left) and gamma rays ≥1 MeV (right) 
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The TOF profiles of total gamma rays, neutrons and gamma rays ≥1 MeV reaching the 
idealised detecting sphere after emitted from the phantom are shown in Figure 26. As the 
incident particle energy increases their penetration depth (and travel time) becomes larger, 
hence the PG TOF peak mean exhibits a shift to longer TOF values while the peak 
width/integral increases. For proton beams, neutrons are not predominantly detected until 
around 3 ns, which may suggest another means of discriminating PG rays from the (neutron-
induced) background and therefore improve the signal-to-background ratio of PG detection. In 
the case of heavier ions, this may be more difficult particularly at high beam energies for which 
there is a greater presence of neutron production and temporal overlap between PG and neutrons. 















Figure 26: TOF spectra of total gamma and neutrons (left) and gamma rays ≥1 MeV (right) reaching the 
detection sphere once emitted from the spherical water phantom for protons, 4He and 12C ions. The bin 
width is 0.1 ns. 
 
 















Figure 27: TOF spectra of total gamma and neutrons (left) and gamma rays ≥1 MeV (right) reaching the 
detection sphere once emitted from the cylindrical PMMA phantom for protons, 4He and 12C ions. The 


























Figure 28: TOF spectra of total gamma and neutrons (left) and gamma rays ≥1 MeV (right) reaching the 
detection sphere once emitted from the cylindrical adipose tissue phantom for protons, 4He and 12C ions. 
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Figures 29 and 30 show 2D representations of the TOF spectra of primary gamma rays 
and those ≥1 MeV along the polar angle θ for each beam type and energy, respectively. Both 
the angular and TOF distributions of PG rays reaching the detection sphere are seen to change 
with increasing particle energy. With respect to the phantom surface, PG detection is seen to be 
increasingly forward-peaked with higher beam energy (as also seen in Figure 21). In addition, 
the TOF width increases and its maximum shifts to longer time values, particularly for proton 
and 4He ions, whereas 12C ion irradiations show less widening/shift in the TOF distribution with 
greater local increase in PG yield. Applying an energy threshold of 1 MeV to the primary 
gamma rays reaching the detecting sphere is seen to almost entirely eliminate the TOF tail, such 












Figure 29: TOF spectra along the polar angle θ of primary gamma rays reaching the detection sphere 




















Figure 30: TOF spectra along the polar angle θ of primary gamma rays ≥1 MeV reaching the detection 
sphere once emitted from the phantom for protons, 4He and 12C ions. 
 
Figure 31 shows the particle range plotted with the PG range and emission time, as well 
as PG TOF data (peak mean, width and integral), for each particle type and energy under study, 
irradiating a homogeneous spherical-shaped water phantom. The PG data are for those with 1 
MeV energy threshold. The PG range offers good correlation with the particle range, as seen in 
Section 3.3. 𝑇  values show a linear increase with particle energy, since the PG emission time 
is correlated to the beam transit time and hence the beam range. For a global idealised detection 
set-up, the PG TOF peak mean and width are found to only slightly increase with particle 
energy, with a minor drop in the case of 12C ions at higher energies. Conversely, the PG TOF 
peak integral values exhibit a greater linear increase with particle beam energy. This may 
suggest that a correlation between the PG range and corresponding emission yield with the 
beam’s range and corresponding energy deposition could potentially serve as a means for in 
vivo dosimetry. In the case of the homogeneous PMMA and adipose tissue cylindrical-shaped 
phantoms, the quantitative correlation of PG emission with the beam range and PG detection 
properties are found to be consistent to those for the spherical water phantom, seen in Figures 
32 and 33, respectively. This suggests that the quantitative PG emission and TOF detection data 
are a suitable means for range or dose monitoring for homogeneous phantoms of varying 
material and shape. 
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Figure 31: Quantitative comparison of the particle beam range with PG emission and detection data in 
the spherical water phantom for protons, 4He and 12C ions. Left: Particle beam range and corresponding 
PG range, with PG emission time. The dotted line joining the particle range values serves to guide the eye. 
Right: PG TOF peak mean, width and integral. All PG data are for gamma rays ≥1 MeV. The uncertainty 


























Figure 32: Quantitative comparison of the particle beam range with PG emission and detection data in 
the cylindrical PMMA phantom for protons, 4He and 12C ions. Left: Particle beam range and 
corresponding PG range, with PG emission time. The dotted line joining the particle range values serves 
to guide the eye. Right: PG TOF peak mean, width and integral. All PG data are for gamma rays ≥1 
MeV. The uncertainty in the beam range is 0.5 mm, PG range is 0.1 mm, emission time/TOF mean is 0.1 

























Figure 33: Quantitative comparison of the particle beam range with PG emission and detection data in 
the cylindrical adipose tissue phantom for protons, 4He and 12C ions. Left: Particle beam range and 
corresponding PG range, with PG emission time. The dotted line joining the particle range values serves 
to guide the eye. Right: PG TOF peak mean, width and integral. All PG data are for gamma rays ≥1 
MeV. The uncertainty in the beam range is 0.5 mm, PG range is 0.1 mm, emission time/TOF mean is 0.1 
ns, and TOF width is 0.2 ns. 
 
3.6.2 Realistic Head Phantom 
The PG production distribution was seen in Figure 20 to closely correlate to the shift in 
the proton beam range between the water-based and realistic head phantoms. Figure 34 shows 
the emission time distribution of total gamma rays and those ≥1 MeV within the phantoms. 
Although minor, the distributions show a profile fall-off difference between the two phantoms 
as a result of the beam range shift. The rise in the emission time profile at approximately 2.4 ns 
is due to the time taken for the protons to arrive at the phantom upon initialisation within the 
simulation. Figure 34 also shows the TOF spectra of total gamma rays and those ≥1 MeV, as 
well as neutrons, for the two head phantoms. The difference in proton beam range between the 
two phantoms is also shown in the TOF distribution of detected gamma rays, for which the 
integral and fall-off are different for the two cases. The TOF distribution of gamma rays emitted 
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from the water-based head phantom shows a fall-off in the profile at a slightly longer time than 
the gamma rays from the realistic phantom due to the greater depth of the proton beam range. 
The integral of the TOF spectrum of gamma rays from the realistic head phantom is slightly 
larger than that from the water-based phantom, which may be correlated to the higher energy 
gamma rays emitted from the realistic head phantom (see Figure 18) that are not attenuated 














Figure 34: Top: Emission time distribution of total gamma rays and gamma rays ≥1 MeV originating in 
the water-based and realistic head phantoms. The bin width is 0.01 ns. Bottom: TOF spectra of total 
gamma, gamma rays ≥1 MeV and neutrons reaching the detection sphere once emitted from the head 
phantoms. The bin width is 0.1 ns. The proton beams irradiating the phantoms are of 100 MeV. 
 
The temporal properties of emitted and detected PG rays were studied with the beam 
incidence marking the start time. As the PG emission time is associated with the beam transit 
time, the particle range can therefore be extracted from the measured PG TOF spectrum as well. 
The PGT [171] method retrieves the beam range by means of the TOF peak’s mean and width 
while the PGPI [173] method makes use of the TOF spectrum count integral; the integral being 
a potential means for in vivo dosimetry. The PG TOF spectrum on the idealised detection sphere 
is most likely to reflect the intrinsic characteristics of the PG TOF spectroscopy from the 
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phantom. In practice, the realistic spectrum could be much more complicated and it largely 
depends on the nature of the delivered beam time structure as well as the detector’s time 
resolution [232]. The very narrow time range of PG TOF (a few nanoseconds) implies that 
ultra-high time resolution of the detector (<1 ns) is needed in order to accurately extract the 
range/dose information from the measured PG TOF spectroscopy. Furthermore, the temporal 
separation between PG rays and neutrons can be exploited to discriminate the PG signal from 
the neutrons and neutron-induced backgrounds. This has been proposed by Testa et al. (2008) 
[146] for 12C ions at low energies where the RF signal of the accelerator at the GANIL facility 
could be used as the start time reference. However, this technique is not suitable for synchrotron 
facilities, where instead a trigger signal from a fast transmission detector may be used. The TOF 
neutron rejection technique for protons was investigated using Monte Carlo simulations [145]. 
Hueso-González et al. (2018) [59] performed experimental measurements of the technique for 
protons accelerated by cyclotrons. However, the application of TOF for proton, 4He and 12C ions 
in synchrotron facilities at clinical energies and intensities has not yet been demonstrated 
experimentally. TOF may be inefficient for PG detection in proton therapy due to long bunch 
times from synchrotrons, while for carbon therapy the detection of individual ion impacts may 
be possible at mean intensities of 107-108 ions/second by means of fast beam hodoscopes [57]. 
Combining the angular preference and TOF of PG measurements may further improve the PG 
signal-to-background ratio. 
3.7 Discussion 
In this study, the emission energy, position and time of PG rays in homogeneous water, 
PMMA and adipose tissue phantoms irradiated with three different particle types (proton, 4He 
and 12C ions) of varying energy were investigated using Geant4 simulations. Heterogeneous 
DICOM-formulated head phantoms (realistic and water-based) were also studied to explore the 
heterogeneity effects on PG range monitoring. The PG production and detectable yields, energy 
spectral, spatial and temporal correlation characteristics with the depth dose profile were 
quantified. A relatively low gamma ray energy threshold of 1 MeV was used to ensure higher 
statistics, while a PG energy window of 3.0-7.0 MeV (adopted in other studies [176,226]) was 
also included for comparison. This thesis study shows that the energy spectra of emitted gamma 
rays are characteristic to the elemental composition of the phantom materials. Higher 
concentrations of oxygen in the target result in greater intensity of the 5.21 and 6.13 MeV 
emission lines of the spectra, while higher concentrations of carbon result in greater intensity of 
the 4.44 MeV line. Hence, the characteristic gamma emission spectra from irradiated phantoms 
can be exploited to identify the target material. 
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The PG signal is seen to be a reliable means for in vivo range verification in particle 
therapy. The primary PG rays exhibit the closest correlation to the particle range but it is 
masked by the concurrent secondary PG rays; which may impose a greater challenge for BP 
tracking in heavy ion therapy (e.g. carbon ions) where secondary PG rays are dominant. The 
effects of target inhomogeneities are seen on the PG production distribution in relation to the 
beam crossing the various materials of the phantom, but the quantitative data shows that the PG-
BP fall-off correlation is consistent for heterogeneous targets as well as homogeneous ones. 
The angular distribution of detected PG rays was studied from spherical and cylindrical 
phantoms, which saw that geometric effects of the phantom play a role in the angular variances 
seen on the idealised detecting sphere due to attenuation/absorption of the gamma rays. The 
angular distribution was also seen to change with beam energy, which may suggest that a 
movable PG detector coordinated with respect to the beam range could serve to optimise the PG 
detection efficiency. The emission and detection (TOF) properties of PG rays showed a 
correlation with the particle beam range that is consistent between the homogeneous target 
geometries and materials under investigation in this study. The PG TOF peak integral showed a 
linear correlation to the increasing beam range for each of the particle species; this suggests that 
associating the PG range and corresponding emission yield with the beam’s range and 
corresponding energy deposition may be a technique toward in vivo dosimetry. Combining an 
energy threshold/window to the PG TOF distribution, in addition to locating the PG detector/s at 
optimal angular positions, could serve to improve the PG signal-to-noise ratio, as seen in the 2D 
representations in Figure 30. The PG TOF spectroscopy encodes essential information on the 
particle range, and potentially dose, but the technique requires fast detection (excellent time 
resolution). Hybrid PG detection systems to exploit the energy, spatial and timing information is 
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 Experimental work was performed at ANSTO to investigate a suitable scintillation 
detector for fast and efficient PG ray timing measurements. As described in the previous 
chapters, real-time range verification utilising the temporal information of the PG rays requires 
fast gamma ray detectors, data acquisition and analysis. This is also crucial for neutron rejection 
techniques and improving the PG signal-to-noise ratio. The detector’s speed of response to a 
gamma ray detection event should complement its efficiency and energy resolution, such that 
the detector can handle the relatively high gamma yield and adequately resolve the PG emission 
energies. This is particularly important for gamma energy selections/windowing or spectroscopy 
techniques used for range/dose monitoring. Hybrid PG detection systems utilising more than 
one feature of PG rays have the potential to overcome the challenges of PG measurements and 
offer a simple technique for in vivo dosimetry. In this study, several scintillation detectors were 
characterised in terms of timing – signal rise and decay times – and spectroscopy – energy 
resolution and efficiency – to determine the most suitable choice for hybrid PG measurements. 
4.1 Experimental Set-up of Scintillation Detector Characterisation 
Table 9 lists the four radioactive sources used in this work, their predominant energies 
emitted and intensity of emission 𝐼 . The photopeak energies utilised for spectroscopic studies 
were 59.5 keV (241Am), 356.0 keV (133Ba), 661.7 keV (137Cs), 1173.2 keV and 1332.5 keV 
(60Co). The energies were selected to be easily resolvable by the detector material of interest 
whilst covering a wide energy range. 
Table 10 lists the instruments used in the measurements and a short statement on their 
purpose. Figure 35 depicts the electronic circuit diagrams of the two experimental set-ups: the 
top set-up is best suited for timing measurements, while the bottom set-up is best suited for 
spectroscopy. Figure 35 (top) shows that when the charge sensitive preamplifier is used there is 
also a capacitor coupling from the detector, and an oscilloscope to display the output pulses. In 
this case, to record the rise and decay times the direct output of the detector, or the preamplifier 
pulses, were used. The preamplifier adds an additional rise time dependent on the amplifier used 
and the input capacitance. In this study, the Amptek A250 charge sensitive preamplifier was 
used, which has a rise time of 2.5 ns at 0 pF [233]. The capacitance added at the preamplifier 
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input, i.e. detector capacitance, slows the rise time at a rate of 0.17 ns/pF, while the output rise 
time is also limited by the speed of the detector [234]. The built-in charge sensitive preamplifier 
preserves the basic information carried by the magnitude of the charge 𝑄, such that the circuit 
uses feedback to mostly eliminate the output amplitude dependence on the capacitance and 
restores proportionality to 𝑄 [66]. 
Table 9: Radiation sources used for detector characterisation measurements. The emission energies and 
intensity of emission were taken from Ref. [235]. 





















Table 10: Instruments used for detector characterisation measurements. The amplifier and power supply 
were mounted on a Nuclear Instrument Module (NIM). 
Instrument Purpose 
Power supply High voltage (HV) power supply (560 V) 
Amptek A250 Preamplifier Drive the input signal to the shaping amplifier (2.5 ns rise time) 
Canberra 2025 Shaping 
Amplifier 
Produce a gain in the signal amplitude and shapes the signal pulse 
into a Gaussian shaped pulse (1 μs shaping time) 
LeCroy Oscilloscope 
Wavesurfer 44Xs 
Display and analyse electronic signals (400 MHz bandwidth, 875 ps 
rise time) 
Amptek Multichannel 
Analyzer (MCA) 8000A 
Digitise the input signal from the shaping amplifier to obtain a pulse 
height spectrum 
Personal computer (PC) Access the ADMCA software for data analysis 
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Figure 35 (bottom) shows an RC feedback preamplifier preceding a shaping amplifier, 
followed by an MCA and PC. Part of the purpose of the preamplifier here is to stretch the signal 
fall into a quasi-square wave for integration by the shaping amplifier. For spectroscopy, a 
shaping amplifier is used to amplify and shape the pulse into a Gaussian for better signal-to-
noise. The signal is then digitised with an MCA to obtain a pulse height spectrum which is 
displayed on a PC for further spectroscopic data analysis. That is, the use of a preamplifier with 
PMTs is better suited for spectroscopy applications where the preamplifier can be used to drive 
the input to the shaping amplifier, whereas for timing studies no shaping amplifier is necessary. 
 
 
Figure 35: Top: Circuit diagram of experimental set-up for timing measurements, showing a capacitor 
coupling from the detector and a charge sensitive preamplifier. Bottom: Circuit diagram of set-up for 
spectroscopy, showing a preamplifier, shaping amplifier, MCA and PC. The oscilloscope is connected for 
display and analysis of signal pulses. The PMT or SiPM (not explicitly shown) is coupled to the detector. 
 
Table 11 lists the scintillation detectors studied in this work as well as the crystal size 
and supplier. In the table, it is indicated whether the detector was coupled to either a PMT 
(gaseous-state) or SiPM (solid-state/semiconductor). LaBr3(Ce) and LaCl3(Ce) were studied 
with and without a built-in charge sensitive preamplifier. PMTs and SiPMs have similar 
response times, with time characteristics of a few nanoseconds rise times and ~10 ns decay 
times. For example, the Saint-Gobain detectors coupled PMTs or SiPMs have positive charge 
sensitive tail pulses with a ~50 μsec decay [236], and with for example a Photonis XP2060 PMT 
(coupled to a ∅1” × 1” LaBr3(Ce) detector) having a rise time of 3 ns [237,238]. 
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Table 11: Scintillation detectors characterised in terms of timing and spectroscopy. * indicates the 
detectors connected to a PMT and ** indicates the detectors connected to a SiPM. LaBr3(Ce) and 
LaCl3(Ce) were studied with and without a built-in preamplifier. 
Scintillation detector material Scintillator crystal size Supplier 
LaBr3(Ce) * ∅1” × 1” Saint Gobain 
LaCl3(Ce) * ∅1” × 1” Saint Gobain 
NaI(Tl) ** ∅2” × 2” Saint Gobain 
CeBr3 ** ∅1.5” × 1.5” Scionix Holland 
SrI2(Eu) ** 1 cm
3 
Radiation Monitoring Devices 
(RMD) 
CLYC ** 1 cm3 
Radiation Monitoring Devices 
(RMD) 
CLLBC376 ** ∅1.5” × 1.5” 
Radiation Monitoring Devices 
(RMD) 
CLLBC398 ** ∅1” × 1” 
Radiation Monitoring Devices 
(RMD) 
CLLBC406 ** ∅1.5” × 1.5” 
Radiation Monitoring Devices 
(RMD) 
CLLBC416 ** ∅1” × 1” 
Radiation Monitoring Devices 
(RMD) 
4.2 Response Time of the Scintillation Detectors 
 The timing properties of each scintillation detector was characterised in terms of the 
signal rise and decay time. The data were recorded using the oscilloscope by measuring the time 
at 10-90% (rise time) and 90-10% (decay time) of the signal amplitude. Figure 36 shows the 
signal waveforms of the various detectors under study, each normalised in the time axis to the 
20 mV signal amplitude. The CLLBC376 and CLLBC398 waveforms displayed in the figure 
were averaged over four and five signal pulses, respectively, to remove pickup noise. Table 12 
lists the rise and decay times of the detector signal waveform, as well as the corresponding 
amplitude for the recorded measurement. The data demonstrates that the LaBr3(Ce) and 
LaCl3(Ce) scintillation detectors connected to a PMT, with bypassing the built-in preamplifier, 
have the fastest timing properties among the detectors studied with sufficient current to still 
drive the shaping amplifier. These detectors show rise times of around 34 ns. As mentioned, 
part of the purpose of the RC feedback preamplifier is to stretch the signal fall into a quasi-
square wave for integration by the shaping amplifier; this justifies the long signal tail (almost 
100 μs decay time) for LaBr3(Ce) and LaCl3(Ce) with preamplifier. Thus, although the 
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preamplifier is best suited for spectroscopy applications and to improve the system energy 
resolution, its inclusion worsens the timing properties. Yet it is important that for hybrid PG 
detection systems, both energy and timing capabilities should be optimised, and improving one 
aspect should not come at the sacrifice of another. Comparing the scintillators coupled to SiPMs, 
those from the elpasolite crystal group were found to have relatively better timing properties; 
CLLBC398 and CLLBC416 were found to have ~200 ns rise times and ~2.5 μs decay times. 
Since the measured rise times are much longer than the sampling rate of the 
oscilloscope, the main contribution to uncertainty is noise. That is, the oscilloscope used in this 
study had a rise time of 875 ps (which can be determined from the equation 𝑡 = 0.35/𝐵, where 
𝐵 is the bandwidth [239]) which is smaller than the measured rise times and so they are not 
bandwidth limited. Also, according to the Nyquist-Shannon sampling theorem [240-243], a 
sufficient sample rate 𝑓  is achieved when 𝑓 > 2𝐵, where 𝐵 is the bandwidth. The oscilloscope 
sample rate was 2.5 GS/s with a bandwidth of 400 MHz, so the theorem also holds. For the 
worst case scenario, there would be ~82 samples over the measured rise times of 34 ns, so the 
sampling rate is sufficient to reconstruct the high frequency components of the waveforms. For 
the vertical resolution, it was estimated that the SNR ≈ 12 in the spectrum for the worst case 
scenario, CLLBC398, and so the noise is not significant. In Table 12, the uncertainties are given 
as the standard deviation of three repeated measurements. 
Comparing the CLLBC scintillation detectors, the influence of crystal size is also seen: 
CLLBC376 and CLLBC406 have size ∅1.5” × 1.5”, whereas CLLBC398 and CLLBC 416 have 
size ∅1” × 1”. The size of the scintillation crystal influences the light collection efficiency and 
uniformity of the scintillator. The largest possible fraction of light emitted isotropically should 
ideally be collected, but fluctuations occur due to the scintillation efficiency and non-perfect 
reflection conditions at the crystal surface. The non-uniform light collection can therefore 
introduce statistical broadening of the signal, particularly in large size crystals [66]. As seen in 
Figure 36, the CLLBC detectors of larger scintillation crystal size produce a broader signal 


















Figure 36: Signal waveforms for each scintillation detector studied.
figures are normalised in the time axis to the 20 mV 
CLLBC376 and CLLBC398 waveforms were averaged across four and five signal pulses, respectively, to 
remove pickup noise. The bin 
Table 12: Timing properties of each scintillation




             (no preamp) 
LaCl3(Ce) (preamp) 










 The waveforms in the bottom row 
signal amplitude for better visual comparison. 
size along the time axis in all figures is 0.4 ns. 
 detector, measured at 10-90% (rise time) and 90
 The uncertainty is given by the standard deviation of three repeated 
Rise time (ns) Decay time (μs) Amplitude
56.12 ± 1.53 
33.88 ± 0.12 
96.33 ± 0.66 
0.79 ± 0.01 
292.33 ± 2.90 
34.29 ± 5.66 
95.18 ± 0.40 
0.89 ± 0.03 
843.52 ± 24.27 6.25 ± 0.50 
258.06 ± 0.85 5.85 ± 0.80 
335.16 ± 22.38 78.83 ± 0.88 
231.51 ± 20.69 5.80 ± 0.11 
305.21 ± 7.33 
197.33 ± 6.24 
292.97 ± 7.83 
178.64 ± 10.51 
6.11 ± 0.15 
2.55 ± 0.30 
5.78 ± 0.17 





106.2 ± 8.7 
538.0 ± 10.2 
84.5 ± 12.7 
493.2 ± 22.4 
120.9 ± 4.6 
121.0 ± 17.2 
471.9 ± 3.5 
70.0 ± 1.5 
120.6 ± 2.8 
127.0 ± 9.7 
118.9 ± 5.1 
117.5 ± 13.5 
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Several studies have utilised LaBr3(Ce) for PG range verification measurements due to 
its fast timing and superior detection capabilities [59,170,173,232]. Yet CeBr3 has been 
determined as the best choice for PG timing range monitoring [60,123]. However, in this thesis 
study, CeBr3 was found to be the slowest by over an order of magnitude with a rise time of 
around 840 ns. Overall, the recorded timing values are larger than values in the literature 
[66,244,245]. These discrepancies may be due to the PMT itself, which may present limitations 
on the signal response, but are representative of the standard matched scintillator and PMT 
detectors available commercially, compared to a specific high speed PMT with lower 
amplification. The LaBr3(Ce) and LaCl3(Ce) scintillation detectors were optically coupled to a 
PMT while the other detectors, including the CeBr3, were coupled to a matched SiPM by the 
manufacturer. The response times of PMTs and SiPMs are comparable, with time characteristics 
of a few nanoseconds rise times and ~10 ns decay times. PMTs are generally stable and low 
noise, but bulky, affected by magnetic fields, and for a gain of 106 require a high bias voltage of 
1-2 kV [114]. SiPMs maintain similar gains and speed to PMTs but have several advantages, 
such as requiring 20-30 times less power than PMTs (achieves high gain with a very low bias 
voltage of ~30 V), compact size, magnetic insensitivity, and higher photon detection efficiency 
of 50-60% compared to 35% for PMTs [114,246]. Shorter recovery times of SiPMs can be 
achieved with smaller microcells (lower fill factor), resulting in higher dynamic range and lower 
capacitances, but is a compromise to lower photon detection efficiency and gain [114]. 
4.3 Spectroscopy: Energy Resolution and Detection Efficiency 
Spectroscopic data analysis was performed using the ADMCA software on a PC, where 
the MCA spectrum x-axis channels were calibrated to energy in units of keV. The energy 
resolution of each detector was calculated as a percentage using equation 10 (Chapter 2). 
As mentioned in Chapter 2 of this thesis, there are two common types of detector 
efficiency: absolute detection efficiency and intrinsic detection efficiency. Counting efficiencies 
can also be categorised by the nature of events recorded, namely peak detection efficiency and 
total detection efficiency, the former being more commonly used. The peak detection efficiency 
is given by the number of events under the full energy peak in a differential pulse height 
spectrum divided by the number of radiation quanta emitted by the source. Total detection 
efficiency is given by the total number of events under the entire differential pulse height 
spectrum divided by the number of radiation quanta emitted by the source. In this study, the 




                                                                   (13) 
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where 𝑁 is the number of events in the full energy peak, 𝑆 is the number of radiation quanta 
emitted by the source, and Ω ≅ 𝐴/𝑑 = 𝜋𝑎 /𝑑  (for d >> a) where 𝐴 is the detector area, 𝑎 is 
the detector radius and 𝑑  is source-detector distance [66]. That is, 𝑁  is determined by the 
number of events in the full energy peak taken from the differential pulse height spectrum 
considering the photopeak intensity 𝐼𝜸  of which the number of events is true. The intensity 
values used in the calculations for each source are presented in Table 9. 𝑆 is determined by the 
activity of the source considering the duration of the measurement. The activity of the source at 
the time of measurement can be determined with 𝐴(𝑡) = 𝐴(0)𝑒 /  where 𝐴(0) is the initial 
activity, 𝑡  is the time since initial activity and 𝜏  is a decay constant whereby 𝜏 = 𝑇 / /𝑙𝑛2 
where 𝑇 /  is the radiation source half-life. 
The detector thickness also governs the detection efficiency, since it relates to the 
gamma ray attenuation within the detectors. Depending on the crystal thickness, gamma rays 
can be partially or fully absorbed; a thicker crystal increases the probability of gamma ray 
attenuation and full absorption which therefore increases the detection efficiency. For example, 
for LaBr3(Ce) at 1 inch thickness, around 60% of 662 keV gamma rays are absorbed [247]. For 
gamma rays of 4 MeV, the crystal thickness required to fully absorb the gamma ray would need 
to be >30 cm, with only around 40% being absorbed for a thickness of 1 inch. The impact of 
scintillator thickness should therefore be considered when comparing results in such 
characterisation studies, particularly for detector efficiency. 
For the energy resolution measurements, the radiation sources were positioned close to 
the detectors (a few centimetres) while ensuring the dead time was still negligible, and the 
spectra acquired for 5 minutes to obtain sufficient statistics. For the efficiency measurements, 
the source-detector distance was 2 m; the distance between source and detector is an important 
parameter in the calculations, such that the further the source the more accurate the calculation. 
Table 13 presents the energy resolution and efficiency of each detector at the photopeak 
energy of 662 keV. The energy resolution values recorded in this study agree within a factor of 
two with those given in the literature [66,244,245]. In this thesis study, CLYC and LaBr3(Ce) 
were found to have the better energy resolution with values of 3.4% and 3.5%, respectively. 
However, between the two, LaBr3(Ce) was seen to have the better efficiency; this could simply 
be due to its thicker crystal of 1 inch, compared to the 1 cm thickness of CLYC. Yet the CLLBC 
detectors of the same size as the LaBr3(Ce) have comparable energy resolutions but poorer 
detection efficiency. Elpasolite detectors, such as CLYC and CLLBC, have the added advantage 
of gamma-neutron discrimination capabilities, whereby differences in the scintillation decay 
response/pulse shapes can be used to distinguish the two types of radiation [127,129,131]. 
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Decay times, rather than rise times, are conventionally used for pulse shape discrimination as it 
is easier to measure. 
Table 13: Energy resolution and detection efficiency at 662 keV, for each scintillator studied. 
Uncertainties were calculated with reference to error propagation (see for example, Knoll (2000) [66]). 
Scintillation detector Energy resolution (%) Detection efficiency 
LaBr3(Ce) 3.5 ± 0.7 0.33 ± 0.02 
LaCl3(Ce) 4.4 ± 0.8 0.15 ± 0.01 
CeBr3 4.9 ± 0.9 0.30 ± 0.01 
SrI2(Eu) 3.6 ± 0.7 0.04 ± 0.01 
NaI(Tl) 6.3 ± 1.0 0.24 ± 0.01 





3.8 ± 0.8 
4.1 ± 0.8 
3.7 ± 0.8 
4.1 ± 0.8 
0.17 ± 0.01 
0.21 ± 0.01 
0.21 ± 0.01 
0.19 ± 0.01 
 
 
Figure 37: Intrinsic peak detection efficiency curves for each scintillator studied. 
 
Figure 37 shows the intrinsic peak detection efficiency curves as a function of gamma 
ray energy for each detector studied. As expected, an exponential trend is seen across the energy 
range, such that at lower energies photoelectric absorption in the scintillator is dominant, where 
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the full energy of the photons are absorbed, while at higher energies Compton scattering and 
pair production are more probable. Although the CeBr3 detector has a larger crystal, the 
detection efficiency is comparable (but slightly worse) than that of the LaBr3(Ce) detector; yet 
both are superior in detection efficiency relative to the other scintillators studied. 
4.4 Discussion 
In this work, the energy- and time-resolved capabilities of several scintillation detectors 
were investigated to determine the most suitable for potential hybrid PG detection systems. 
Hybrid PG detection systems utilising more than one characteristic of PG rays have the 
potential to overcome present challenges and offer a simple technique for in vivo dosimetry. Yet 
achieving simultaneous resolved detection and data acquisition is challenging. 
The results in this study showed that the LaBr3(Ce) detector, without a built-in 
preamplifier and coupled to a PMT, offered the fastest timing capabilites, having shorter signal 
rise and decay times compared to the other detectors studied. Results also showed that LaBr3(Ce) 
and CLYC offered better energy resolution, with LaBr3(Ce) being the more efficient. Elpasolite 
crystals, such as CLYC and CLLBC, have the added ability of gamma-neutron discrimination 
via pulse shape differences between the two radiation types [127,129,131]. These scintillators 
therefore have the potential for hybrid systems utilising PG energy and time information in 
addition to simultaneous neutron discrimination. To the authors’ knowledge, these elpasolite 
crystals have not yet been studied for the purpose of PG range monitoring in particle therapy. 
In terms of efficiency, LaBr3(Ce) and CeBr3 were seen to be comparable but relatively 
superior than the other scintillation detectors across the energy range. Although CeBr3 has been 
determined to be the best choice for PG timing measurements due to its fast response and 
superior energy resolution [60,123], LaBr3(Ce) has been shown to be an adequate alternative, 
with the best compromise between timing and energy resolution, and utilised in several PG 
range verification studies [173,232], including the PGS measurements performed at MGH 
[59,170]. 
In practice, the choice of detector should ideally exhibit excellent energy and timing 
resolutions simultaneously, with superior efficiency for the high-energy PG rays. The data 
acquisition system accompanying the detector should also be fast enough to allow timing 
measurements that provide valuable data and real-time feedback. In addition, the overall 
detection system should have the capability to cope with the beam time structure and accurately 
synchronise with the accelerator RF; the bunch time spread is a key factor influencing the 
resolution of PG timing measurements. A proton bunch monitor that measures the bunch time 
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structure and potential phase drifts could be used to overcome these limitations. High-
throughput and high-efficient PG detector systems are desired for simultaneous energy- and 
time-resolved PG measurements. 
Future work investigating the scintillator performance for high-energy PG rays, through 
measurements and in clinical conditions, as well as possible hybrid detector systems, will be 
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Simulation tools are not only widely employed for the fundamental research concerning 
PG ray physics and detection concepts, but they are also used clinically, and a PG method may 
require comparing the obtained measurements with expected outcomes to determine deviations 
from the prescribed treatment plan. Thus, it is important that the physics models and data in the 
simulation are accurate and reliable for use in particle therapy beam range monitoring. In this 
study, simulations were performed to determine the performance of physics models available in 
Geant4/TOPAS for use in PG simulations. The simulation data were compared to measurements 
performed in the pencil beam scanning treatment gantry at the Francis H. Burr Proton Therapy 
Center, MGH, Boston USA. Preliminary measurements at MGH with the full-scale range 
verification prototype using PGS was published in Hueso-González et al. (2018) [59]; this paper 
should be referred to for details about the PGS detection system, measurements and data 
analysis. This chapter provides an overview of relevant information from Ref. [59] (Sections 
5.1-5.2) followed by my research work (Sections 5.3-5.4). 
TOPAS was used to model the MGH PGS detection system, incident proton beam and 
phantom. Simulation results were quantitatively compared with respect to the corresponding 
experimental data obtained for a pencil beam spot. Two Geant4 physics lists (which are also 
available in TOPAS), QGSP_BIC_HP and QGSP_BIC_AllHP, were investigated with Geant4 
version 10.06.p01. Two phantom materials were explored, water and high-density polyethylene 
(HDPE), to determine the simulation reproducibility for oxygen and carbon, respectively. The 
same simulation was performed with Geant4 version 10.05.p01 for regression testing purposes. 
Hence, this study is performed to offer recommendations to the scientific community for 
simulating PG rays, which is a significant aspect in the current status of PG research, and 
potentially in practice, for in vivo range/dose monitoring. 
5.1 Experimental Set-up of the Prompt Gamma Detection System 
The MGH proton therapy treatment facility housed an IBA C230 cyclotron (Ion Beam 
Applications SA, Louvain-la-Neuve, Belgium) that accelerates protons to 230 MeV, which are 
then degraded by an energy selection system and transported to the treatment room through a 
~35 metre beam line. The RF of the cyclotron is 106.3 MHz. The beam current for 
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all pencil beam layers is 2 nA incident on the phantom, which corresponds to approximately 
100 protons per bunch every 9.4 ns. The reproducibility of the beam range in water is better 
than 0.5 mm [59]. 
The PGS detection system consisted of eight LaBr3(Ce) scintillation crystals (50.8 mm 
diameter, 76.2 mm length) coupled to a PMT and resting on a custom-built base. There were 
two rows of four detectors, each focusing on a different position along the beam direction, 
allowing for a larger field-of-view (FOV). The system was comprised of a tungsten collimator 
configuration: five tungsten slabs (each 25.4 × 203.2 × 127.0 mm3 ± 0.5 mm) with a (12.7 ± 
0.2) mm slit opening after the first and fourth slab (along the beam direction), and (6.4 ± 0.2) 
mm slit opening after the second slab (see Figure 38), as well as an acrylic front plate and 
aluminium aperture. The collimator spacing after the fourth slab was a trade-off between spatial 
resolution and detector efficiency, while the spacing after the first and second slab allow for a 
larger area of blocking background gamma rays (e.g. from the nozzle and range shifter) without 
additional tungsten slabs (i.e. increasing the weight of the detector body). The system 
(scintillators and electronics) can sustain high overall event rates of up to 107 events per second 
[59]. 
Figure 38 shows the experimental set-up configuration used for cross section 
optimisation measurements conducted by the MGH group. The PGS system remained in a fixed 
position perpendicular to the beam incidence during treatment delivery. The distance from 
isocentre (located centrally in the target volume) to the front face of the phantom (beam 
incidence) was (124.0 ± 0.5) mm. The measurements were performed with a single high-dose 
spot of 3×1010 protons delivered consecutively to 19 energy layers along the central beam axis. 
That is, no merging of lateral spots was performed; this therefore allows a better comparison 
with simulation results. Proton beam irradiation of water and HDPE phantoms were performed. 
The proton beam ranged between (100 ± 1) mm and (150 ± 1) mm water equivalent depth. The 
distance between isocentre and the collimator front plane was (150.0 ± 0.5) mm, including an 
air gap of (100.0 ± 0.5) mm (between collimator and phantom) which is clinically realistic. The 
reader is encouraged to see Ref. [59] for further details regarding the experimental set-up. For 
the purpose of this thesis study, to compare simulation and measurement, a single pencil beam 
spot in the most distal energy layer is used. Further details of the simulation modelling are given 














Figure 38: Schematic diagrams showing the experimental set-up configuration for the water phantom 
(left) and HDPE phantom (right). All units are in mm. The eight (two rows of four detectors) LaBr3(Ce) 
detectors are 50.8 mm in diameter and 76.2 mm in length. The collimator consists of five tungsten slabs 
(each 25.4 × 203.2 × 127.0 mm3 ± 0.5 mm) with a (12.7 ± 0.2) mm slit opening after the first and fourth 
slab (along the beam direction), and (6.4 ± 0.2) mm slit opening after the second slab. For simplicity and 
clarity, the front plate and aluminium aperture (between collimator and phantom) are omitted. The red 
line indicates the proton pencil beam incidence on the phantom, and the centre of the target volume (red 
dotted-square) represents the position of isocentre in the treatment room. The distance from isocentre to 
the front face of the phantom was (124.0 ± 0.5) mm. The distance between isocentre and the collimator 
front plane was (150.0 ± 0.5) mm, with an air gap of (100.0 ± 0.5) mm. Figures adapted from Ref. [59] 
with permission. 
 
5.2 Data Acquisition and Processing 
The custom data acquisition system for the PGS detection system was synchronised 
with the beam delivery system and the cyclotron. The signals from the detector modules were 
independently read out with a 14-bit analog-to-digital converter that was phase-locked to the 
accelerator at a frequency twice that of the cyclotron RF for a sampling rate of ~2.13×108 
samples per second. The data streams were processed in real-time by field-programmable gate 
arrays (FPGAs). An event was triggered when the digitised signal magnitude exceeded a 
predefined threshold. Integrating the area under the pulse signal over a time window of 200 ns 
was used to calculate the gamma ray energy. The gamma ray arrival time was determined by 
subtracting a delayed copy of the digital signal from the original and finding the zero crossing 
time of the resulting signal. The analysis of the arrival time was initially performed with a time 
resolution equal to the sample rate, followed by a polynomial interpolation to achieve sub-
nanosecond resolution [59]. 
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The acquired data were stored in a memory buffer that was continuously read out by the 
control software (custom C++ application) which performed several corrections to normalise the 
measurements to absolute units. Corrections included energy and time calibration, as well as 
pile-up and coincidence rejection. The corrected data were then combined in energy vs time 
histograms; two histograms were created for each proton pencil beam, i.e. one for each row of 
four detectors. The measured 2D histograms were split into three components iteratively [59]: 
 proton-induced continuum, PG rays that undergo incoherent scattering in the detector or 
have scattered prior to reaching the detector; 
 neutron-induced continuum, gamma rays that scatter before or inside the detector or 
from unresolved cascades; and 
 resolved lines, whereby the continuum components (background) are subtracted from 
the measured to give the neutron-induced and proton-induced spectrum. 
See Ref. [59] for an example of such 2D histograms. The proton-induced continuum is 
unresolved in energy but well-resolved in time, while the neutron-induced continuum is 
unresolved in both dimensions, and the resolved lines spectrum is resolved in both energy and 
time dimensions. The count rate in each detector was on the order of 106 events per second, 
such that an energy resolution of 1.3% FWHM at 6.1 MeV was achieved. Due to several 
sources of scatter such as the treatment head, phantom, couch, room walls and floor, half of the 
detected gamma rays make up the background. A small fraction of neutron-induced gamma rays 
are also produced in the collimator, but the majority of these will be re-absorbed internally [59]. 
In the PGS technique, the proton range for each pencil beam is determined by 
comparing the intensity of measured PG emission lines in the gamma ray energy spectrum to 
expected values obtained from a model. The model simulates the fundamental physical 
processes (including nuclear interactions, attenuation and detector system response) and predicts 
the PG emissions and detections. The PGS detection system geometry, CT to material 
conversion, proton stopping, PG emission, gamma ray attenuation and detection made up the 
model. Further details can be found in Ref. [59]. The reliability of such models/simulations is 
therefore important. Hence, for the purpose of this thesis study, the performance of Monte Carlo 
simulations was investigated, in particular, by comparing the intensity of simulated PG emission 
lines with measured data. 
5.3 Modelling of the Prompt Gamma Detection System 
TOPAS version 3.3.p1_expanded was used with Geant4 version 10.06.p01 to model the 
MGH PGS detection system, and proton beam irradiations of water and HDPE phantoms, as 
5   Simulating Prompt Gamma Rays for Clinical Range Verification 120 
 
performed in the experimental measurements. The TOPAS version used at MGH had been 
adapted to include the ParticleHP model (discussed later in this section). 
Figure 39 shows an image of the simulation set-up with the water phantom. The same 
set-up applies to the HDPE phantom (see Figure 38). The simulation application includes the 
acrylic front plate and aluminium aperture of the collimator configuration. The water phantom 
(“G4_WATER”, density of 1.0 g/cm3) was 406 ×  200 ×  200 mm3, including the acrylic 
(C5O2H8, density of 1.19 g/cm
3) tank walls and base. The HDPE phantom (C2H4, density of 
0.955 g/cm3) was a 305 × 152 × 102 mm3 solid block. The proton pencil beam in the simulation 
(and experiment) was incident on the phantom along the +x direction. In the simulation, the 








Figure 39: TOPAS model of the MGH PGS detection system with the water phantom, based on the 
experimental set-up. The proton beam is not to scale. 
 
For the quantitative comparison between simulation and measurement, a single proton 
pencil beam spot was considered; the spot in the simulation was the equivalent as in the 
experiment in terms of beam parameters, incidental longitudinal and lateral position, as well as 
beam range (80% distal dose fall-off). The proton beam was incident along the central axis of 
the phantom in both model and experiment. The experimental proton beam range was (150 ± 1) 
mm in the water phantom and (149 ± 1) mm in the HDPE phantom. The simulation proton 
beam energies were tuned to obtain a simulated beam range within 1 mm agreement with the 
experiments; beam energy of 149.0 MeV for the water phantom and 147.5 MeV for the HDPE 
phantom. The number of simulated protons for the beam spot was 108 to obtain a 1% statistical 
uncertainty in the simulation results. The physical quantity, subject of comparison between 
simulation and experiment, was the absolute gamma ray counts per giga-protons (GP) (more 
details are given in the next section). 
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A TOPAS extension, written in C++, was included in the simulation framework to score 
the gamma rays interacting in each of the detectors. Total gamma rays, proton-induced and 
neutron-induced gamma rays were scored. The gamma ray energy deposition in the detector and 
TOF were recorded. The TOF was calculated as the interval of time between the generation of 
the proton beam to the gamma ray energy deposition in the detector. Optical photons, which 
arise from scintillation, although measured in the experiment, were not modelled in the 
simulation, and so the hypothesis is that all the optical photons were counted (reach the PMT 
window). Experimentally, not all gamma rays were counted due to, for example, selecting 
gamma rays between 1.4 and 7.2 MeV; this energy range of interest was thus also adopted to the 
simulation analysis. Within this energy range, corrections were applied for dead time, energy 
and time calibrations, pile-up and coincidence rejection, as discussed in Ref. [59]. A beam time 
spread (𝜎) of 0.38 ns [248] was also incorporated into the simulation to more accurately mimic 
the beam time structure of the proton therapy (accelerator) beam, such that the scoring of the 
gamma rays resembled a 9.4 ns proton bunch time. That is, the IBA 230 cyclotron at the MGH 
proton therapy centre has a RF of 106.3 MHz, and all pencil beam layers were delivered with 
the standard clinical system at the full beam current of 2 nA incident on the phantom, 
corresponding to a bunch of approximately 100 protons every 9.4 ns. 
Simulation results using the Geant4 physics lists QGSP_BIC_HP and 
QGSP_BIC_AllHP were compared to investigate which physics approach was more accurate in 
reproducing the PGS output (i.e. gamma ray energy spectra). In particular, the two physics lists 
have the following features: 
 QGSP_BIC_HP is used for hadrons up to 200 MeV with the high precision neutron 
(NeutronHP) data libraries used to model the neutron elastic and inelastic scattering, capture 
and fission, below 20 MeV [249,250]. Hadronic inelastic scattering of primary protons and 
neutrons on nucleons of the target nuclei is described by the Binary Intranuclear Cascade 
(BIC) model below ~10 GeV [197]. Following the BIC, the Precompound model describes 
the de-excitation of the remnant nucleus, followed by the Fermi breakup, neutron and light 
ion evaporation and photon evaporation models [249]. The LightIonBinaryCascade 
describes the intranuclear cascade of deuteron, triton, helium isotopes and heavier nuclei up 
to 6 GeV/n [221,249]. 
 QGSP_BIC_AllHP is identical to QGSP_BIC_HP but uses ParticleHP data libraries for 
protons, deuterons, tritons, helium-3 and alpha particles below 200 MeV [249]. That is, 
rather than using the Binary cascade model for these reactions, ParticleHP is used, which 
uses only evaluated nuclear data, mostly derived from the TALYS-based Evaluated Nuclear 
Data Library (TENDL) (i.e. TENDL-2014) with some isotopes from ENDF/B-VII.1 [251]. 
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Therefore, in comparing QGSP_BIC_HP and QGSP_BIC_AllHP, it is predominantly a 
comparison between the Binary cascade and ParticleHP models. 
The developers of Geant4 recommend the use of QGSP_BIC_HP for proton therapy 
studies, and indicate that QGSP_BIC_AllHP is promising [221,249]. QGSP_BIC_HP was found 
adequate for particle therapy studies in a recent benchmarking report by Arce et al. (2020) [221]. 
Hence, these physics lists were chosen to be studied in this work. While QGSP_BIC_HP has 
been studied for many years for proton and carbon ion therapy [173,176,202,205,225,252], 
QGSP_BIC_AllHP is a relatively new development and is worth to investigate its performance, 
particularly for PG rays and particle therapy. 
When using QGSP_BIC_HP, the modularised Geant4 physics modules included the 
electromagnetic physics G4EmStandardPhysics_option4, G4DecayPhysics, 
G4HadronElasticPhysicsHP and G4StoppingPhysics, with G4IonBinaryCascadePhysics 
modelling the final state of inelastic scattering. When using QGSP_BIC_AllHP, the modularised 
modules G4EmStandardPhysics_option4, G4DecayPhysics, G4HadronElasticPhysicsPHP, 
G4IonPhysicsPHP, G4IonElasticPhysics and G4StoppingPhysics were active in the physics list. 
5.4 Comparison Study of Simulation and Experimental Results 
The simulation data were quantitatively compared to measurements in terms of absolute 
gamma ray counts per giga-protons (GP) for the two rows of detectors. The total gamma, 
proton- and neutron-induced gamma ray counts were studied, as well as the 4.44 and 6.13 MeV 
PG emission lines. The 2.22 MeV gamma ray line from neutron capture was also included to 
study the neutron production in the simulation. The neutron-induced interference background 
was also studied, in this case, by quantitatively comparing the simulated and measured count 
per GP per MeV at 4.44 and 6.13 MeV. 
In the measurement, the total count was taken as the total events recorded. The neutron-
induced gamma count was taken as the background of the total count TOF histogram (counts vs 
time), while the proton-induced gamma count was taken as the peak above this background 
baseline. In other words, the neutron-induced counts do not include prompt neutron counts with 
discrete energy lines. This results from the specific design of the Recursive Bisection Neutron 
Subtraction (ReBiNS) algorithm applied to the experimental results; see Ref. [59] for details. 
In the simulation, the total gamma count was taken as the total gamma rays recorded. 
The total proton-induced count was retrieved from the TOF histogram of proton-induced 
gamma rays with no background subtraction. The total neutron-induced count was taken as the 
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background count of the neutron-induced gamma energy spectrum, i.e. not including prompt 
counts with discrete energy lines. The background from the simulations was retrieved using the 
ROOT TSpectrum class reference [253]. For the aforementioned total counts, the integrals were 
taken within the energy region 1.40-7.19 MeV, which is the same energy region of interest as in 
the measurement. 
For the PG emission lines, the proton-induced 4.44 and 6.13 MeV lines were retrieved 
by subtracting the background of the proton-induced gamma energy spectrum and taking the 
integral of a Gaussian fit of the respective peak. The neutron-induced 2.22 MeV count was 
retrieved in the same manner. 
5.4.1 Evaluating Geant4 Physics Lists: QGSP_BIC_HP and QGSP_BIC_AllHP 
In this section, the simulation-measurement data comparison with the water phantom 
using Geant4 version 10.06.p01 is presented. Figure 40 shows simulated energy spectra for total 
gamma, proton- and neutron-induced gamma rays in detector row 1 obtained with the 
QGSP_BIC_HP physics list. That is, as in Ref. [59], ‘detector row 0’ is labelled here as 
detectors 0-3 and ‘detector row 1’ as detectors 4-7. The figure shows the proton- and neutron-
induced components, which make up the total gamma spectrum. The prominent PG emission 
lines at 2.31 MeV (14N*), 3.93 MeV (12C*), 4.44 MeV (12C*), 5.21 MeV (15O*), 5.62 MeV 
(16O*) and 6.13 MeV (16O*) can be clearly seen. The 2.22 MeV line, arising from neutron 









Figure 40: Simulated energy spectra of total gamma, proton- and neutron-induced gamma rays in 
detector row 1 from the water phantom using Geant4 10.06.p01 and the QGSP_BIC_HP physics list. 
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Figure 41 shows the energy spectra of proton-induced gamma rays in detector row 1 
obtained from measurement and simulation using Geant4 physics lists QGSP_BIC_HP and 
QGSP_BIC_AllHP. The measured spectrum clearly showed the gamma emission lines, 
particularly the 3.93, 4.44, 5.21, 5.62 and 6.13 MeV lines. The relative intensities of measured 
gamma emission lines seemed to agree with evaluated nuclear cross section data [230], such 
that the intensity of lines from 16O are larger than those from 12C, followed by that from 15O. A 
peak at 2.22 MeV from neutron capture remained present in the measured spectrum, since only 
the neutron continuum was subtracted from the measured data, such that the neutron discrete 
lines (energy resolved) were stored in the same histogram as the proton discrete lines. The use 
of the PG ray timing information was utilised in the PGS technique to reduce the interference of 
neutron-induced gamma rays, as discussed in Sections 5.2 and 5.4. Due to the dominating 2.22 
MeV peak, the 2.31 MeV PG peak was barely visible in the measured spectrum, but could be 
seen in the simulated (using QGSP_BIC_HP) spectrum. 
The simulated spectrum obtained with QGSP_BIC_HP (Binary cascade) showed good 
agreement with the 3.93 and 4.44 MeV peaks, but significant underestimation of the higher 
energy PG emission lines, and slight overestimation of the lower energy region in the spectrum. 
The QGSP_BIC_AllHP (ParticleHP) physics list showed an overall better base shape agreement 
with the measured spectrum across the energy range, but does not reproduce the PG emission 
lines. Further developments are still being made for ParticleHP, with some reactions not fully 
described due to limited evaluated data or incomplete implementation of the model [250], and 









Figure 41: Energy spectra of proton-induced gamma rays in detector row 1 from the water phantom. The 
measured spectrum is shown with the simulated spectra using Geant4 (10.06.p01) physics lists 
QGSP_BIC_HP and QGSP_BIC_AllHP. 
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Figure 42 shows the measured and simulated neutron-induced gamma ray background 
curves from the water phantom for detector row 1, which indicate the contribution of neutron 
interference to the PG signal. The simulated background was seen to be significantly lower than 
the measured background. The simulated Count/GP/MeV around 4.44 MeV (1 MeV window) 
was a factor of ~5 lower than the measured count with QGSP_BIC_HP and factor of ~7 with 
QGSP_BIC_AllHP, while around 6.13 MeV (1 MeV window) the simulated count was a factor 
of ~5 and ~6 lower than the measured with QGSP_BIC_HP and QGSP_BIC_AllHP, 
respectively. The insert in the figure shows the measured data at 20%, to identify a possible 
correlation in the trend with the simulated plots; the largest differences were seen below ~3 
MeV. These discrepancies should be further investigated, but may be due to sources of neutrons 
and neutron scatter that have not been taken into account in the simulation, as well as biases in 
the subtraction algorithms applied to the data (the measured data were obtained with an 
empirical background subtraction algorithm, such that changing the parameters may result in 









Figure 42: Measured and simulated neutron-induced gamma ray background curves for detector row 1 
from the water phantom. The simulated plots were obtained using Geant4 (10.06.p01) physics lists 
QGSP_BIC_HP and QGSP_BIC_AllHP. The insert shows the measured plot at 20%, to identify a 
possible correlation in the trend with the simulated plots. 
 
Table 14 presents the quantitative data of the total gamma, proton- and neutron-induced 
gamma counts, comparing simulated with measured values. The total proton-induced gamma 
count obtained from the simulation showed good agreement with the measured value; within a 
factor of two different. Since rounding of the yields were done only taking into account 
statistical errors, and there are additional systematic errors on the measurements (due to bias in 
the background subtraction algorithm, etc) and in the simulation (uncertainties in the yields, 
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differences among the physics lists, etc), the factor of two different is considered a reasonable 
result. In contrast to the total proton-induced count, the total neutron-induced gamma count 
exhibits a greater discrepancy between simulated and measured results, underestimating the 
measured value within a factor of 10 different. The total gamma count was reproduced by the 
simulation within a factor of four, with the divergence perhaps due to the discrepancy in the 
neutron-induced count. Moreover, summing the proton- and neutron-induced gamma counts in 
Table 14 (also Tables 16 and 18) do not exactly add up to the total gamma counts since, as 
mentioned, the total neutron-induced gamma ray count does not include prompt neutron counts 
with discrete energy lines. 
Comparing the two Geant4 physics lists quantitatively, QGSP_BIC_HP was seen to 
deliver a better outcome. This may be due to QGSP_BIC_HP producing the gamma ray 
emission lines, whereas QGSP_BIC_AllHP does not, as seen in Figure 41. For example, for 
detector row 1, the simulated total proton-induced count is a factor of ~1.1 different to the 
measured count, while for QGSP_BIC_AllHP is a factor of ~1.4 different. 
Table 14: Total gamma, proton- and neutron-induced gamma counts in the energy range of 1.40-7.19 
MeV per giga-proton (GP) in the detector rows, obtained with Geant4 (10.06.p01) QGSP_BIC_HP and 
QGSP_BIC_AllHP physics lists, from proton beam irradiation of the water phantom. The total neutron-
induced count was taken as the background (it does not include prompt counts with discrete energy lines). 
Rounding of the counts was done only taking into account statistical errors. 
Data Detector row 
Total gamma 
count per GP 
Proton-induced 
gamma count per 
GP 
Neutron-induced 
gamma count per 
GP 
QGSP_BIC_HP 0 41000 26100 10500 
QGSP_BIC_AllHP 0 35300 21900 9700 
Measured 0 113600 32000 81500 
QGSP_BIC_HP 1 92100 63600 18000 
QGSP_BIC_AllHP 1 78400 52200 15300 
Measured 1 162300 70600 91700 
 
Table 15 presents the quantitative data of the gamma ray energy spectra peak intensities, 
comparing simulated with measured values. Binary cascade reproduced the proton-induced 4.44 
MeV PG emission line quite well (within a factor of ~1.5 for detector row 0, and ~1.1 for row 1), 
while significantly underestimating the 6.13 MeV PG peak (factor of ~15 for detector row 0, 
and ~4 for row 1). The proton-induced counts for QGSP_BIC_AllHP are omitted in Table 15, 
since this physics list does not reproduce the PG emission lines. 
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Both physics lists reproduce the neutron-induced 2.22 MeV line within a factor of two 
different to the measured data; NeutronHP data libraries are included in the modules to 
accurately model neutron interactions from thermal energies up to 20 MeV. As mentioned, 
experimentally, the measured data were obtained with an empirical background subtraction 
algorithm, such that changing the background subtraction parameters may result in slight 
variations in the measured data, and therefore may slightly bias the comparison. 
Table 15: Absolute counts per giga-proton (GP) for the proton-induced 4.44 and 6.13 MeV PG peaks, 
and the neutron-induced 2.22 MeV peak, obtained with Geant4 (10.06.p01) QGSP_BIC_HP and 
QGSP_BIC_AllHP physics lists, from proton beam irradiation of the water phantom. The proton-induced 
counts from QGSP_BIC_AllHP are omitted since this physics list does not reproduce those PG emission 
lines. Rounding of the counts was done only taking into account statistical errors. 
Data Detector row 
Proton-induced gamma 
count per GP 
        4.44                     6.13 
Neutron-induced gamma 
count per GP 
2.22 
QGSP_BIC_HP 0 200 30 1690 
QGSP_BIC_AllHP 0 - - 1650 
Measured 0 300 460 1380 
QGSP_BIC_HP 1 990 320 4340 
QGSP_BIC_AllHP 1 - - 4170 
Measured 1 1100 1160 3120 
 
5.4.2 Evaluating the Reproducibility of Oxygen and Carbon: Water and HDPE 
Here, the simulation-measurement data comparison for the HDPE phantom using 
Geant4 version 10.06.p01 is presented. Water is comprised of hydrogen and oxygen, while 
HDPE contains hydrogen and carbon, and so the ability for Monte Carlo to reproduce PG 
emission from oxygen and carbon elements can be investigated. 
Figure 43 shows the energy spectra of proton-induced gamma rays in detector row 1 
obtained from measurement and simulation. The measured spectra showed the gamma emission 
lines, particularly the 3.42, 3.93 and 4.44 MeV lines from 12C*. The 5.21, 5.62 and 6.13 MeV 
peaks that arise from oxygen, and were evident in the energy spectrum from the water phantom 
(Figure 41), do not appear in this spectrum since HDPE is not comprised of oxygen. The 
simulated spectra obtained with both physics lists showed relatively good agreement to the 
measured spectrum outside the region of the PG peaks (i.e. ~3-5 MeV), while QGSP_BIC_HP 
significantly underestimates the PG emission lines. In contrast, the 3.42, 3.93 and 4.44 MeV 
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peaks were reproduced quite well in the water phantom, from which the carbon nuclei were 
produced from proton reactions with oxygen. This may suggest that simulated gamma emissions 
from oxygen are more reliable than those from carbon, but for energies below ~5 MeV, since 









Figure 43: Energy spectra of proton-induced gamma rays in detector row 1 from the HDPE phantom. The 
measured spectrum is shown with the simulated spectra using Geant4 (10.06.p01) physics lists 
QGSP_BIC_HP and QGSP_BIC_AllHP. 
 
Figure 44 shows the measured and simulated neutron-induced gamma ray background 
curves from the HDPE phantom for detector row 1. The insert in the figure shows the measured 
data at 20%. Both magnitude and trend of the simulated plots differ significantly to the 
measured. The simulated Count/GP/MeV around 4.44 MeV (1 MeV window) was a factor of ~8 
lower than the measured count with both physics lists, while around 6.13 MeV (1 MeV window) 
the simulated count was a factor of ~9 and ~13 lower than the measured with QGSP_BIC_HP 
and QGSP_BIC_AllHP, respectively. The largest differences in the trend of the curves were 
seen below ~3 MeV and around 5 MeV. 
Tables 16 and 17 present the quantitative data of the total counts, and the gamma ray 
energy spectra peak intensities, comparing simulated with measured values. Similar to the data 
from the water phantom, the simulated total gamma count was seen to be within a factor of four 
different to the measured count, the total proton-induced count was within a factor of two 
different, and the total neutron-induced count within a factor of 10 different. The proton-
induced 4.44 MeV PG line obtained with QGSP_BIC_HP was within a factor of ~4.5 different 
to the measured count, which is a larger discrepancy than that for the water phantom (factor of 
~1.5 different). As for the water phantom, the 2.22 MeV neutron-induced counts were seen to 
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be within a factor of two different. Again, the proton-induced counts for QGSP_BIC_AllHP are 









Figure 44: Measured and simulated neutron-induced gamma ray background curves for detector row 1 
from the HDPE phantom. The simulated plots were obtained using Geant4 (10.06.p01) physics lists 
QGSP_BIC_HP and QGSP_BIC_AllHP. The insert shows the measured plot at 20%, to identify a 
possible correlation in the trend with the simulated plots. 
 
Table 16: Total gamma, proton- and neutron-induced gamma counts in the energy range of 1.40-7.19 
MeV per giga-proton (GP) in the detector rows, obtained with Geant4 (10.06.p01) QGSP_BIC_HP and 
QGSP_BIC_AllHP physics lists, from proton beam irradiation of the HDPE phantom. The total neutron-
induced count was taken as the background (it does not include prompt counts with discrete energy lines). 
Rounding of the counts was done only taking into account statistical errors. 
Data Detector row 
Total gamma 
count per GP 
Proton-induced 
gamma count per 
GP 
Neutron-induced 
gamma count per 
GP 
QGSP_BIC_HP 0 24800 15100 6800 
QGSP_BIC_AllHP 0 21500 12900 6600 
Measured 0 74700 13500 61200 
QGSP_BIC_HP 1 43600 28200 10100 
QGSP_BIC_AllHP 1 41300 27500 9000 
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Table 17: Absolute counts per giga-proton (GP) for the proton-induced 4.44 and 6.13 MeV PG peaks, 
and the neutron-induced 2.22 MeV peak, obtained with Geant4 (10.06.p01) QGSP_BIC_HP and 
QGSP_BIC_AllHP physics lists, from proton beam irradiation of the HDPE phantom. The proton-induced 
counts from QGSP_BIC_AllHP are omitted since this physics list does not reproduce those PG emission 
lines. Rounding of the counts was done only taking into account statistical errors. 
Data Detector row 
Proton-induced gamma 
count per GP 
4.44 
Neutron-induced gamma 
count per GP 
2.22 
QGSP_BIC_HP 0 140 820 
QGSP_BIC_AllHP 0 - 590 
Measured 0 610 880 
QGSP_BIC_HP 1 670 1950 
QGSP_BIC_AllHP 1 - 1650 
Measured 1 2130 2270 
 
5.4.3 Comparison of Geant4 Versions: 10.05.p01 and 10.06.p01 
In a study to determine the variation of outcomes from two different versions of Geant4, 
simulations were performed with the QGSP_BIC_HP physics list and with the water phantom. 
Figure 45 shows the proton-induced gamma ray energy spectra from Geant4 10.05.p01 and 
10.06.p01 with QGSP_BIC_HP physics list, along with the measured spectrum for comparison. 
In the lower energy region of the spectrum (below ~3.3 MeV), version 10.05.p01 was seen to 
better reproduce the measured data, where 10.06.p01 slightly overestimates. Both Geant4 
versions reproduced the 3.93 and 4.44 MeV emission lines well, but significantly underestimate 
the higher energy PG lines (above ~4.5 MeV). 
Tables 18 and 19 present the quantitative data of the total counts, and the gamma ray 
energy spectra peak intensities, comparing simulated with measured values. The Geant4 version 
10.05.p01 reproduced the measured total gamma count within a factor of ~3.3, whereas 
10.06.p01 reproduced the count within a factor of ~2.8. The total proton-induced count was 
reproduced better with 10.06.p01 than 10.05.p01, such that differences to the measured count 
were within a factor of ~1.2 and ~1.6, respectively. Both versions of Geant4 resulted in 
significant, within a factor of 10, underestimation of the total neutron-induced count. The 
proton-induced 4.44 MeV PG line was reproduced quite well by both versions, within a factor 
of ~1.3 with 10.05.p01 and ~1.5 with 10.06.p01, while the 6.13 MeV PG line was significantly 
underestimated. Again, the neutron-induced 2.22 MeV gamma line was within a factor of two 
different to the measured count. 










Figure 45: Energy spectra of proton-induced gamma rays in detector row 1 from the water phantom, 
using Geant4 versions 10.06.p01 and 10.05.p01 with the QGSP_BIC_HP physics list. The measured 
spectrum is also included for comparison. 
 
Table 18: Total gamma, proton- and neutron-induced gamma counts in the energy range of 1.40-7.19 
MeV per giga-proton (GP) in the detector rows, obtained with Geant4 (10.05.p01) QGSP_BIC_HP 
physics list, from proton beam irradiation of the water phantom. The total neutron-induced count was 
taken as the background (it does not include prompt counts with discrete energy lines). Rounding of the 
counts was done only taking into account statistical errors. Data from version 10.06.p01 (Table 14) are 
also added for comparison. 
Data Detector row 
Total gamma 
count per GP 
Proton-induced 
gamma count per 
GP 
Neutron-induced 
gamma count per 
GP 
10.05.p01 0 34000 20600 9500 
10.06.p01 0 41000 26100 10500 
Measured 0 113600 32000 81500 
10.05.p01 1 73100 47200 16000 
10.06.p01 1 92100 63600 18000 
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Table 19: Absolute counts per giga-proton (GP) for the proton-induced 4.44 and 6.13 MeV PG peaks, 
and the neutron-induced 2.22 MeV peak, obtained with Geant4 (10.05.p01) QGSP_BIC_HP physics list, 
from proton beam irradiation of the water phantom. Rounding of the counts was done only taking into 
account statistical errors. Data from version 10.06.p01 (Table 15) are also added for comparison. 
Data Detector row 
Proton-induced gamma 
count per GP 
        4.44                    6.13 
Neutron-induced gamma 
count per GP 
2.22 
10.05.p01 0 270 10 1560 
10.06.p01 0 200 30 1690 
Measured 0 300 460 1380 
10.05.p01 1 1390 120 4090 
10.06.p01 1 990 320 4340 
Measured 1 1100 1160 3120 
 
5.5 Discussion 
In this study, TOPAS was used to model the MGH PGS detection system, proton beam 
and phantom. Simulated and measured data were quantitatively compared in terms of the 
intensity of selected gamma emission peaks to determine the performance of Monte Carlo codes 
for PG ray simulations. ParticleHP showed an overall better base shape agreement with the 
measured proton-induced gamma ray spectrum across the energy range of interest (1-7 MeV), 
but it does not reproduce the PG emission lines. Binary cascade, although underestimated the 
PG emission lines above ~5 MeV, reproduced the 4.44 MeV PG line within a factor of ~1.1 (for 
detector row 1, from the water phantom). QGSP_BIC_AllHP is an experimental physics list 
which requires further work and validations, unlike QGSP_BIC_HP which has been developed 
and validated extensively. Some reactions are not fully described in ParticleHP due to limited 
evaluated data and implementation of the model is incomplete [250]. With further developments 
and improvements, ParticleHP could potentially be a suitable choice for simulating PG rays and 
associated detection systems. In the meantime, Binary cascade is a suitable choice, as it 
reproduces the gamma emission intensities around 4 MeV well, but for higher energy emissions 
the models need further improvement. 
The simulated gamma ray energy spectra also showed characteristic differences 
between the water and HDPE phantoms. Data from the water phantom showed a better 
quantitative correlation, particularly in terms of the proton-induced PG emission line intensities. 
For example, the 4.44 MeV PG line obtained with QGSP_BIC_HP was within a factor of ~1.5 
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different to the measured count for the water phantom, and factor of ~4.5 different for the 
HDPE phantom. The 3.42, 3.93 and 4.44 MeV gamma ray peaks from 12C* were present in the 
spectra from both phantoms and reproduced better for the water phantom (see Figure 41) than 
the HDPE phantom (see Figure 43). This may suggest that gamma emissions from oxygen are 
more reliably reproduced than those from carbon. With further improvements to the models to 
achieve superior reproducibility of simulated to measured data, the composition of irradiated 
tissue could be predicted prior to measurement by means of PG spectroscopy. 
Additionally, Geant4 versions 10.05.p01 and 10.06.p01 were compared for the case of 
the water phantom to observe the differences between various versions of the Monte Carlo 
toolkit. The main variation between the two versions was seen at energies below ~3.3 MeV and 
above ~4.5 MeV, while the simulated intensities of PG rays around 4 MeV were in good 
agreement with the measurement. That is, the 4.44 MeV PG line agreed with the measured data 
within a factor of ~1.3 with version 10.05.p01 and ~1.5 with 10.06.p01. These variations may 
be due to differences in the nuclear reaction data of the particular version, such that the 
parameters of models used to calculate the nuclear cross sections are generally tuned for 
different releases of Geant4. 
High precision (HP) physics modules accurately model neutron interactions from 
thermal energies up to around 20 MeV. In this study, the simulation was seen to overestimate 
the 2.22 MeV neutron capture gamma ray peak from proton irradiation of the water phantom, 
within a factor of two different to the measured value, but significantly underestimate (within a 
factor of 10) the total neutron-induced gamma count. Generally, the number of neutrons 
captured in the target will be dependent on the energy distribution of created neutrons produced 
by the model, as well as the angular distribution and scattering accuracy of the models. The 
neutron-induced gamma count then depends on the accuracy of the PG distributions when the 
nucleus de-excites. Another factor to consider in modelling PG detection systems is the 
contribution of neutrons in an unwanted background gamma signal. In particle therapy, there are 
several sources of neutron production and scatter: components of the gantry, collimator, 
phantom, patient table, floor and walls, etc. 
A simulation was performed testing the theory that the absence of the treatment room 
walls may play a role in the discrepancies seen for neutron-induced counts between simulated 
and measured data. The MGH treatment room walls [254] were modelled as concrete, taken as 
the NIST composition, density of 2.3 g/cm3, as also used in Ref. [255]. The simulation retrieved 
the neutron-induced counts from the water phantom, with Geant4 version 10.06.p01 and 
QGSP_BIC_HP physics list. The data were compared to the case in which the treatment room 
walls were not modelled (Tables 14-15), and it was found that the data differed within 3% only. 
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This suggests that perhaps the treatment room walls have a minor impact on the background 
signal arising from neutrons, whereas a greater impact may be present from other sources of 
neutrons/scatter that are in closer proximity to the detection system, particularly the beam 
delivery nozzle, collimator and phantom. Hence, future PG simulations may benefit from taking 
into account these close-distance sources of neutrons and neutron scatter, to more accurately 
determine the influence on the PG signal. 
It should also be noted that the results shown in this study only apply to the TOPAS and 
Geant4 versions studied. That is, depending on which version of Geant4 is used, the results can 
vary significantly, particularly for nuclear reaction data, as this is a domain of on-going 
improvement in Geant4. As well, rounding of the yields was done only taking into account 
statistical errors. Yet there are additional systematic errors on the experimental measurements 
(due to bias in the background subtraction algorithm, etc) and in the simulations (uncertainties 
in the yields, differences among the physics lists, etc). 
The MGH PGS prototype detection system has demonstrated that hybrid PG detection 
from simultaneous energy- and time-resolved spectral measurements can provide superior beam 
range verification in realistic clinical conditions [59]. The remaining challenges are to explore 
clinical integration with treatment systems and practices. 
In practice, Monte Carlo simulations could be used to generate PG distributions for real 
patient data obtained from CT scans of the patient, such that the PG data would be integrated 
into the TPS. The detection system would also be modelled, including the geometry and 
composition of the scintillators, collimators (if employed), etc, to predict the PG ray detection. 
Deviations from the prescribed treatment plan could then be determined by comparing the 
measured PG data with pre-calculated ones. Yet, this implies that the Monte Carlo codes 
providing the reference are indeed accurate. Although the PG energy lines are modelled well, 
the yields require further improvements. As seen in this study, simulated PG emission peak 
intensities as well as the background neutron contributions varied significantly from the 
measured data. Hence, the nuclear models and cross section data need improvement, with 
experimental data and extensive validations. Modelling the full treatment room could offer a 
better indication of the background contributions, but this may lead to long compute times. 
Accelerated Monte Carlo simulations are beneficial for the high patient throughput and real-
time monitoring. Overcoming these limitations could see Monte Carlo codes advancing PG ray 
beam monitoring in clinical applications, by having a solid reference for comparing the 






The research effort of this thesis was focused on PG detection methodology and 
technology from in vivo range verification towards non-invasive in vivo dosimetry for high-
precision charged particle therapy. The ultimate goal is to pave an effective pathway in the 
development of clinically applicable and reliable PG detectors and procedures, which can 
further improve cancer treatment precision and release the full clinical efficacy of particle 
therapy. Three major aspects were investigated in this work: (i) systematic simulation studies of 
PG emission and detection characteristics in energy, space and time dimensions (Chapter 3). 
This has led to a proposal for hybrid PG detection to utilise multi-features of PG characteristics 
for enhanced beam range extraction. (ii) Characterisation of commercially available advanced 
scintillation crystals to explore suitable high-performance detectors for energy- and time-
resolved PG ray measurements towards potential hybrid PG detection systems (Chapter 4). (iii) 
Evaluation of the performance of Geant4-based Monte Carlo simulation predictions with the 
experimental data from MGH’s PGS system (Chapter 5). This was the first comprehensive 
evaluation study regarding the PG signal along with interference backgrounds in a realistic 
clinical condition. This work provides valuable information on Geant4 physics capability to 
investigate PG detection systems and predict outcomes for comparison to measured data to 
determine deviations from the prescribed treatment plan. 
The PG emission characteristics from water, PMMA and adipose tissue targets, in either 
sphere or cylinder phantoms irradiated with three different particle types (proton, 4He and 12C) 
of varying beam energies, have been investigated using Geant4 simulations and presented in 
Chapter 3 of this thesis. The PG production yield, energy spectral characteristics and spatial 
correlation with the BP have been quantified [217,231]. The results of this work showed that the 
PG signal is a reliable means for in vivo BP tracking in particle therapy, particularly the primary 
PG rays generated from the incident particles. In this case, the closest correlation between the 
PG emission yield and particle beam range was found. The characteristic energy and spatial PG 
emission results for proton and carbon ion beams agreed with prior published results 
[57,140,150]. However, the concurrent secondary PG rays may impose a greater challenge for 
BP tracking in heavy-ion therapy, such as carbon ions, where secondary PG rays become 
dominant. The effects of target inhomogeneities were seen on the PG production distribution in 
relation to the beam crossing the various materials of the phantom, but the quantitative data 




The detectable PG characteristics have been investigated by virtue of an air-filled 
idealised detecting sphere encompassing the phantoms. The spatial and temporal properties 
regarding PG propagation to the detecting sphere have been characterised with changing beam 
ranges. Several important points were found in this study: 
(i) Energy- and time-resolved PG detections would be essential for high-precision BP 
tracking. The PG time properties can be utilised not only for interference 
background rejection but also for beam range extraction. The PG TOF encodes the 
essential information of the beam range but needs high time resolution 
measurements to retrieve it. 
(ii) A non-isotropic longitudinal distribution of the detected PG rays was observed and 
showed a changing angular propagation distribution with beam energy. This may 
suggest that a movable PG detector coordinated with respect to the beam range 
could serve to optimise the detection efficiency of PG rays. 
(iii) The geometric size and shape of phantoms also exhibit a considerable effect on the 
angular distribution. This indicates that the attenuation, absorption and scatter of 
PG rays inside the phantom are factors which should be taken into account in the 
development of quantitative in vivo range and dosimetry verifications. 
(iv) Hybrid PG detection systems, to utilise the energy, timing and spatial 
characteristics of PG rays, is highly desirable for BP tracking in real-time. 
This work has provided a solid basis for further PG system design. 
The energy- and time-resolved spectroscopy capabilities of several scintillation 
detectors were also characterised in this work to determine a suitable choice for high-throughput 
and highly efficient hybrid PG ray systems. Presented in Chapter 4 of this thesis, LaBr3(Ce), 
LaCl3(Ce), NaI(Tl), CeBr3, SrI2(Eu), CLYC and CLLBC scintillators were studied in terms of 
rise/decay times, energy resolution and intrinsic peak detection efficiency. LaBr3(Ce) and 
LaCl3(Ce) scintillators were coupled to a PMT, whereas the others were coupled to a SiPM, 
while LaBr3(Ce) and LaCl3(Ce) were also studied with and without a built-in charge sensitive 
preamplifier. Comparable traits were seen when using a PMT or SiPM, and the inclusion or 
absence of a preamplifier. Although the preamplifier is generally best suited for spectroscopy 
applications and to improve the system energy resolution, this study showed that its inclusion 
worsens the timing properties. Yet it is crucial that, for hybrid PG detection systems, both 
energy and timing capabilities are optimised without a trade-off between the two features. The 
results in this work could therefore offer beneficial information for the development of hybrid 
PG detection systems. 
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The results showed that LaBr3(Ce), without a built-in charge sensitive preamplifier, is 
an excellent choice for PG measurements due to its superior timing (34 ns rise time and 790 ns 
decay time) and energy resolution (3.5% at 662 keV). Other studies have also shown the 
potential of LaBr3(Ce), which has been utilised in several PG beam range verification studies 
[173,232], including the PGS measurements performed at MGH [59,170]. Furthermore, 
elpasolite crystals such as CLYC and CLLBC have not yet been studied for the purpose of 
range monitoring in particle therapy using PG rays. They have the added ability of gamma-
neutron discrimination, and therefore have the potential for hybrid systems utilising PG energy 
and time information in addition to simultaneous neutron discrimination. CLLBC detectors of 
various sizes were also studied, and it was seen that those of smaller crystal size produced a 
faster signal compared to those with larger crystal. Among those studied, CLYC was also seen 
to offer a good energy resolution of 3.4% at 662 keV.  
A comparison study between simulated and measured gamma emission peak intensities 
was carried out to determine the performance of Monte Carlo codes for PG ray simulations in 
research and clinical applications. This study is presented in Chapter 5 of this thesis. TOPAS 
was used to model the MGH PGS detection system, proton beam and phantom. Two Geant4 
physics lists, QGSP_BIC_HP and QGSP_BIC_AllHP, were investigated with Geant4 version 
10.06.p01. Two phantom materials, water and HDPE, were also explored to determine the 
simulation reproducibility for oxygen and carbon elements, respectively. The simulations were 
repeated for Geant4 version 10.05.p01 for regression testing purposes. The total gamma, proton- 
and neutron-induced counts, as well as PG emission lines 4.44 and 6.13 MeV, were analysed 
and quantitatively compared for a specific proton pencil beam spot. 
Several important points are highlighted from this study: 
(i) The QGSP_BIC_HP physics list underestimates the higher energy (above ~5 
MeV) PG emission lines, whereas QGSP_BIC_AllHP showed an overall better 
base shape agreement across the energy spectrum but does not reproduce the 
PG emission peaks. Therefore, this work showed that QGSP_BIC_HP is 
currently more suitable, as it reproduces the gamma emission intensities around 
4 MeV quite well, e.g. the 4.44 MeV PG line agreed with the measured count 
within a factor of two for the case of the water phantom, but for higher energy 
emissions the models need further improvement. 
(ii) Data from the water phantom showed a better quantitative correlation, 
particularly in terms of the proton-induced PG emission line intensities. This 
may suggest that simulated gamma emissions from oxygen are more reliably 
reproduced than those from carbon. Also, simulated gamma ray energy spectra 
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showed characteristic differences between water and HDPE; with further 
improvements to the models, the composition of irradiated tissue could be 
predicted and determined by means of PG spectroscopy. 
(iii) The simulation overestimated the 2.22 MeV neutron capture peak in the gamma 
energy spectra from the water phantom within a factor of two compared with 
the measured data, but significantly underestimated (within a factor of 10) the 
total neutron-induced gamma count. This may be due to various factors, 
including sources of neutrons and unwanted background signal. Yet a 
difference of only 3% in the neutron-induced counts was seen when comparing 
simulated data with and without modelling the MGH treatment room walls. 
This suggests that future PG ray simulations may benefit from taking into 
account potential neutron sources in closer proximity to the measuring device, 
to more accurately predict the PG signal. 
(iv) The comparison of the simulation results obtained with Geant4 versions 
10.05.p01 and 10.06.p01 showed differences at energies below ~3.3 MeV and 
above ~4.5 MeV, while the simulated intensities of PG rays around 4 MeV 
were in good agreement with the measurement. That is, the 4.44 MeV PG line 
agreed with the measured data within a factor of ~1.3 with version 10.05.p01 
and ~1.5 with 10.06.p01. Thus, simulation results can greatly depend on the 
Geant4 version utilised and it is therefore recommended to perform regression 
testing on some physical observables among different versions of Geant4, 
including the latest one. 
The novelty of this project is such that it combines several areas of research to improve 
the PG detection methodology, detector technology and simulation resources for non-invasive 
real-time beam range monitoring in particle therapy. The characteristic properties of PG 
emission and detection have been investigated for not only proton and carbon beam irradiation, 
but also helium ions for which the PG distributions have not yet been widely studied. The 
results showed that there is the opportunity to optimise the strategy for PG detection and 
improve image formation with optimal energy, angular and TOF windows. Hence, combining 
space, energy and time methods could be utilised to improve the PG signal for range/dose 
monitoring. As well, several scintillators were characterised in terms of energy and timing 
properties for potential hybrid PG systems. To the authors’ knowledge, elpasolite scintillation 
crystals have not yet been studied for the purpose of PG range monitoring in particle therapy, 
and therefore the results obtained here could also be beneficial to other groups. Moreover, a 
quantitative comparison study of Monte Carlo simulation data with experimental measurements 
conducted in a particle therapy facility was performed. Binary cascade was seen to reproduce 
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the measured data well, but the models need further improvement, particularly if PG 
spectroscopy is to be utilised for determining target material compositions, and in turn, 
exploited for in vivo dosimetry. 
The PGS prototype detection system developed at MGH demonstrates the possibility of 
hybrid PG detection from simultaneous energy- and time-resolved spectral measurements with 
clinical proton beams, but challenges remain for its integration with clinical treatment systems 
and practices. As well, utilising both energy and time characteristics for the purpose of range 
verification, in addition to neutron background rejection, is worth further exploration. Superior 
detectors and data acquisition offering excellent energy and time resolutions simultaneously are 
desired, as well as the ability to cope with the beam time structure and accurately synchronise 
with the accelerator RF. Reliable Monte Carlo codes are also important, as they would provide 
the reference for which the measured data would be compared. The PG data and detection 
system would be incorporated into the TPS to obtain the predicted outcomes, with accelerated 
simulations beneficial for the high patient throughput and real-time monitoring. Yet the nuclear 
models and cross section data require further improvement, with experimental data and 
extensive validations. 
Hence, this thesis work will aid in developing optimal PG detection strategies and 
support the implementation of clinically feasible PG systems for improving cancer treatment 
QA. Further studies investigating the scintillator performance for high-energy PG rays through 
measurements, and in clinical conditions, will be valuable for the development of high-
resolution and high-performance novel detector systems with fast electronics and high-
throughput processing. Future work will focus on the acquisition system and implementation of 
a hybrid PG detection system that utilises the energy- and time-resolved information, which is 





Appendix 1 – Previous Publication 
 
In Chapter 3, I referred to my previous publication, Zarifi et al. (2017) [231], which I 
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